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UTILIZING COMPUTED TOMOGRAPHY IMAGE FEATURES TO ADVANCE PREDICTION OF RADIATION
PNEUMONITIS
Shane Paul Krafft, B.S., P.S.M.
Advisory Professor: Mary K. Martel, Ph.D.
Improving outcomes for non‐small‐cell lung cancer patients treated with radiation therapy (RT)
requires optimizing the balance between local tumor control and risk of normal tissue toxicity. In
approximately 20% of patients, severe acute symptomatic lung toxicity, termed radiation pneumonitis
(RP), still occurs. Identifying the individuals at risk of RP prior to or early during treatment offers
tremendous potential to improve RT by providing the physician with information to assist in making
clinical decisions that enhance therapy. Our central goal for this work was to demonstrate the potential
gain in predictive accuracy of normal tissue complication probability models for RP by considering CT‐
based image features extracted from the normal lung volume.
To accomplish this, a software framework was first built to facilitate CT image feature extraction using
multiple image analysis methods. Subsequently, we applied the implemented methods towards
understanding the temporal change in the normal lung volume during treatment. After identifying a
subset of highly reproducible and non‐redundant image features, we investigated change in lung
features on weekly CT image sets acquired during treatment. While multiple features exhibited
significant association with dose, no temporal response was identified and we were unable to produce
a predictive model that could outperform simple treatment‐related factors.
CT‐based image features calculated in regional subvolumes and on a voxel‐wise basis in the normal
lung were explored in the context of RP incidence. There was no clear spatial variation in the considered
regionally extracted features or voxel‐based feature maps. However, a limited subset of features were
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significantly associated with RP which may be a useful finding to consider in development of predictive
models to assess toxicity risk.
We also considered the utility of pre‐treatment total normal lung CT features for predicting RP using
LASSO logistic regression and were able to successfully demonstrate improved discrimination of RP
using such features relative to models constructed with clinical and dosimetric variables only. This is a
significant step towards building robust models of RP with image based features that can subsequently
be used to achieve personalized RT.
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CHAPTER 1: INTRODUCTION
Standard of care for patients with locally advanced non‐small‐cell lung cancer (NSCLC) is combined
chemotherapy and radiation therapy (RT). The use of RT in the treatment of stage I and II disease has
also become a viable alternative to surgical resection, particularly in patients with inoperable disease
stemming from poor cardiopulmonary function [1]. As RT is commonly utilized for treatment of NSCLC
and other thoracic cancers, it is vital to know a safe and efficacious dose that can be delivered to limit
severe radiation‐induced toxicity and provide adequate local control. For NSCLC patients treated with
RT the risk of developing severe radiation‐induced lung damage (RILD) is the major toxicity concern.
The acute symptomatic presentation of RILD is known as radiation pneumonitis (RP). Resulting from an
early inflammatory process, RP is typically manifested within 10 months [2] after RT, but most patients
who develop the toxicity present within 1 to 3 months following treatment [3]. RP symptoms can
include dyspnea, mild cough, and fever. Medical intervention in the form of steroids or oxygen is
common in patients experiencing severe RP. Without such interventions, RP progression can result in
hospitalization, ventilatory support, or death. While severe RP is of concern, even subclinical RILD often
results in radiographic changes and/or reduced cardiopulmonary function, contributing to reduced
quality of life for the patient.
The incidence of RP has been reported to occur in as much as 50% of patients [2]. However, with
current RT modalities, symptomatic RP occurs in approximately 10‐20% of the population treated for
locally advanced disease. Much of the challenge in defining the rate of RP is in establishing objective
scoring criteria. Ordinal scoring systems have been developed by multiple groups to define RP severity
on a scale of 1 to 5. Table 1 illustrates one such scoring system suggested by the National Cancer
Institute, the Common Toxicity Criteria for Adverse Events (CTCAE) v3.0 [4]. Consistent use of such a
scoring system is difficult across institutions and between clinicians as symptoms of RP are frequently
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non‐specific due to confounding comorbidities. A further complication stems from the inclusion of
medical intervention in the scoring rubric, which implicitly introduces the physician preferences (e.g.
administration of steroids or oxygen) into the process. While CTCAE is the most commonly used scoring
system for RP, other groups including the Radiation Therapy Oncology Group (RTOG) and Southwest
Oncology Group (SWOG) have proposed similar systems adopted by different institutions. This
complicates the search to identify objective measures of RP response and makes identification of
consistent parameters for RP risk assessment difficult to determine.
Table 1. Common toxicity criteria for adverse events v3.0 [4] scoring rubric for pneumonitis.
Grade Description
1

Asymptomatic, radiographic findings only

2

Symptomatic, not interfering with activities of daily living (ADL)

3

Symptomatic, interfering with ADL; oxygen indicated

4

Life‐threatening; ventilatory support indicated

5

Death

While dose to the normal lung volume is the primary driver of RILD, achieving optimal balance between
toxicity risk and probability of tumor control is the main challenge of RT. Even with current clinical
standards, 10‐20% of patients experience RP. Additionally, multiple studies have indicated improved
local control and overall survival is possible with higher dose delivered to the tumor volume [5–10].
Some individuals may benefit from increased dose without substantial risk of RP, while others may
require decreased dose to limit severe RP. Personalizing RT treatment accordingly can produce
substantial clinical benefit.
Accurate prediction of toxicity can assist in minimizing incidence and optimization of the therapeutic
ratio. Specifically, toxicity prediction has been extensively studied in the literature with the bulk of it
centered on identifying dose‐volume correlates of normal tissue response. The first comprehensive
effort to provide guidance on the risk of normal tissue toxicity was by Emami et al [11]. They estimated
the complication probabilities of uniform irradiation to total and partial organ volumes on the basis of

3
clinical experience. Using a compilation of clinical tolerance data, normal tissue complication
probability (NTCP) could be estimated using a model suggested by Lyman [12,13]. This model was later
extended by Kutcher and Burman to consider non‐uniform irradiation of normal organ volumes giving
rise to the Lyman‐Kutcher‐Burman NTCP model [14,15].
The LKB model is widely used for determining NTCP for RP, but more simplistic single parameter
"models" have found a foothold in assisting with clinical decisions. For instance, the most frequently
used parameters to assess RP risk are based on simple dose‐volume metrics [2] including mean lung
dose (MLD) and the volume of the lung receiving greater than a threshold dose (e.g. volume

20Gy,

). Often, decisions based on treatment plan quality are made on the basis of these and other
dosimetric indices. While such simple dosimetric parameters are useful for treatment plan comparison,
they are of limited predictive value [16]. Successful incorporation of added patient‐specific data is
necessary to provide more accurate and personalized estimates of complication risk [17,18].
While dose and the irradiated volume are the most frequently considered parameters influencing
NTCP, clinical, treatment, functional, and/or genetic information are additional categories of data
reported to affect risk. Age, sex, smoking status, tumor location, surgery, pulmonary comorbidity,
chemotherapy, single nucleotide polymorphisms (SNPs), and inflammatory cytokines have all been
considered as potential non‐dosimetric risk factors [19,20]. Despite the wealth of data that has been
considered for RP prediction, findings are often imprecise and inconsistent due to small sample size
[19], inappropriate statistical evaluation [21], and/or difficulty with endpoint definition [22].
As the number of candidate variables related to lung toxicity increases, analysis using traditional
modeling techniques has become impractical. While the LKB model has been adapted to incorporate a
limited number of potential RP risk factors [23], dose‐response prediction has recently taken a data‐
driven (or data mining) approach [24,25]. As a consequence, multivariable logistic regression models
are being increasingly utilized to incorporate a wide range of factors for RP prediction [26–28]. Still, the
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capability of these models is limited by their inability to handle analysis of high‐dimensional datasets
(predictors >> observations) or to probe complex, nonlinear interactions between predictive variables
and outcome [29]. As a result, statistical (or machine) learning [30] approaches have been considered
for normal tissue toxicity prediction [31] and provide potential to identify meaningful patterns in data
to improve prediction accuracy.
Particularly in the era of precision medicine, accurate prediction of outcomes is a necessary tool to
support clinical decisions [32,33]. Not only are new approaches for modeling necessary, but diverse
categories of high‐quality data are also needed. In particular, imaging has and will continue to play an
important role for assessment of radiation‐induced normal tissue toxicities [34], particularly in the lung.
The spatial and temporal heterogeneity of the lung volume makes both anatomical and functional
imaging well‐suited for understanding and quantifying RILD progression and risks.
In particular, post‐RT imaging of the lung volume provides the potential to identify RP before the onset
of symptoms. Additionally, assessment via imaging methods can serve as quantitative measures of
severity that overcome limitations with ordinal grading scales. Accordingly, imaging in the context of
RILD assessment has been widely investigated. Multiple imaging modalities have been used to identify
lung changes indicative of RILD after conventionally‐fractionated RT. Chest X‐ray [35,36], SPECT [37,38],
MRI [39], FDG‐PET [40,41], and 4‐dimensional computed tomography (4D‐CT) based ventilation [42]
have been employed to measure changes in the lung after therapy. Diagnostic quality CT is the most
widely considered method for RP assessment [43–53]. Despite the abundance of resources devoted to
identifying an imaging assay useful for RILD quantification, there is no accepted standard. Furthermore,
successful association of imaging assessment to clinically relevant symptoms is sparse.
Beyond post‐RT assessment, there is substantial advantage to identifying image characteristics that
may correlate with symptomatic RILD during or before treatment. SPECT perfusion studies have been
used to identify functional areas of the lung which may be more vulnerable to damage for NSCLC
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patients treated with RT [54–57]. Pre‐RT FDG‐PET studies have also been used to localize areas of lung
more susceptible to injury [58,59]. De Ruysscher et al. [60] found an increase in FDG‐PET
uptake during RT correlates to symptomatic lung toxicity. The use of 4D‐CT based ventilation has also
been investigated during RT [61], though no consistent change in ventilation has been discovered.
Vinogradskiy et al. [62] considered the interaction of dose with 4D‐CT ventilation but failed to identify
a significant correlation to RP. Bertelsen et al. [63] demonstrated early, dose‐dependent changes in
lung density on serial cone‐beam CT scans that subsequently have been related to post‐RT lung CT
density [64]; however, no link to clinical lung toxicity has been noted.
The impact of pre‐existing interstitial lung disease (ILD) [65,66] and chronic obstructive pulmonary
disease (COPD) [67,68] on RP risk have been assessed via CT imaging. Makimoto et al. [65] suggested
that pre‐existing lung changes assessed on CT or plain chest films may predict for symptomatic RP in
patients treated with thoracic RT. Sanuki et al. [66] similarly demonstrated that pre‐existing pulmonary
changes on CT judged by a panel of radiologists was significantly associated with RP grade

3 in

patients treated with conventionally fractionated thoracic RT. Visual classification of severe pulmonary
emphysema by radiologists using low attenuation areas (LAAs) on CT was significantly associated with
higher incidence of RP by Kimura et al. [67]. However, assessing the severity of lung disease using
observer studies is still subjective and does not sufficiently capture the variation across the lung volume
or between patients. Given that there is evidence that application of CT lung imaging may relate to RP,
improved methods for lung analysis should be considered in this context.
Fortunately, outside of the radiation oncology community, quantitative analysis of lung parenchymal
changes using CT has been widely investigated as means to describe the morphology and understand
the mechanisms of lung disease [69–78]. Particularly in the context of interstitial and obstructive lung
diseases, lung densitometry and texture analysis methods have been applied for differentiation of lung
phenotypes that might assist in early diagnosis and understanding of pathogenesis. Furthermore, new,
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high‐throughput methods of image analysis are being employed to extract more information from
medical images. Recently, Cunliffe et al. considered some of these methods for correlation with visually
scored severity of lung changes [79] and development of symptomatic radiation pneumonitis after RT
[80]. This field of research, referred to as radiomics, has significant potential to provide high‐quality
descriptors that may be useful with advanced modeling methods to significantly improve our ability to
predict RP.

Purpose and Central Hypothesis
In the design and optimization of radiation therapy (RT) treatment plans, it is vital to balance the risk
of normal tissue toxicity against peak tumor control. This, however, is challenging as individual patients
differ in their response to radiation ‐‐‐ some may be more radioresistant, requiring an escalated dose
to achieve acceptable tumor control while others may be more radiosensitive, necessitating a lower
dose to limit toxicity. Currently, approximately 10‐20% of patients treated with standard of care RT for
non‐small‐cell lung cancer experience severe acute radiation‐induced lung damage. Symptomatically
this injury is manifested as radiation pneumonitis and is considered a significant issue for lung cancer
patients. RP may necessitate the administration of oxygen or steroids and can be lethal if progression
occurs without intervention. Normal tissue complication probability models of lung toxicity can provide
an estimate of RP risk and can be used before treatment to guide selection of the prescribed radiation
dose and limit severe lung damage. While numerous patient and treatment‐related characteristics
have been used in these models, they have limited clinical applicability due to poor predictive
performance.
In the presented research, I have leveraged a different class of data ‐ computed tomography‐based
image features ‐ as means of improving our understanding of and ability to predict RP. Over the past
decade the role of CT imaging in the treatment of cancer has migrated from being primarily used as a
diagnostic tool and is now seen as a means to provide information that complements clinical,
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pathologic, and genomic data. Extraction of image features from CT datasets provides potential to
better understand progression and risk of lung damage on a patient‐specific basis. At present, lung
cancer poses a major problem to public health. The presented research methodologies have the
potential to significantly improve patient outcomes by identifying personalized risk of treatment
related toxicity.
The long‐term goal is to advance personalized radiation therapy for NSCLC patients by improving the
accuracy of NTCP models for predicting radiation pneumonitis risk. The objective of this project was to
identify quantitative image features which will discern the spatial and temporal differences in the lung
that influence the baseline risk of radiation‐induced lung damage.
Our central hypothesis is that CT‐based quantitative image features can be incorporated into NTCP
models to significantly improve prediction of radiation pneumonitis.

Specific Aims
The specific aims of my research and the related studies are stated below:
Specific Aim 1: To detect and quantify the time and dose related response of normal lung tissue during
radiation therapy using CT image features.
Working Hypothesis: The time and dose related progression of radiation‐induced lung damage can be
detected by using CT image features extracted from 4‐dimensional CT (4D‐CT) studies acquired during
radiation therapy.
•

Study 1.1: Characterizing radiomics features for analysis of 4‐dimensional CT images in the normal
lung

•

Study 1.2: Time and dose related response of normal lung CT image features during radiation
therapy for non‐small‐cell lung cancer
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Specific Aim 2: To determine the relationship between the incidence of radiation pneumonitis and the
spatial distribution of both dose and CT image features.
Working Hypothesis: Investigation of the spatial dose distribution and CT image analysis can be used to
understand and localize regions of the lung that are more susceptible to injury.
•

Study 2.1: Quantifying CT radiomics features in regionally‐defined subvolumes of the normal lung

•

Study 2.2: Investigation of the relationship between radiation pneumonitis and the spatial
differences in CT‐based lung radiomics features

Specific Aim 3: To incorporate CT image features into dose response modeling of radiation pneumonitis.
Working Hypothesis: The accuracy of radiation pneumonitis risk models can be significantly improved
by incorporating image features extracted from CT studies.
•

Study 3.1: Incorporation of CT lung radiomics feature distributions in predictive modeling of
radiation pneumonitis

•

Study 3.2: The utility of quantitative CT radiomics features for improved prediction of radiation
pneumonitis
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CHAPTER 2: DEVELOPING A FRAMEWORK FOR EXTRACTION OF CT
IMAGE FEATURES IN A RADIATION ONCOLOGY ENVIRONMENT
INTRODUCTION
Imaging is a routine and increasingly important aspect of medical care in the era of precision medicine.
Having evolved from being primarily used for diagnostic purposes, medical imaging plays a central role
in defining prognosis, monitoring disease progression, screening, treatment planning and guidance,
and assessment of therapeutic interventions. An already abundant and growing number of imaging
technologies can provide anatomical, functional, and molecular information to non‐invasively probe
the spatial and temporal heterogeneities that are present in the underlying disease of an individual
[81].
With the wealth of imaging studies now being conducted, medical image analysis has grown rapidly as
means to improve clinical decision making [32,33,82,83]. In particular, the field of radiomics involves
the extraction and analysis of large numbers of advanced quantitative features from medical image
data [83–85]. Inspired by the "omics" revolution (i.e. genomics, proteomics, metabolomics), data
gathered from a variety of imaging modalities are being routinely mined and analyzed to aid clinicians
[83]. Though much of the methodology is similar, radiomics is distinct from more narrowly defined
computer‐aided diagnosis (CAD) systems typically designed to solve one specific diagnostic task [83].
As a result, radiomics is being applied to study a multitude of disease sites and interventions [83].
At its core, the radiomics hypothesis is that the quantifiable structure of an imaged volume of interest
reflects its underlying physiology and pathology [81,84]. In turn, this can provide information that may
be useful for diagnosis, prognosis, or prediction. The term "radiomics" has been popularized in the
oncology community in recent years where mineable databases of quantifiable image measures have
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been created to characterize solid tumors. The image analysis techniques utilized, however, are not
unique to oncologic imaging, nor are they unique to the discipline of medical imaging. Haralick et al.
[86], for instance, originally proposed a set of measures to describe the texture of satellite images, but
they have since become a widely used set of features to describe heterogeneity with multiple medical
imaging modalities. A myriad of methods can be implemented, giving rise to datasets that extract
hundreds or thousands of features, thus earning the ‐omics suffix to describe the field.
While technological advances and conception of the term "radiomics" have resulted in increased
exposure and appeal, commonly implemented methods for extracting quantifiable image features have
been well‐established. Of particular interest is the utility of CT based image features to aid in
quantification and classification of interstitial and diffuse lung diseases. Diagnosis of mild COPD, for
example, is often challenging and lacks objectivity in assessment. In response, multiple groups have
analyzed CT image sets to define low attenuation areas of the lung as quantitative measures of COPD
status. Correlation of simple CT metrics to pathologic specimens [69,70] and pulmonary function tests
[71] demonstrates the potential of image‐based analysis. The introduction of texture analysis methods
[87] applied to multiple parenchymal pathologies [72–78] has further improved quantification and
classification of underlying lung disease. This work has established a precedent for utilizing CT‐based
analysis of lung volumes that may achieve better characterization of disease prognosis and treatment‐
related response in a variety of medical disciplines.
The key difference between these existing studies and radiomics is in the size of the feature space and
methods for analysis. Radiomics is partially defined by the high‐dimensionality of the extracted image
feature data. Computational requirements used to pose limits on the number and type of features to
be extracted, but this obstacle is no longer a primary barrier to medical image analysis with current
computing resources. Additionally, more sophisticated methods for statistical analysis, primarily
machine learning methods, can be employed to account for the dimensionality of the data. Proper
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application of such techniques allows for thousands of features to be considered in construction of
prognostic or prediction models while still being able to achieve a clinically useful and generalizable
result.
While there is much promise, there are several limitations to radiomics research. Anatomical or image
noise during acquisition, region of interest identification and segmentation, and appropriate statistical
methods for analysis of high‐dimensional datasets are barriers that must be conquered for radiomics
to provide clinically relevant information. Secondary to these impediments, parameters utilized for
feature extraction can vary and make it difficult to achieve reproducible results; however, this problem
is more easily overcome. While a limited number of software packages suitable for radiomics feature
extraction have been made available, only recently has a true open‐source solution for reproducible
radiomics research been shared in the form of the open source, MATLAB‐based package, ibex [88].
Similarly, we have designed a platform specific to the purposes of this project and studies to be
presented in the following chapters. "TREX" is a MATLAB‐based software platform for analysis of CT‐
based images that exist within the framework of a radiation therapy treatment planning system. It
provides the ability to extract both image and dosimetric data using multiple methods. Further
amendments have been incorporated to facilitate analysis specific to that of the normal lung volume,
but TREX can be utilized for analysis of any segmented CT structure. Here we describe the current
functionality of TREX.

DESCRIPTION OF SOFTWARE
TREX was developed in a MATLAB (Mathworks, Natick, MA) environment and primarily facilitates
analysis of CT images and regions of interest (ROIs) that exist within the Pinnacle3 treatment planning
system (Philips HealthCare, Fitchburg, WI). Accordingly, though it is an important part of high‐
throughput radiomics research, data preparation including image segmentation and dose calculation,
rely on the tools available in Pinnacle3.
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Figure 1. TREX project setup GUI. The user navigates through the TPS file system by selecting the server,
institution, patient, plan, and structure (i.e. ROI). Optionally, a dose distribution associated with the
selected plan can be added. Multiple entries are added to the project workspace to build the TREX
project for subsequent image and dosimetric feature analysis.

A graphical user interface was constructed to facilitate browsing of an existing Pinnacle3 TPS file system
after establishing an FTP connection with the TPS server (Figure 1). The user is prompted to navigate
each level of the TPS file system (institution, patient, and treatment plan) to identify the primary CT
image set associated with a given plan for a patient of interest. The user can select and view the
contoured structures, primary CT image set, and calculated dose distributions that exist within the
selected patient treatment plan. The option also exists to create new structures based on simple
Boolean operations applied to the set of existing contoured structures. The user builds a project by
adding multiple structures, plans, and patients to the project workspace. The data can then be
imported and converted for further analysis or visualization. Two main categories for data analysis are
currently implemented: 1) CT‐based image feature extraction and 2) dosimetric data extraction. Each
category contains a subset of different modules to calculate different classes of features. A set of tools
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to visualize the image, structure, and dose data have also been created to facilitate local review (Figure
2).

Figure 2. An example of the current visualization module. Image, structure, dose, and feature maps can
be displayed and browsed for easy review.

Project Creation and Data Import
Each new TREX project is initiated by defining a specific project name and a local directory location.
The user proceeds by establishing a connection with the Pinnacle3 server and identifying the set of CT
images and contoured structures to serve as input through the image and/or dose feature extraction
algorithms. After selecting the image set and structure associated with a given patient treatment plan,
the user adds an entry with the selected information to the project workspace. Optionally, an available
dose distribution associated with the given plan can be added to the workspace for extraction and
comparison of dosimetric data.
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Once the setup workspace is populated with the patient of interest, including image, and structure
data, TREX proceeds with a local import and conversion of the data to more easily facilitate analysis.
This automated process steps through each entry in the project workspace, establishes a connection
with the Pinnacle3 server, and downloads all of the requisite data from the TPS in its native format.
Each patient is given a subdirectory within the main project directory where the data is locally
transferred. For each entry, the CT image data is subsequently read and stored as a 3‐dimensional array
with the available metadata in a binary MATLAB data format (.mat file). The contoured structure (i.e.
ROI) data is read and converted to a binary mask with the same dimensions as the primary CT image
set. The ROI data is saved as a separate MATLAB file along with available image metadata. If a trial dose
distribution is included with a given entry, the native Pinnacle files are used to reconstruct the planned
dose distribution as well. This is also saved as a separate MATLAB file. Each MATLAB file is saved to the
appropriate patient directory and tagged with a randomly generated unique identifier. After each entry
in the project setup workspace has been imported and converted to the desired format, dosimetric
and image feature analysis can proceed.
If changes are made to the project setup workspace, data import can easily be run again to add a new
or remove an existing entry. If import is run again, a feedback mechanism is also established to look for
any changes that may have also occurred in the TPS due to alterations in the selected ROIs and/or dose
distributions.

CT‐based Image Feature Extraction
CT‐based image (i.e. radiomics) feature extraction was the primary purpose for the creation of TREX
and it was implemented in two different ways depending on how the ROI is defined.
1)

Global/regional feature extraction: The imported and converted structure mask for each entry is
the considered ROI for feature calculation. All voxels within the masked volume are used to
generate global measures from the input image.

15
2)

Local feature extraction: The imported and converted structure mask for each entry serves as the
boundaries to limit calculation of local feature values. Features are calculated in smaller ROIs (e.g.
31 x 31 pixel blocks) within the larger masked structure. Depending on the spacing of the ROIs,
feature values can be calculated on a voxel‐by‐voxel basis throughout the masked image or, if
coarser spacing of ROIs is required, interpolation can be used to create a voxel‐wise feature map
at all locations in the masked structure volume.

With a given image set and ROI, six different radiomics feature classes were considered with
independent modules being built in TREX for each:
•

First Order Histogram Features: Twenty‐three first order histogram features are extracted from
each image. The features can be calculated from the original, unfiltered image. Additionally, prior
to feature calculation, image preprocessing can be applied with 14 different filters or thresholds
(2D and 3D gradient sobel, local entropy, local range, local standard deviation, 5 Laplacian of
Gaussian 2D filters, and 4 image thresholds).

•

Gray Level Co‐occurrence Features: The gray level co‐occurrence matrix (GLCM) is used to define
texture in an image by determining the distribution of co‐occurring voxel values along a given
displacement [86]. From each GLCM, 23 gray level co‐occurrence features are extracted [86,89].
The original CT scan can be linearly downsampled to 16, 32, 64, 128, and 256 gray levels (bit
depths 4‐8). The displacement vector is defined by both the direction and distance for comparison
of voxel pairs. Thirteen unique directions in 3‐dimensional space are considered. Two additional
GLCMs can be calculated by summing the GLCM from all axial (i.e. 2D) directions and from
summing all 13 3D directions. The displacement is also defined using distances of 1, 3, and 5
voxels.

•

Gray Level Run Length Features: The gray level run length matrix (GLRLM), similar to the GLCM,
is used to define texture in an image by considering strings of consecutive voxels that have similar
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gray values along a given direction [90]. From each GLRLM, 11 gray level run length features are
extracted [90–93]. The original image can be downsampled to bit depths from 4 to 8. As with the
GLCM, 13 individual 3D directions as well as the 2D and 3D summed GLRLMs can be calculated.
•

Neighborhood Gray‐Tone Difference Features: The neighborhood gray‐tone difference matrix
(NGTDM) defines texture in an image by calculating the average gray level difference between
each voxel and its neighboring voxels [94]. Five different neighborhood gray‐tone difference
features are extracted from each NGTDM [94]. As with the GLCM and GLRLM methods, the
original image can be downsampled to bit depths of 4‐8. Additionally, each neighborhood is
defined by considering only immediately adjacent voxels (i.e. distance = 1) in two or three
dimensions.

•

Laws' Filtered Features: Laws' filters are a series of 5 one dimensional spatial filters that are
convolved with the image to emphasize textural structure [95]. Fifteen pairs of the Laws' 1x5
filters are implemented and can be applied to each axial slice of the original image. Eight
histogram metrics are subsequently extracted from the filtered image.

•

Lung‐Specific CT Features: Multiple methods have been proposed to quantify COPD in patients
using CT. In total, 23 unique features [70,76,96–100] representing the volume and cluster density
of low attenuation areas in the lung are calculated from the original image.

Further description of the calculated features is provided in Appendix 1.
Feature extraction parameters specific to the radiomics feature class can be selected and project‐
specific parameter profiles can be defined within TREX (Figure 3 and Figure 4). Once the modules and
parameters of interest are selected, image feature calculation can be initiated. TREX steps through each
module (or class) sequentially. After all features have been calculated for every entry with a given
feature module, the result is saved as a MATLAB file within the project directory. The extracted feature
space is written to an array with each row representing a separate entry from the project workspace
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and each column defining a unique feature. If feature extraction is repeated with a given module using
additional parameters, TREX searches the previously created feature space and ignores calculation of
features that have already been completed to save computation time. Additionally, certain image
calculation algorithms can take advantage of multiple CPUs via MATLAB's parallel processing toolbox.

Figure 3. Global image feature extraction parameter window. Six different radiomics feature classes can
be used, each with their own set of control parameters.
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Figure 4. Local image feature (i.e. map) extraction parameter window. Similar to Figure 3, but additional
options to select the locally‐defined ROI are included.

Dosimetric Data Extraction
A necessary component of RT response assessment or prediction is the dosimetric data, which has
been explicitly considered in TREX. After the data has been imported, several modules exist to extract
dosimetric and plan‐specific data (Figure 5). These include:
•

Dose‐Volume Histogram (DVH) Features: Using the imported dose distribution, a series of first
order statistics are calculated in the given ROI. Additionally, absolute and relative volume
receiving at least X Gy (

,

), minimum dose to the hottest X% volume (

), and mean dose
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to the hottest and coldest X% volume (

,

) are calculated in 5% or 5 Gy intervals. In

total 149 different dosimetric features are returned. This is the primary module for dosimetric
data extraction.
•

Location Features: Based on the masked ROI volume, the absolute and relative locations of the
bounding box encompassing the ROI as well as the location of the ROI centroid are determined.
This has proven useful for defining the relative position of the GTV volume within the total lung
as in Reference [26].

•

Plan Features: The Pinnacle3 data is parsed to return a set of 25 different treatment plan
parameters. This includes parameters pertaining to the machine energy, number of beams,
number of fractions, machine name, and heterogeneity correction, among others.

•

Spatially‐weighted DVH: Borrowing from the method proposed by Vinogradskiy et al. [101], a set
of DVH features was calculated from several spatially‐weighted dose distributions. Four different
weighting matrices were created by linearly scaling values on the range [0, 1] in the following
orientations: superior‐inferior, anterior‐posterior, right‐left, and radially (see Reference [101]).
Each weighting matrix was created to match the dimensions of the bounding box encompassing
the ROI such that the dose distribution can be weighted with each of the considered weighting
schemes.

•

Dose‐Radiomics Histogram (DRH) Features: As detailed above, a set of local CT image features
can be calculated to give a series of voxel‐wise feature maps. These feature maps are
subsequently used as surrogates of function and used to extract DRH features in a manner
analogous to the concept of a dose‐function histogram [54,56,57].

Further description of the features is provided in Appendix 2.
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Figure 5. Dosimetric feature extraction parameter window. Five different classes are implemented.

Initial Validation
Accuracy of the dosimetric and image feature calculation is vital to build robust and useful clinical
decision making tools. Validation of the image feature calculation methods was challenging due to
scarcity of packages for such analysis during development. Several virtual phantom image sets were
employed when possible to test calculated feature values. A package originally created for MRI texture
analysis, Mazda [102], was used to aid in validation of some features. Additionally, the alpha version of
IBEX [88] served as a check in the later stages of development. In some cases, the implementation of
the feature algorithm can result in differences upon comparison. Typically this is a function of the
preferred methods used for image preprocessing or bit depth downsampling that can easily be
accounted for, but this does complicate comparison of results between different software packages.
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Dosimetric features have been compared to those calculated in the TPS. Minor differences in the
calculated volumes, presumably due to partial voxel averaging within Pinnacle3 produce differences in
feature values on the order of 3%. Multiple treatment plans were also exported from Pinnacle3 using
a DICOM exporter. These plans were subsequently imported into CERR [103] to facilitate direct
comparison of scan, structure, and dose objects in a MATLAB environment.
To strengthen validation and encourage reproducible research practices, the MATLAB source code will
be provided at https://github.com/Krafft‐Research/.

SUMMARY
TREX was initially conceived to provide a single framework for image feature calculation and dosimetric
data extraction from RT treatment plan data. Other packages are now widely used specifically for
radiomics analysis [88] and well‐established radiotherapy research platforms such as CERR [103] have
begun to develop similar radiomics tools. This leaves the future of TREX uncertain; however, the
package is easily extensible. Moving outside of the Pinnacle3 environment, DICOM import and ROI
contouring tools can be integrated. Additionally, new feature classes can be implemented by creation
of new modules and current methods can be extended with alternative image preprocessing schemes
and new features. The ability to move beyond CT‐based image feature calculation to other modalities
is also on the horizon. We have successfully implemented multiple methods to permit true high‐
throughput calculation of mineable image and treatment data.
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CHAPTER 3: CHARACTERIZING RADIOMICS FEATURES FOR ANALYSIS OF
4‐DIMENSIONAL CT IMAGES IN THE NORMAL LUNG
INTRODUCTION
Quantitative analysis of lung parenchymal changes using CT has been widely investigated as means to
describe the morphology and understand the mechanisms of lung disease [69–78]. Particularly in the
context of interstitial and obstructive lung diseases, lung densitometry and texture analysis methods
have been applied for differentiation of lung phenotypes that might assist in early diagnosis and
understanding of pathogenesis. Building off of this work, there is obvious interest in application of such
methods for improved and automated assessment of the risk, progression, and/or quantification of
lung response in multiple disciplines.
Specific to the radiation oncology community, use of CT density measures have been considered for
assessing lung changes that might correlate to the delivered radiation dose and symptomatic radiation‐
induced lung damage resulting from radiation therapy (RT) [43–53]. The baseline appearance and
radiation‐induced changes in the lung volume, however, are heterogeneous in nature [104], making
simple radiologic density measurements of limited value for risk prediction or treatment response
assessment in the normal lung. Bearing in mind the quantitative lung CT literature, this has led to
consideration of a large number of radiomics‐based [83–85,89] image features which may capture
additional information about the structure and function of the organ. Cunliffe et al., for example, have
demonstrated change in several CT‐based image features are correlated with visually scored severity
of lung changes [79] and development of symptomatic radiation pneumonitis after RT [80].
Prior to application of quantitative image features to aid in any clinical decision making, it is necessary
to understand the inherent uncertainties. Though challenges still exist, this is well investigated,
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particularly in radiomics analyses of NSCLC tumors [85,105,106]. Analysis of the normal lung, however,
presents unique problems due to the anatomical composition of the organ and the effect of respiratory
motion, necessitating independent characterization of features extracted from normal lung. While the
differences in inspiratory and expiratory lung density have been well studied [107–109], investigation
of higher‐order (i.e. texture) radiomics features have not. Additionally, the use of 4 dimensional CT
[110–112] (4D‐CT) in patients treated with RT for thoracic cancers is now routine, but reproducibility
and repeatability of image features in the lung volume using this modality remains unexplored.
The purpose of this study is to characterize the potential variability in total lung CT image features
resulting from respiration and to quantify test‐retest repeatability. We consider reproducibility and
repeatability of images obtained under breath‐hold and 4D‐CT acquisition on two different scanner
models and investigate collinearity in the image feature set. We aim to identify the most repeatable CT
image type and present a non‐redundant CT image feature set for use in further analysis of lung
volumes in an RT environment.

METHODS
Patient Selection and CT Image Acquisition
Twenty nine patients with non‐small‐cell lung cancer (NSCLC) were previously enrolled in an
institutionally approved protocol at the University of Texas MD Anderson Cancer Center and
considered in this study. Patients underwent definitive RT between 05/2005 and 05/2009. Prior to
beginning RT, each patient participated in an imaging session where they were scanned under two CT
acquisition modes: 4‐dimensional and breath‐hold. Patients were required to lie flat for the duration
of the imaging session (~30 minutes) during which they were imaged twice under both acquisition
modes. Any patient unable to breathe in a reproducible manner was removed from the study. After
the first scan, the patient was asked to leave the couch and walk before returning to the imaging table
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for the second scan. This provided test‐retest image sets to assess repeatability. Standard marking
technique and immobilization using an extended wing board with T‐bar grip and Vac‐Lok cushion
(Civco, Orange City, IA) was performed.
In the current cohort, patients were imaged on one of two available commercial CT scanners: GE
Discovery ST or GE LightSpeed RT 16 (General Electric Healthcare, Milwaukee, WI). Table 2 contains the
available scanner and acquisition related characteristics. 4D‐CT acquisition occurred under cine mode
with each reconstructed image sorted based on the respiratory phase recorded using the Real‐Time
Position Management (RPM) Gating System (Varian Medical Systems, Palo Alto, CA). Images were
sorted into 10 phases with 0% (T0) being defined as end‐inhale and 50% (T50) end‐exhale. Additionally,
a secondary average (AVG) image set was derived by averaging all 10 phase images from the 4D‐CT
data. Breath‐hold acquisition occurred under helical mode at both maximum inspiration (INSP) and
expiration (EXP) for patients who were able to hold their breath for a sufficient length of time.
Table 2. CT acquisition parameters for the test‐retest data.
Parameter

GE Discovery ST

GE LightSpeed RT 16

Number of Patients

12

11

17

17

Acquisition Mode

4D‐CT

Breath‐Hold

4D‐CT

Breath‐Hold

Scan Options

CINE MODE

HELICAL MODE CINE MODE

HELICAL MODE

Slice Thickness (mm) 2.5

2.5

2.5

2.5

Axial Pixel Size (mm)

0.977

0.977

0.977

0.977

kVp

120

120

120

120

Tube Current (mA)

100

300

200

493 +/‐ 20

Focal Spot Size (cm)

0.7

1.2

0.7/1.2

1.2

Filter Type

BODY FILTER

BODY FILTER

BODY FILTER

BODY FILTER

Convolution Kernel

STANDARD

STANDARD

STANDARD

STANDARD

Patient Position

HFS

HFS

HFS

HFS
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Volume Segmentation
In the current cohort, 17 patients were treated with passive scattered proton therapy while the
remaining 12 were treated with 3D‐conformal or intensity modulated photon therapy. Initial
segmentation of the lung volumes was performed manually using the AVG image set acquired for
treatment plan dose calculation in either Eclipse (Varian Medical Systems, Palo Alto, CA) or Pinnacle
(Philips Radiation Oncology Systems, Fitchburg, WI) for the proton or photon patients, respectively.
The total lung volume is defined as the normal lung excluding the clinically accepted GTV.
Contours on all image sets of interest were generated using an initial rigid registration of the thoracic
vertebral bodies followed by an in‐house deformable image registration technique [113]. Each image
set was registered to the planning CT (AVG) to create a deformation vector field. This was then used to
propagate the total lung contours to the pairs of breath‐hold INSP, EXP, T0, T50, and AVG image sets
for investigation of test‐retest repeatability. Additionally, contours were deformably registered to each
remaining phase of the initial (i.e. test) 4D image set for assessment of phase‐related reproducibility.
All contours were visually reviewed for accuracy and any inconsistencies (i.e. inclusion of the trachea)
were corrected manually.

CT Image Feature Extraction
For image analysis, the in‐house system described in Chapter 2 was built to extract features from the
native Pinnacle data using MATLAB (Mathworks, Natick, MA). Six different radiomics feature classes
were considered:
•

First Order Histogram Features (336 HIST features)

•

Gray Level Co‐occurrence Features (5175 GLCM features)

•

Gray Level Run Length Features (825 GLRLM features)

•

Neighborhood Gray‐Tone Difference Features (50 NGTDM features)

26
•

Laws' Filtered Features (120 LAWS2D features)

•

Lung‐Specific CT Features (19 LUNG features)

A total of 6526 features were extracted from using each contour‐defined region of interest on every
available image set.

4D‐CT Phase Reproducibility and Test‐Retest Repeatability
To assess how reproducible a given feature was as a function of 4D‐CT phase, all 10 phase images from
29 patients were collected providing 290 image sets for analysis. The correlation between feature value
and phase‐measured volume was calculated for each patient using the Spearman rank correlation. The
percent difference on each phase image was also calculated with respect to the T50 image set. The
mean percent difference across the population was subsequently calculated for each phase and used
to determine the range (max ‐ min) in variation of each feature due to respiratory‐correlated phase.
Additionally, the concordance correlation coefficient (CCC) was used to determine the relative
reproducibility of each feature between phases. CCC as a measure of agreement describes the
correlation between two measurements that fall on a 45o line passing through the origin and is defined
as:
2

where

,

,

, and

are the mean and variance of two measurements

is the correlation coefficient between

and

and , respectively, and

[114]. The CCC is an index scaled to the range [‐1, 1]

where a value of one indicates perfect agreement between the two measures.
For assessing test‐retest repeatability, a total of 286 images were collected which included 29 pairs of
AVG, T0, and T50 and 28 pairs of EXP and INSP image sets. CCC was similarly calculated as a scaled
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measure of agreement for each feature extracted from the total lung volume using the test and retest
image sets to identify whether one image type was more repeatable than another.
Since patients underwent an imaging session on one of two CT scanners, we considered the impact of
machine on total lung feature values. We utilized the Mann‐Whitney U test to first determine if there
was a difference in the distributions between the two machines for each feature individually. This was
performed with the T50 image sets only and p‐values were adjusted using the Bonferroni correction.
Secondly, we considered difference in repeatability of a given image type due to machine by calculating
CCC for each feature using the patients imaged on the GE Discovery ST (n = 12 patients) or GE
LightSpeed RT 16 (n = 17) separately.

Assessment of Feature Set Collinearity
While repeatability and reproducibility are well characterized, many of the features are highly
correlated to one another. Different strategies can be employed to reduce the feature set dimension
to identify a robust subset of non‐redundant image features. We have utilized a heuristic approach
based on Kuhn et al. [115] utilizing the pairwise Pearson correlation coefficients between total lung
features from the T50 test‐retest scans. The initial feature set was limited to the subset considered
highly repeatable (CCC

0.95) and a correlation matrix of the remaining features was constructed. To

remove highly correlated predictors, two features with the highest pairwise correlation were initially
selected. The average correlation for each of these features across the entire feature set was calculated
and the variable with the greater average correlation was removed. This process repeated until the
maximum pairwise correlation in the resulting feature set was less than 0.85. Additionally, we explored
the similarity of features and patients with the reduced feature set by employing agglomerative
hierarchical clustering with a complete linkage function. All analyses were performed using R version
3.2.3 [116].
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RESULTS
4D‐CT Phase Reproducibility
Figure 6 demonstrates the absolute change in lung density as a function of phase. The difference in
density between near end‐inhale (T0) and end‐exhale (T50) varies as little as 7 HU to as much as 99 HU
across the population. Figure 7 illustrates the percent change in different features relative to the T50
image set can vary substantially more or less in other features than the change in volume itself. The
mean Spearman rank correlation exceeded 0.70 (| | > 0.70) in 4682 of 6526 features suggesting that
the variation in feature value was at least moderately correlated to respiratory‐related changes in the
total lung volume for the majority of features. Across all features, 3300/6526 have a range of variation
10%, 2364 have range > 10% and

25% and 862 have a range

25%. LUNG features exhibit

noticeably more variation relative to the other feature classes as only 4/19 (21.1%) have range of
variation < 25%. Figure 8 demonstrates the fraction of the features with a range in percent difference
(mean value across the population) for each feature class.

29

Figure 6. Absolute change in lung density as a function of phase.

Figure 7. Percent change in feature value (relative to T50) as a function of phase for four different
features.
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Figure 8. Cumulative distribution of the range of variation in % difference (relative to T50) by feature
class.

The results detailed above were calculated using data from all 10 phase image sets, but less variation
is expected between a limited subset of temporally sequential phases ‐ that is, the range between T40
to T60 should be substantially less than the range across all phases. This is shown in Figure 9 for a
subset of HIST features and LUNG features. The maximum/minimum deviation with respect to T50
across all phases is substantially larger compared to the deviation across only the T40 and T60 phases.
This plot also illustrates that the T50 phase is at or near an extremum ‐ feature values tend to either
increase or decrease as a function of phase relative to T50 which is consistent with increasing lung
volume. Figure 10 shows the relative agreement between the T50 image set and each of the other 4D
phases determined by CCC. Nearly all of the features (6198/6526, 95.0%) have a CCC

0.95 between

T50 and T60 whereas only 749/6526 (11.5%) reach that same threshold on comparison of T50 and T0.
The further from T50, the less reproducible the feature set.

31

Figure 9. Maximum and minimum variation in % difference (relative to T50) image sets for HIST and
LUNG features. Variation across all phases and 40‐60% phases is shown. A randomly selected subset of
100 HIST features is included in this plot.

Figure 10. Cumulative distribution of CCC values across all features between T50 and the other image
phases.
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Test‐Retest Repeatability
Figure 11 shows the cumulative distribution of CCC values across all features for each of the available
test‐retest image sets. Using a threshold for repeatability of CCC

0.95, 74.3%, 58.2%, 5.8%, 96.7%,

and 98.7% of the feature set is repeatable in the AVG, EXP, INSP, T0, and T50 image sets, respectively.
The INSP image set is the least repeatable while the T50 image set is the most repeatable at this
threshold. Though repeatability is influenced by many factors, the variation in volume between test
and retest image sets is believed to be a major cause for poor repeatability in the INSP image set in
particular. This is demonstrated in Figure 12 as the standard deviation in test‐retest total lung volume
difference is greater for the INSP scans relative to any other image type.

Figure 11. Cumulative distribution of CCC on test‐retest image sets.
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Figure 12. Absolute difference in total lung volume between test and retest scans. Mean difference 1
SD is 25 180, ‐33 190, 43 355, NaN NA, NaN NA cc for the AVG, EXP, INSP, T0, and T50
image sets, respectively.

Though most features are highly repeatable on the T50 image set, there are some differences in CCC
among the different radiomics classes (Figure 13). The NGTDM features are less repeatable than the
remaining feature classes as 13/50 have a CCC < 0.95. Despite the large variation in feature value due
to phase, the LUNG features have high overall repeatability (94.7% of features have CCC

0.95).
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Figure 13. Cumulative distribution of CCC on T50 test‐retest image sets by feature class.

Machine‐Related Repeatability
After multiplicity correction, a total of 108 out of 6526 features had significantly different distributions
between the two available machines suggesting that there is no substantial machine‐dependent
response for the majority of features calculated in the total lung. Differences in repeatability of the
features between the two machines are shown in Figure 14. There are 95.7% of the features considered
highly repeatable (CCC

0.95) on both machines. Though most features are highly repeatable on both

machines, CCC is < 0.95 for 236 and 75 features on the LightSpeed RT 16 and Discovery ST scanner,
respectively.
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Figure 14. Machine dependent CCC determined from T50 test‐retest image sets.

Feature Set Collinearity
We demonstrate the level of redundancy present in the feature set by considering the pairwise Pearson
correlation between features extracted from the total lung volume on the T50 image sets. The
correlation matrix limited to the 50 most repeatable features is presented in Figure 15 and
demonstrates high pairwise correlation among many features. Of the 6526 features extracted, 6442
were highly repeatable on the T50 test‐retest analysis. The approach utilized to limit the redundancy
in the feature set was subsequently applied and resulted in the selection of only 53 features with a
maximum pairwise correlation of 0.85 (Figure 16, Table 3). Using these resulting features, a cluster
heatmap was generated (Figure 17). The rows are clustered according to patient scan using a Euclidean
distance metric and the columns are clustered according to the Pearson's correlation distance between
the remaining features. While this cluster analysis does not reveal any clear groups of patients with
similar feature values, it was able to successfully cluster the test and retest scans together for all
patients confirming greater interpatient dissimilarity relative to the intrapatient test‐retest differences.
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Features are clustered with no discernable pattern as there are no contiguous groupings according to
their respective feature classes.

Figure 15. Correlation matrix of the top 50 features with the highest CCC.
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Figure 16. Correlation matrix of the filtered subset of features. 53 features have a maximum pairwise
correlation of 0.85.
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Table 3. Full description of non‐redundant features. Necessary parameters utilized for image feature
extraction are provided: Preproc = Image preprocessing method, BD = Bit depth, Dir = Offset direction,
Dist = Offset distance, Dim = Neighborhood dimension.
Feature
Class
Feature Name
Image Feature Parameters
HIST

Kurtosis

Preproc = 3D Sobel Gradient Filter

HIST

Sum

Preproc = Laplacian of Gaussian Filter (Size=12;
Sigma=2.5)

HIST

Minimum

Preproc = Laplacian of Gaussian Filter (Size=12;
Sigma=2.5)

HIST

25th Percentile

Preproc = Laplacian of Gaussian Filter (Size=12;
Sigma=2.5)

HIST

99th Percentile

Preproc = Laplacian of Gaussian Filter (Size=12;
Sigma=2.5)

HIST

Kurtosis

Preproc = Local Entropy Filter (NHood=3)

th

HIST

90 Percentile

Preproc = Local Entropy Filter (NHood=3)

HIST

95th Percentile

Preproc = Local Entropy Filter (NHood=3)

HIST

Skewness

Preproc = Local Standard Deviation Filter
(NHood=3)

HIST

Interquartile Range

Preproc = Local Standard Deviation Filter
(NHood=3)

HIST

Kurtosis

Preproc = None

HIST

Energy

Preproc = None

HIST

Kurtosis

Preproc = Threshold ‐750 HU

st

HIST

1 Percentile

Preproc = Threshold ‐750 HU

HIST

Variance

Preproc = Threshold ‐500 HU

HIST

Energy

Preproc = Threshold ‐500 HU

HIST

Variance

Preproc = Threshold ‐250 HU

HIST

Energy

Preproc = Threshold ‐250 HU

GLCM

Contrast

Preproc = None; BD = 4; Dist = 3; Dir = [1 0 0]

GLCM

Inverse Variance

Preproc = None; BD = 5; Dist = 5; Dir = [1 1 1]

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1; Dir = [0 1 0]

GLCM

Information Measures of
Correlation 1

Preproc = None; BD = 7; Dist = 1; Dir = [1 0 0]

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1; Dir = [1 0 0]

GLCM

Information Measures of
Correlation 1

Preproc = None; BD = 7; Dist = 5; Dir = [‐1 1 1]

GLCM

Cluster Prominence

Preproc = None; BD = 8; Dist = 3; Dir = [1 1 ‐1]

GLRLM

Long Run High Gray Level
Emphasis

Preproc = None; BD = 4; Dir = [‐1 1 ‐1]

GLRLM

Run Length Nonuniformity

Preproc = None; BD = 4; Dir = [0 1 ‐1]
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GLRLM

Short Run Low Gray Level
Emphasis

Preproc = None; BD = 4; Dir = [0 1 0]

GLRLM

Short Run Emphasis

Preproc = None; BD = 4; Dir = [1 0 0]

GLRLM

Long Run High Gray Level
Emphasis

Preproc = None; BD = 5; Dir = [1 1 ‐1]

GLRLM

Long Run High Gray Level
Emphasis

Preproc = None; BD = 6; Dir = [1 0 0]

GLRLM

Run Length Nonuniformity

Preproc = None; BD = 7; Dir = [1 0 0]

NGTDM

Busyness

Preproc = None; BD = 5; Dist = 1; Dim = 3D

LAWS2D

L5E5_Mean

Preproc = None

LAWS2D

L5E5_Skewness

Preproc = None

LAWS2D

L5E5_Uniformity

Preproc = None

LAWS2D

L5S5_Skewness

Preproc = None

LAWS2D

L5S5_Kurtosis

Preproc = None

LAWS2D

L5W5_Skewness

Preproc = None

LAWS2D

L5R5_Uniformity

Preproc = None

LAWS2D

E5E5_Skewness

Preproc = None

LAWS2D

E5S5_Mean

Preproc = None

LAWS2D

E5S5_Skewness

Preproc = None

LAWS2D

E5S5_Kurtosis

Preproc = None

LAWS2D

S5W5_Skewness

Preproc = None

LAWS2D

S5R5_Skewness

Preproc = None

LAWS2D

W5W5_Mean

Preproc = None

LAWS2D

W5R5_Mean

Preproc = None

LAWS2D

R5R5_Mean

Preproc = None

LUNG

%Reserve

Preproc = None

LUNG

Cluster Count

Preproc = None

LUNG

Mean Cluster Volume

Preproc = None

LUNG

Cluster Count

Preproc = None
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Figure 17. Hierarchical clustering of the filtered subset of features. The rows are clustered according to
patient scan using a Euclidean distance metric and the columns are clustered according to the Pearson's
correlation distance between the remaining features.

DISCUSSION
In this study we examine the 4D phase‐related reproducibility and test‐retest repeatability of a large
number of CT image features extracted from normal lung volumes. The use of respiratory‐correlated
phase images obtained using 4D‐CT demonstrates the range in variation in many image features as a
function of respiratory phase (Figure 8). Poor agreement between near end‐exhale (T50) and end‐
inhale (T0) image sets (Figure 10) confirms the need for images to be consistently acquired under
similar respiratory conditions in future analyses that consider CT image features to describe the normal
lung. Test‐retest repeatability was better when images were acquired using 4D‐CT compared to helical
breath‐hold in the same set of patients (Figure 11). Additionally, we note substantial redundancy in the
features extracted (Figure 15) and we propose a simple correlation based filter to reduce the size of
the feature set for applications which are not well‐suited for analysis of high‐dimensional data.
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It is well understood in the quantitative lung CT literature that anatomical variation in volume is the
main barrier to achieving reproducible densitometry measures [117] due to variations in HU between
inspiration and expiration by as much as 80‐100 HU in the total lung volume [108,118]. However, unlike
most quantitative lung CT analyses which acquire images near the peak of lung vital capacity, 4D‐CT is
obtained under quiet respiration and it is, therefore, necessary to characterize reproducibility both
with this acquisition mode and with our expanded set of image features. Using 4D‐CT images, variation
in mean lung density between near end‐exhale and end‐inhale varies by 39 HU on average, well less
than reported when comparing peak breath‐hold inspiration and expiration. Consequently, many of
the CT specific indices proposed for diffuse or obstructive lung disease quantification are likely
inappropriate if applied to 4D‐CT studies.
Though the change in lung density is less on 4D‐CT than breath‐hold acquired scans, numerous other
features have substantially greater relative changes as a function of respiratory phase. While there is
better agreement between neighboring phases of the scan (Figure 10, T40 versus T50, CCC

0.95 in

99.3% of features), agreement to T50 across the feature set decreases substantially as a function of
phase (T0 versus T50, CCC

0.95 in 11.5% of features). As a result, comparison of radiomics features

extracted from the normal lung volume under different levels of inspiration (i.e. 4D T50 vs 4D T0 or 4D
T50 vs BH EXP) is likely inappropriate. In situations where variation in CT acquisition due to respiration
must vary (i.e. multi‐center retrospective analyses), filtering of the feature set based on an acceptable
range of variation or application of appropriate corrections to individual features could be considered.
We demonstrate a clear superiority in image feature repeatability of the 4D‐CT end‐exhale and end‐
inhale scans relative to the breath‐hold acquired images (Figure 11). This is primarily a function of the
relative repeatability of the lung volume (Figure 12) and possible differences in acquisition parameters
(namely tube current) between patients during breath‐hold imaging. Of particular note, the INSP scan
features are far less repeatable than the EXP features in our population (Figure 11). Quantitative lung
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CT typically considers the inspiratory acquired images as more repeatable in long term studies. For
instance, Lamers et al. [119] identified breath‐holding at maximum inspiration provided the most
consistent measurements of lung densitometry using several metrics in a cohort of hospitalized
patients. This is at odds with our results showing even short‐term repeatability is poor with inspiration
breath‐hold; however, the impact of advanced stage disease and minimal breath‐hold coaching may
be the reasons for greater deviation in features extracted from test‐retest inspiration image sets.
Repeatability on 4D‐CT similarly illustrates slightly better agreement across the feature set with T50
compared to T0 (Figure 11). This is consistent with Vedam et al. [120] who demonstrated better
reproducibility of the diaphragm position at exhale, likely indicating more repeatable lung volumes than
inhale. Rosen et al. [121] also demonstrated that lung volume was most repeatable near end‐exhale in
serially acquired 4D‐CT images. As we have determined that respiratory‐related changes in lung volume
are a significant source of variation in many radiomics features, we expect and observe the image sets
with the most repeatable lung volume produce the best agreement in extracted feature value. Relative
to the T50 and T0 image sets, the decreased repeatability of the AVG image features (Figure 11) is not
unexpected. Averaging of the 10 phase image sets blurs the lung morphology, effectively concealing
detectable and useful irregularities in the volume.
The impact of various image acquisition parameters and scanner design on quantitative indices is well
known [122–124]. Mackin et al. [125] for example, demonstrated scanner‐related variability in
radiomics features calculated from CT images of a specially designed radiomics phantom. With our
single institution study, the protocol and scanner were highly consistent as kVp, voxel dimension, filter
type, convolution kernel and patient positioning were identical across all 4D and breath‐hold scans.
This resulted in high repeatability measures observed with both machines available and a significant
difference determined in a limited number (1.7%) of features. We believe this provides the basis to
compare image features acquired between either of the two scanners using the given protocol, but
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performance may degrade with the use of a different make/model of scanner or adjustment to protocol
parameters. Methods can be employed to correct image features based on differences in acquisition
or reconstruction [126], but protocol standardization and characterization of image acquisition
parameters specific to quantitative analysis of lung volumes is still needed.
While there is need for better understanding of the factors that contribute to uncertainty in extracted
feature values, the high repeatability (CCC

0.95) observed on both T0 (96.7%) and T50 (98.7%) phase

images from 4D studies is encouraging. This is in contrast to several groups that have performed similar
test‐retest repeatability analyses of CT features extracted from NSCLC tumors [85,105,106]. Hunter et
al. [105] illustrate high repeatability (CCC

0.95) in roughly 50‐60% of 328 radiomics features extracted

from semi‐autonomously segmented lung tumor volumes on a 4D near end‐exhale (T50) scan.
Balagrurunathan et al. [106] identify only 45/219 (20.5%) features extracted from semi‐autonomously
segmented lung tumor volumes in the RIDER lung CT database as highly repeatable. Across all
investigated image types and in every feature class (Figure 13), repeatability is considerably higher than
these previous studies with lung tumor features. We suggest this is due to the nature of lung anatomy
and improved volume delineation compared to lung tumors. Though there may be benefit from
automatic lung segmentation methods [127], the lung is a structure that poses less of a challenge to
interobserver delineation than lung tumor volumes. Additionally, the morphology of lung tumors is
generally observed to be more subtle than that of a normal lung due to a wider range of attenuation
in the lung volume which may have an impact on higher order (i.e. texture) features.
Our approach of semi‐autonomous segmentation on a single scan followed by deformable image
propagation of contours appears adequate on the basis of repeatability of features in the total lung
volume (Figure 11). Cunliffe et al. [128] previously explored the impact of deformable image
registration on image features extracted from localized (32x32 pixel) regions of interest in healthy lung
volumes and considered only 19 of 140 image features were stable due to image registration. They,
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however, calculated features from a follow up CT scan which had been deformably registered to a
baseline scan for each patient. This is in contrast to our approach of using the deformation vector field
to map much larger contoured volumes from baseline CT to the remaining image sets. This method
allows for adequate mapping of anatomically matched regions between scans without the need to
consider a deformably registered image and the differences that result on account of the deformation
process.
Along with the understood limitations inherent to any radiomics type analysis resulting from volume
segmentation and image acquisition parameters, the use of the concordance correlation coefficient as
a relative measure of agreement is limited [129,130]. Calculation of CCC depends on characteristics of
measures in the presented population [130] thus caution should be exercised when comparing these
results to agreement indices determined using a different population. Bland‐Altman analysis [131] is
an alternative for determining absolute agreement which would provide information that could
translate across different populations in a meaningful way; however, the differences in scale and large
number of variables investigated in the current study make application of this methodology
challenging. Thus, our preference was to utilize CCC throughout this study.
As demonstrated in Figure 15, there is substantial collinearity in the dataset which can be problematic
depending on the intended application. Particularly for use in development of predictive models,
reduced collinearity can aid in feature selection stability and better performance [115]. There is also
increased computational burden of extracting all available features that can be reduced by narrowing
the dataset. Multiple methods have been proposed to deal with this. Kumar et al. [85] originally
proposed a methodology for employing a series of empirical filters to identify reproducible,
informative, and non‐redundant features. Hunter et al. [105] utilized a hierarchical clustering based
approach to identify non‐redundant features with high reproducibility across multiple machines and
CT image types. A similar approach could be used to identify a subset of features that are both
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repeatable and reproducible due to machine, respiratory phase and/or interobserver segmentation;
however, we prefer a simple heuristic approach based on pairwise redundancy [115] in the dataset to
demonstrate the level of redundancy in the dataset followed by hierarchical clustering to characterize
the remaining features (Figure 17). Principal component analysis is another technique for
dimensionality reduction achieved by predictor transformation. However, we suggest the use of a
simple correlation filter as data transformation makes the relationship between features and an
outcome of interest more difficult to probe, reducing overall interpretability of the image features.
While removal of variables based on correlation may be necessary, it removes potentially useful
information from the feature space. As there are no perfect pairwise correlations between features,
removal of a single feature may result in removal of complementary information. Ultimately, the need
to reduce dimensionality and the necessary data preprocessing technique is dependent on the
application.

CONCLUSIONS
Careful consideration of radiomics features extracted from normal lung volumes is necessary to
develop appropriate methods for monitoring progression of disease or assessing therapeutic response.
As assessed using 4D‐CT image sets, many image features extracted from the normal lung are
susceptible to uncertainties introduced because of respiratory‐related changes in the volume;
however, there is high test‐retest repeatability of features in 4D‐CT image sets that is superior to
breath‐hold studies in the investigated population. Near end‐exhale 4D‐CT image sets provide the
highest overall repeatability and are the preferred 4D‐CT phase reconstruction from which to extract
image features from the lung volume. There is substantial redundancy within the set of considered
image features that can be reduced on the basis of a heuristic correlation filter to identify a subset of
repeatable and non‐redundant lung CT image features extracted from 4D‐CT image sets.
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CHAPTER 4: TIME AND DOSE RELATED RESPONSE OF NORMAL LUNG CT
IMAGE FEATURES DURING RADIATION THERAPY FOR NON‐SMALL‐CELL
LUNG CANCER
INTRODUCTION
Achieving optimal balance between the risk of normal tissue toxicity and probability of tumor control
is the main challenge of radiation therapy (RT). For non‐small‐cell lung cancer patients treated with
standard of care RT, radiation‐induced lung damage (RILD) and its acute presentation, radiation
pneumonitis (RP), is the greatest toxicity concern. Population‐based analyses have proposed several
dose‐related constraints to limit the incidence of RP, but severe toxicity can still occur [2]. True RT
optimization requires understanding of patient‐specific response to radiation ‐‐‐ radioresistant patients
may benefit from escalated dose without substantial increase in RP risk while more radiosensitive
patients may require lower dose to prevent severe RP. Stratifying patients prior to or early during
treatment would be of benefit to minimize RP incidence and subsequently permit optimization of the
therapeutic ratio.
The use of imaging for quantitative assessment of RILD after conventionally fractionated RT has been
widely studied. Chest X‐ray [35,36], SPECT [37,38], MRI [39], FDG‐PET [40,41], and 4‐dimensional
computed tomography (4D‐CT) based ventilation [42] have been employed to measure changes in the
lung post‐RT. Most widely considered are post‐irradiation changes in lung density as determined from
diagnostic CT [43–53]. Imaging after RT provides critical information regarding dose‐response
relationships and potential warning before the onset of clinically significant RP. Additionally, a truly
objective endpoint can be useful in defining the range of radiation‐induced lung responses and provide
a better endpoint for identifying robust correlates of toxicity across institutions and patient populations
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[51]. Post‐RT assessment, however, does not provide clinicians with information that would be useful
for treatment modification. This could include a variety of strategies such as dose escalation, treatment
delay or termination, margin modification or other interventions to mitigate expected clinical toxicity.
Since multiple modalities have demonstrated sensitivity to detect post‐RT changes, the ability to detect
subclinical lung damage before RT ends has been explored. De Ruysscher et al. [60] found an increase
in FDG‐PET

uptake during RT correlates to symptomatic lung toxicity. The use of 4D‐CT based

ventilation has also been investigated during RT [61], though no consistent change in ventilation was
discovered. Bertelsen et al. [63] demonstrated early, dose‐dependent changes in lung density on serial
cone‐beam CT scans which subsequently have been related to post‐RT lung CT density [64]; however,
no link to clinical lung toxicity was noted.
We hypothesize that analysis of serial weekly 4D‐CT studies acquired during RT can similarly
characterize patient‐specific time and dose related changes in the normal lung. Furthermore, while CT
density has been investigated for lung RT response assessment, we suggest that CT‐based image (i.e.
radiomics) features [83,84] may provide complementary information to enhance prediction of
symptomatic RP that could facilitate treatment modification. These features have demonstrated utility
in assessing the post‐RT severity of lung response [79] and subsequent development of RP [80] but
have not been previously explored on 4D‐CT studies acquired during treatment. Our goals were to 1)
determine if a subset of CT radiomics features extracted from normal lung exhibit a measurable
response as a function of dose and/or time during RT and 2) investigate whether these features might
be useful early predictors of clinically relevant RP.
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METHODS
Patient Selection and Treatment Data
Between 05/2005 and 05/2009, 21 patients with non‐small‐cell lung cancer (NSCLC) were imaged
weekly using 4D‐CT during RT as part of an institutionally approved protocol at the University of Texas
MD Anderson Cancer Center. To be eligible for the protocol, patients were required to breathe in a
reproducible manner and be able to lie flat for the duration of each CT acquisition session. Each patient
was immobilized with a T‐bar grip and Vac‐Lok cushion (Civco, Orange City, IA) and positioned using a
standard marking technique.
Patients in the current study were scheduled to receive 3D conformal (n = 3) or passive scattered
proton beam therapy (n = 18) for at least 4 weeks, with (n = 18) or without (n = 3) concurrent
chemotherapy. All patients were treated with standard fractionation (180 ‐ 250 cGy) once daily. Total
delivered dose was between 6300 and 8750 cGy. RP was scored by the treating physician according to
the Common Terminology Criteria for Adverse Events v3.0 with RP grade

2, defined as symptomatic

but not interfering with activities of daily living, the considered endpoint. Unless toxicity was observed
earlier, at least 6 months of follow up was necessary for a patient to be included in the current study.
Table 4 provides a description of the available treatment parameters in current cohort. The association
between each available parameter and outcome was determined using either the chi‐square test
(categorical variables) or Mann‐Whitney U test (continuous variables).
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Table 4. Available treatment characteristics for the current cohort
Treatment Variable
Median (Range) / N (%) RP Incidence p
Total Number of Fractions

37 (28 ‐ 37)

0.72

Delivered Dose (cGy)

7400 (6300 ‐ 8750)

0.42

Mean Lung Dose (cGy)

1622 (710 ‐ 2435)

0.43

Treatment Modality

PROTON: 18 (85.7%)

44.4%

3DCRT: 3 (14.3%)

66.7%

Concurrent Chemotherapy FALSE: 3 (14.3%)

33.3%

TRUE: 18 (85.7%)

50.0%

0.59

1.00

CT Image Acquisition and Volume Segmentation
In addition to a treatment planning scan, an attempt was made to acquire weekly 4D‐CT scans for each
patient during the length of treatment on one of two available commercial CT scanners: GE Discovery
ST or GE LightSpeed RT 16 (General Electric Healthcare, Milwaukee, WI). Scans were grouped by week
relative to the start of treatment, but due to scheduling issues with the patient and/or clinic, image
sets were not necessarily obtained every week for each patient. Table 5 presents the total number of
scans available for analysis based on weekly time points. 4D‐CT acquisition occurred under cine mode
with the Real‐Time Position Management (RPM) Gating System (Varian Medical Systems, Palo Alto, CA).
Our institutional protocol is to reconstruct 10 phase images with end‐inhale defined as 0% (T0) and
end‐exhale defined as 50% (T50). All scans were acquired under free breathing with a cine 4D scan
mode using 120 kVp, slice thickness of 2.5 mm, axial pixel dimensions of 0.977 x 0.977 mm with the
body filter and reconstructed with the standard convolution kernel.
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Table 5. Number of scans acquired and grouped by week
Week Count
0

21

1

11

2

17

3

20

4

15

5

17

6

14

Using the 50% phase of the initial treatment plan image set (i.e. week 0 T50), lung volume segmentation
was performed manually in either Eclipse (Varian Medical Systems, Palo Alto, CA) or Pinnacle (Philips
Radiation Oncology Systems, Fitchburg, WI) for the proton and photon patients, respectively. We
define the total lung volume for this analysis based on the contoured T50 normal lung minus the
physician‐contoured GTV. In addition, the planned dose distribution was utilized to create contours in
10 Gy increments from 5 to 55 Gy. Contours from the week 0 T50 image set were propagated to all
subsequent weekly T50 image sets using in‐house software for deformable image registration [113].
After rigid registration of the thoracic vertebral bodies, each weekly image set was deformably
registered to the week 0 CT. This resulted in a deformation vector field which could be used to
propagate the contours to the remaining image sets. For all patients, the weekly CT image sets were
stored within a single Pinnacle institution. Visual review and correction of any small obvious
inaccuracies (i.e. inclusion of the trachea) were done manually. Based on results presented in Chapter
3, CT‐based image features extracted from the 50% phase image have high repeatability and are the
preferred image set for analysis of lung volumes on serial 4D‐CT. Consequently, analysis here is limited
to the T50 phase image sets only.

CT Image Feature Extraction
As introduced in Chapter 2, an in‐house MATLAB (Mathworks, Natick, MA) based system was developed
for CT image feature extraction from native Pinnacle data. Six different radiomics feature classes were
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considered, including first‐order histogram, gray level co‐occurrence, gray level run length,
neighborhood gray‐tone difference, Laws' filtered, and lung‐specific CT image features. In Chapter 3,
we identified a subset of non‐redundant features with high test‐retest repeatability when extracted
from images obtained with the same acquisition parameters and reconstructed under similar
respiratory conditions (i.e. 4D‐CT T50 image sets). We also include mean lung density as a candidate
feature as this parameter is frequently considered in the literature for RP quantification. In the present
study, we limit our analysis to this set of 54 features extracted from the total lung volume and dose‐
defined regions (i.e. 5‐15, 15‐25 Gy, etc.) within the normal lung (Table 6).
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Table 6. Full description of investigated features and the FDR‐corrected p‐values for dose, time, and RP
status fixed effects determined via likelihood ratio. Necessary parameters utilized for image feature
extraction are provided: Preproc = Image preprocessing method, BD = Bit depth, Dir = Offset direction,
Dist = Offset distance, Dim = Neighborhood dimension.
RP Status
Fixed
Dose Fixed Time Fixed
Effect, p
Feature
Effect, p
Effect, p
value
Class
Feature Name
Image Feature Parameters
value
value
HIST

Mean

Preproc = None

6.67e‐01

0.695

0.971

HIST

Kurtosis

Preproc = 3D Sobel Gradient
Filter

5.83e‐01

0.969

0.971

HIST

Sum

Preproc = Laplacian of
Gaussian Filter (Size=12;
Sigma=2.5)

0.00e+00

0.969

0.953

HIST

Minimum

Preproc = Laplacian of
Gaussian Filter (Size=12;
Sigma=2.5)

2.16e‐02

0.969

0.953

HIST

25th Percentile

Preproc = Laplacian of
Gaussian Filter (Size=12;
Sigma=2.5)

4.19e‐02

0.969

0.953

HIST

99th Percentile

Preproc = Laplacian of
Gaussian Filter (Size=12;
Sigma=2.5)

2.96e‐03

0.692

0.953

HIST

Kurtosis

Preproc = Local Entropy Filter
(NHood=3)

4.82e‐01

0.969

0.953

HIST

90th Percentile

Preproc = Local Entropy Filter
(NHood=3)

1.60e‐01

0.969

0.971

HIST

95th Percentile

Preproc = Local Entropy Filter
(NHood=3)

8.47e‐01

0.969

0.971

HIST

Skewness

Preproc = Local Standard
Deviation Filter (NHood=3)

5.28e‐02

0.969

0.971

HIST

Interquartile
Range

Preproc = Local Standard
Deviation Filter (NHood=3)

4.22e‐01

0.969

0.971

HIST

Kurtosis

Preproc = None

2.89e‐01

0.969

0.953

HIST

Energy

Preproc = None

0.00e+00

0.969

0.953

HIST

Kurtosis

Preproc = Threshold ‐750 HU

7.20e‐01

0.692

0.953

st

HIST

1 Percentile

Preproc = Threshold ‐750 HU

2.64e‐03

0.419

0.971

HIST

Variance

Preproc = Threshold ‐500 HU

4.73e‐03

0.969

0.971

HIST

Energy

Preproc = Threshold ‐500 HU

0.00e+00

0.969

0.953

HIST

Variance

Preproc = Threshold ‐250 HU

1.18e‐02

0.969

0.953

HIST

Energy

Preproc = Threshold ‐250 HU

0.00e+00

0.969

0.971

GLCM

Contrast

Preproc = None; BD = 4; Dist
= 3; Dir = [1 0 0]

9.16e‐01

0.969

0.953
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GLCM

Inverse Variance

Preproc = None; BD = 5; Dist
= 5; Dir = [1 1 1]

6.11e‐01

0.969

0.971

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist
= 1; Dir = [0 1 0]

1.28e‐02

0.969

0.953

GLCM

Information
Measures of
Correlation 1

Preproc = None; BD = 7; Dist
= 1; Dir = [1 0 0]

5.40e‐04

0.969

0.971

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist
= 1; Dir = [1 0 0]

6.63e‐02

0.695

0.971

GLCM

Information
Measures of
Correlation 1

Preproc = None; BD = 7; Dist
= 5; Dir = [‐1 1 1]

9.53e‐01

0.969

0.971

GLCM

Cluster
Prominence

Preproc = None; BD = 8; Dist
= 3; Dir = [1 1 ‐1]

5.37e‐01

0.969

0.953

GLRLM

Long Run High
Gray Level
Emphasis

Preproc = None; BD = 4; Dir =
[‐1 1 ‐1]

1.00e‐06

0.969

0.953

GLRLM

Run Length
Nonuniformity

Preproc = None; BD = 4; Dir =
[0 1 ‐1]

0.00e+00

0.969

0.971

GLRLM

Short Run Low
Gray Level
Emphasis

Preproc = None; BD = 4; Dir =
[0 1 0]

8.00e‐06

0.692

0.971

GLRLM

Short Run
Emphasis

Preproc = None; BD = 4; Dir =
[1 0 0]

6.67e‐01

0.969

0.953

GLRLM

Long Run High
Gray Level
Emphasis

Preproc = None; BD = 5; Dir =
[1 1 ‐1]

2.50e‐06

0.969

0.971

GLRLM

Long Run High
Gray Level
Emphasis

Preproc = None; BD = 6; Dir =
[1 0 0]

0.00e+00

0.695

0.953

GLRLM

Run Length
Nonuniformity

Preproc = None; BD = 7; Dir =
[1 0 0]

0.00e+00

0.969

0.971

NGTDM

Busyness

Preproc = None; BD = 5; Dist
= 1; Dim = 3D

0.00e+00

0.969

0.971

LAWS2D

L5E5_Mean

Preproc = None

6.67e‐01

0.969

0.953

LAWS2D

L5E5_Skewness

Preproc = None

7.63e‐02

0.969

0.953

LAWS2D

L5E5_Uniformity

Preproc = None

8.60e‐01

0.969

0.971

LAWS2D

L5S5_Skewness

Preproc = None

1.18e‐02

0.969

0.971

LAWS2D

L5S5_Kurtosis

Preproc = None

6.00e‐01

0.969

0.953

LAWS2D

L5W5_Skewness

Preproc = None

6.82e‐01

0.969

0.953

LAWS2D

L5R5_Uniformity Preproc = None

9.53e‐01

0.969

0.953

LAWS2D

E5E5_Skewness

Preproc = None

6.35e‐01

0.969

0.561

LAWS2D

E5S5_Mean

Preproc = None

1.50e‐01

0.969

0.953
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LAWS2D

E5S5_Skewness

Preproc = None

7.48e‐04

0.969

0.971

LAWS2D

E5S5_Kurtosis

Preproc = None

1.28e‐02

0.969

0.718

LAWS2D

S5W5_Skewness

Preproc = None

1.06e‐01

0.969

0.971

LAWS2D

S5R5_Skewness

Preproc = None

6.07e‐04

0.969

0.953

LAWS2D

W5W5_Mean

Preproc = None

1.42e‐01

0.969

0.953

LAWS2D

W5R5_Mean

Preproc = None

7.44e‐01

0.969

0.971

LAWS2D

R5R5_Mean

Preproc = None

1.08e‐01

0.969

0.953

LUNG

%Reserve

Preproc = None

5.65e‐01

0.969

0.953

LUNG

Cluster Count

Preproc = None

9.05e‐04

0.969

0.953

LUNG

Mean Cluster
Volume

Preproc = None

1.75e‐01

0.969

0.971

LUNG

Cluster Count

Preproc = None

1.28e‐02

0.969

NA

Univariable Analysis: Total Lung Features
Univariable analysis was performed using the features extracted from the total lung volume. A
Wilcoxon signed rank test was utilized to determine whether there was a significant difference in
feature value extracted from a given weekly image set relative to the baseline (week 0) feature value.
Additionally, univariable logistic regression was performed with the absolute difference in each feature
relative to baseline and the considered endpoint (RP grade

2) to assess the association between

feature change and outcome. All p‐values were adjusted using Benjamini & Hochberg false discovery
rate [132] to account for multiple comparisons. All statistical analyses were performed using R version
3.2.3 [116].

Linear Mixed Modeling and Random Forest RP Classifier
Using features extracted from the isodose‐defined regions of the total lung volume, a random slope
linear mixed modeling approach was employed to examine each feature as a function of dose and time.
The raw feature value serves as the dependent variable with dose and time both considered fixed
effects. The dose value was the midpoint of the dose region used for feature extraction and time was
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the number of days after the start of RT. Random effects to account for within‐patient and within‐
image set correlation was included by using a patient identifier and image set instance number as
grouping variables. All models were fit via maximum likelihood and the significance of both fixed effects
was determined with a likelihood ratio test of the appropriate reduced model to the full model for a
given feature. Additionally, the binary RP outcome was included as a fixed effect to determine if there
was improvement in model fit. P‐values for the significance of each fixed effect were corrected using
Benjamini & Hochberg false discovery rate. Analysis was performed with R using the lme4 version 1.1.11
package [133].
After application of the linear mixed model approach, the patient‐specific coefficient estimates were
considered for potential utility in RP classification via a random forest model. The random forest
learning algorithm is an ensemble method that combines the results from a collection of decision trees
[134]. Each individual tree is built with a bootstrap resample of the data and each decision split is
chosen from a random subset of available predictors. The resulting tree is used to predict the class
label with the data not contained in the bootstrap resample, referred to as the out‐of‐bag (OOB) data.
The fraction of class votes across all trees grown in the OOB data determines the final prediction. This
OOB prediction facilitates an internal unbiased estimate of classification performance as the final
prediction is generated from a model trained on independent observations. The random forest also
provides an estimate of variable importance by randomly permuting each variable in the OOB samples
and determining the resulting decrease in model accuracy.
Two random forest models were generated using two different sets of predictors. First, only treatment‐
related variables (p = 6 in total) were considered. Subsequently, patient‐specific mixed model intercept,
dose, and time coefficients were added to the treatment‐related variables. This adds potential
predictors to the classification model that may be useful for describing a measureable individual
response of the normal lung during treatment. This resulted in a set of p = 168 total variables (6
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treatment and 162 mixed model coefficients) retained and used as input into a random forest to predict
RP grade

2. In the present study, 2500 trees were grown for each random forest model and

variables were randomly sampled at each split with each model.
Classification performance of the random forest model is evaluated using receiver operating
characteristic (ROC) analysis and the resulting area under the curve (AUC). The 95% confidence interval
for AUC is determined from 2000 stratified bootstrap replicates. The method of Delong et al. [135] was
used to test for statistically significant differences in the OOB AUC obtained from the two models. The
random forest models were constructed with the randomForest version 4.6.12 package [136] and ROC
analysis was performed with the pROC version 1.8 package [137] in R.

RESULTS
RP grade

2 was observed in 10 of 21 patients (47.6%). One patient had grade 3 RP. There was no

statistically significant association between RP and delivered dose, fractional dose, treatment modality,
administration of concurrent chemotherapy or planned mean lung dose. In total, 115 weekly image
sets were collected during RT with a median of 5 per patient.
Figure 18 demonstrates multiple population average feature values extracted from the total lung
volume as a function of time and separated by outcome. Qualitatively, no obvious trend is noted in any
mean feature change over time. There is no significant difference in any feature values between any
week relative to baseline. Similarly, any difference in feature values relative to week 0 were not
associated with outcome on univariable analysis with total lung features.
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Figure 18. Population averaged change in three different features extracted from the total lung volume
during RT grouped by RP outcome. Shaded areas represent 95% confidence intervals.

Figure 19 illustrates the population average change in lung density as a function of dose and time.
There is no separation in density at any dose level or between any week, but inter‐patient variation is
not well demonstrated in this manner. Figure 20 is a lattice plot by patient of the mean lung density
extracted from several dose‐defined regions of the lung versus scan week. Within‐subject linear fits
highlight the differences in feature values between the time points and given regions of interest across
the population ‐ some patients have a positive, negative, or no change in density over the course of
treatment. Qualitatively, however, there is no clear relationship between the patient‐specific density
slope or intercept on the basis of outcome. Similar visual examination of the remaining features also
failed to identify an association between feature change and outcome.
Linear mixed modeling of the features from isodose‐defined regions failed to identify a single feature
that demonstrated a significant relationship with time after RT was initiated; however, 25 of the 54
features considered were significantly associated with dose (e.g. Figure 21). The addition of RP status
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in the mixed model was not significantly associated to any single feature in the investigated set. The
corresponding FDR‐corrected p‐values are provided in Table 6.

Figure 19. Population dose‐response curve for change in lung density during RT. Shaded areas represent
95% confidence intervals.
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Figure 20. Lattice plot of lung density for multiple dose‐defined regions during RT. Each panel represents
a unique patient. Displayed lines are within‐patient and within‐region linear regression fits. Panels with
shaded background indicate patients with RP grade 2. Patient F is the lone patient that developed
severe (grade 3) RP.
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Figure 21. Population dose‐response curve for Laws' filtered (L5,S5) skewness. Shaded areas represent
95% confidence intervals.

Application of the random forest to the set of treatment characteristics resulted in an OOB determined
AUC of 0.74 (95% CI: 0.49‐0.94). The OOB AUC obtained from the random forest model built by adding
in the patient‐specific mixed model coefficient estimates was 0.69 (95% CI: 0.45‐0.91). The
corresponding ROC plots are provided in Figure 22. There is no observed statistically significant
difference in model performance (p = 0.69).
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Figure 22. ROC plot for random forest models constructed with 1) only treatment‐related metrics and 2)
the addition of patient‐specific mixed model coefficients for intercept, dose, and time. Shaded areas
represent 95% confidence intervals on sensitivity.

DISCUSSION
To our knowledge, this is the first study to analyze total and regional normal lung volumes on serial
weekly 4D‐CT scans acquired during treatment. We consider subset of radiomics features (including CT
density) for potential utility in early prediction of symptomatic radiation pneumonitis. The data fail to
successfully demonstrate a time‐dependent change in any single feature value extracted from the total
lung volume over the course of RT (Figure 18). A linear mixed modeling approach was utilized to
consider a dose‐defined regional response in image feature during RT; however, no image feature
exhibited a statistically significant relationship to time. There were a subset of features that did exhibit
a significant relationship to dose, but no single feature was significantly related to the outcome of
interest. Despite this, a multivariable random forest model was built to classify RP response using the
patient‐specific linear mixed model coefficient estimates for intercept, time, and dose, but this model
did not outperform a similarly constructed random forest model with simple treatment‐related factors.
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While radiation‐induced changes in the normal lung volume are anticipated within the treatment field,
we first investigated the potential change measured in image features extracted from the entire lung
volume. Observable lung changes indicative of RP typically occur within the treatment fields [138,139],
but there have been reported cases of changes present in areas of unirradiated lung [140,141].
Furthermore, since our clinical endpoint is based on global, symptomatic assessment, the contribution
of the entire lung volume to subsequent response should be considered. Unsurprisingly, however, we
did not identify an image feature that had a significant change relative to baseline or association to
outcome when the full volume was considered.
Though we anticipate regional (as opposed to total) lung features may better demonstrate the
temporal changes in the normal volume, this was not observed. Figure 20 illustrates wide inter‐patient
variation in the time‐related response of regional lung density (highlighted by within‐patient linear
regression fit lines), but time was not significantly associated with any feature investigated.
Absence of features demonstrating significant response with time suggests an overall inability to
identify early predictors of RP during treatment.
While no other group has performed similar analysis using an expanded set of quantitative image
features, Bertelsen et al. [63] considered change in lung density during RT on cone‐beam CT (CBCT).
They demonstrated a time‐related evolution of dose‐defined regional changes in the lung density
(Figure 3, [63]) which is in contrast to our results presented in Figure 19. They, however, applied a
density correction based on the region of the lung receiving < 5 Gy, which we have similarly applied in
Figure 23 to better facilitate comparison. After applying this adjustment, the same general dose‐
response trend is noted, but the magnitude of density change, particularly later in treatment, is not
consistent between the two studies. The reasons for this are unclear. The treatment characteristics of
the population differ in terms of treatment modality (IMRT/VMAT versus IMRT/proton) which may be
a contributing factor. Additionally, the influence of deformable image registration method and
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repeatability of CBCT density in the lung may influence the accuracy of measurement and result in the
observed differences. We also believe the need for such a density‐based correction with the current
set of features on 4D‐CT images is not indicated, but may be appropriate for CBCT applications due to
greater daily variations in signal intensity, increased image noise due to detector design and patient‐
related scatter, and/or motion artifacts during acquisition.

Figure 23. Population dose‐response curve for lung density during RT. Adjustment applied such that
difference in region receiving < 5 Gy is zero. Shaded areas represent 95% confidence intervals.

Multiple features did exhibit significant linear relationships to the dose‐defined region from which they
were extracted. This confirms that regional lung features differ in a measureable way that might be
useful for characterizing the lung volume, even in the absence of temporal changes during treatment.
Figure 21, for example, illustrates a linear relationship between dose‐region and Laws' filtered image
skewness. While there is no change in this feature during treatment, the composition of the lung is
heterogeneous across its volume and may provide complementary information about the baseline
status of the lung that could be a useful quantitative predictor of RP. It should be noted that we limited
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the analysis to dose‐defined regions less than 55 Gy. The influence of tumor progression or regression
during RT typically occurs in the high‐dose regions of the lung which are adjacent to the tumor. This
has the potential to change the structure of the lung in a way that is not indicative of RT‐induced lung
damage, but we mitigate this effect by analyzing only the dose regions which received less than the
minimum prescribed tumor dose (63 Gy) across the current population. Though post‐RT density
changes are seen at dose levels as low as 35 Gy [49], further investigation is needed to determine how
changes to the lung in higher dose regions near the tumor might contribute to RP development.
The reported OOB AUC is satisfactory, but the bootstrapped confidence interval for either of the two
random forest models indicates the wide variability of unbiased model discriminative performance.
Correspondingly, there is no significant difference when comparing the performance of treatment
variables to the performance of a random forest model that includes measures of patient‐specific time
and dose response. The slightly better OOB AUC with only treatment variables (AUC = 0.74) compared
to the entire set of available predictors (AUC = 0.69) suggests there may be some benefit in tuning the
number of variables sampled at each split. This is likely due to the growth of correlated trees in the
random forest with all predictors [134], but parameter tuning does not alter the results to a point that
changes the statistical comparison between performance of the two models.
The number of patients in our study is a limitation that is most clearly evident by the illustrated and
reported confidence intervals throughout. While no statistically significant associations between time
and lung image features were identified, an expanded population could enable detection of smaller
effect sizes and could identify predictors with temporal response. Additionally, RP model classification
with a limited number of observations is challenging. We elected to use a random forest for this task
as it easily accounts for the high‐dimensional nature of our dataset generated with all potential
predictors (168 predictors >> 21 observations), but the confidence interval of our model performance
metric is large in part due to the limited number of patients available for analysis. Implementation and
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execution of a trial to obtain serial imaging of patients, however, is not without substantial cost and
time burden to both institution and patient, making it difficult to gather a larger dataset.
The uncertainty in OOB AUC is also a function of the endpoint definition. Radiation pneumonitis scoring
is subjective in nature due to the use of ordinal scoring systems [22]. These scoring rubrics often take
into account physician preferences (i.e. administration of steroids or oxygen) and make baseline lung
status difficult to consider. Typically, RP grade

3 is considered a more stable endpoint as the patient

presents with more severe symptoms; however, only one patient experienced such severe RP in the
current cohort. Even a stable binary endpoint, however, fails to capture the continuous nature of
radiation‐induced lung damage. This has led several groups [40,51,53,80] to work on developing a
quantitative measure of lung response post‐RT which may allow for improved identification of robust
predictors of treatment‐related toxicity. Accordingly, there may be benefit to determining whether
there is an association between the features we have extracted during RT to post‐RT quantification of
RILD. To date, however, no quantitative measure of lung response strongly correlates to patient‐
experienced symptoms of lung toxicity which limits the overall clinical applicability of such techniques.
The subset of lung features considered here have demonstrated repeatability and reproducibility when
extracted under the current imaging conditions, specifically with the use of the T50 phase from 4D‐CT
studies acquired on one of two different GE scanner models within our institution. The consistency of
scan acquisition parameters in the current study reduces potential variation in feature values, but these
parameters may not be optimized for detecting RP response. Post‐treatment CT quantification often
considers contrast‐enhanced, diagnostic quality thoracic CT. Analysis of similar datasets with consistent
protocols or other imaging methods obtained during treatment may be of benefit, but are not routinely
acquired.
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CONCLUSIONS
Identifying a time or dose related response of the normal lung before RT has been completed may
allow for improved treatment personalization by escalation and/or adaptation of treatment based on
the underlying risk of lung toxicity in an individual. Extraction of CT image features from weekly image
sets acquired during treatment, however, failed to identify a significant image feature with
demonstrated temporal response. Multiple features exhibited significant association to the dose‐
defined region of the lung from which they were extracted, but the modeled patient‐specific time and
dose effects were not able to produce a more discriminative model for classifying RP than a limited
subset of treatment‐related metrics.
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CHAPTER 5: QUANTIFYING CT RADIOMICS FEATURES IN REGIONALLY‐
DEFINED SUBVOLUMES OF THE NORMAL LUNG
INTRODUCTION
Analysis of lung volumes on computed tomography scans is regularly considered for diagnosis and
assessment of treatment response. Multiple groups have considered simple CT density measures
[70,96–98,142,143] and advanced texture analysis methods [72–78] to improve classification of lung
phenotypes. In a radiation oncology setting, lung densitometry measures have been frequently
investigated for treatment response assessment, with specific consideration given to the relationship
between delivered dose and development of symptomatic radiation‐induced lung damage (RILD) after
radiation therapy (RT) [43–53]. Currently, there is renewed interest in the use of more sophisticated
methods (e.g. texture analysis) to mine quantitative information from medical images, a growing field
of study that has coined the name "radiomics" [83–85,89]. Such methods provide potential to
understand the baseline risk, progression, and assessment of radiation‐induced lung toxicity. Recently,
Cunliffe et al. successfully demonstrated that CT‐based image (i.e. radiomics) features correlate with
the visual severity of lung damage [79] and its symptomatic presentation [80].
Lung function and radiosensitivity are heterogeneous across the lung volume due to underlying genetic
and/or environmental differences. Accordingly, the use of SPECT [55,144,145], 4D‐CT ventilation [62],
and FDG‐PET [58,59] have all been considered to identify functional regions of the lung more likely to
contribute to RT‐related injury. While not strictly a measure of function, CT image features serve as
potential surrogates of function that have demonstrated ability to differentiate between lung
phenotypes. As a result, these features may be particularly useful in describing the spatial
heterogeneity in organ structure that contributes to regional radiosensitivity and increased risk of
developing clinically‐significant RILD.
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Before investigating the utility of CT image features for characterizing the spatial variation in lung
structure and the resulting influence on treatment‐related response, it is vital to consider the
appropriate implementation and uncertainties involved in image feature calculation methods. While
we have previously analyzed the test‐retest repeatability and respiratory‐related variation of CT image
features extracted from the total lung volume on 4‐dimensional CT (4D‐CT), extension of similar
conclusions to an analysis of regional subvolumes of the lung [55,146] and voxel‐wise feature
determination cannot be assumed. The purpose of the current study is to 1) quantify the variation,
repeatability, and redundancy of CT image features extracted from geometrically‐defined regional
volumes of normal lung and 2) describe the methodology for calculation of voxel‐wise lung CT image
feature maps and assess repeatability of this technique.

METHODS
Patient Selection, CT Image Acquisition, and Lung Volume Segmentation
Details of the patient database and image acquisition methodology have been provided previously in
Chapter 3. Briefly, an institutionally approved protocol at the University of Texas MD Anderson Cancer
Center enrolled 29 non‐small‐cell lung cancer patients. Test‐retest image sets were acquired for each
patient prior to the start of RT using a 4D‐CT acquisition mode. Patients were required to breathe in a
reproducible manner and lie flat for each imaging session, which lasted approximately 30 minutes.
After the first (i.e. test) scan was obtained, each individual left the imaging table and was subsequently
repositioned for a second (i.e. retest) scan. An extended wing board and Vac‐Lok bag (Civco, Orange
City, IA) with standard marking techniques were used for reproducible immobilization during the
imaging session.
One of two available commercial GE CT scanner models were used for 4D‐CT image acquisition: GE
Discovery ST or LightSpeed RT 16 (General Electric Healthcare, Milwaukee, WI). The Real‐Time Position
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Management (RPM) Gating System (Varian Medical Systems, Palo Alto, CA) was used to capture
respiratory motion for later sorting of the reconstructed images. Our clinical protocol sorts the images
into 10 different phases with 0% (T0) indicating end‐inhalation and 50% (T50) being near end‐
exhalation. For treatment planning, all 10 phase image sets from the 4D‐CT data were averaged to
create an additional average (AVG) image set. Scanner and acquisition related characteristics were
previously presented in Table 2.
The total lung volume is defined as the normal lung minus the physician‐contoured GTV. Both the
normal lung and GTV were contoured manually on the AVG image set in an available treatment
planning system, either Eclipse (Varian Medical Systems, Palo Alto, CA) or Pinnacle (Philips Radiation
Oncology Systems, Fitchburg, WI) depending on whether the patient was scheduled to receive proton
or photon RT, respectively. The total lung volume was later propagated to the test and retest T50 image
sets via an in‐house deformable image registration technique [113]. Following an initial rigid
registration, each T50 image set was deformably registered to the corresponding treatment planning
(AVG) CT image set. This generated a deformation vector field that was used to propagate the total
lung contours to the T50 scan. The visual accuracy of each propagated contour was reviewed and any
obvious errors were corrected.

CT Image Feature Extraction: Geometrically‐Defined Subvolumes
Geometrically‐defined subvolumes of the lung were created and used as a region of interest (ROI) for
CT image feature extraction (Figure 24). Each regional subvolume was defined similarly to
Seppenwoolde et al. [55] with the extent of the contoured total lung volume used to determine the
midway plane along the superior‐inferior and anterior‐posterior axes. Additionally, along the coronal
axis, planes at 25% and 75% between the maximum extent of the lung from left to right were found to
create central and distal subvolumes.
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Figure 24. Illustration of the method for defining regional lung subvolumes. Coronal and axial views.

As detailed previously in Chapter 2, an in‐house system was built with MATLAB (Mathworks, Natick,
MA) for extraction of CT image features. Six different radiomics feature classes were considered: 1)
first order histogram features (HIST), 2) gray level co‐occurrence features (GLCM), 3) gray level run
length features (GLRLM), 4) neighborhood gray‐tone difference features (NGTDM), 5) Laws' filtered
features (LAWS2D), and 6) lung‐specific CT Features (LUNG). With a given ROI on each scan, 23 HIST,
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23 GLCM, 11 GLRLM, 5 NGTDM, 8 LAWS2D, and 19 LUNG features were extracted using multiple
options for image preprocessing/filtering, bit depth downsampling, and/or voxel displacement. As a
result, a total of 6528 features were extracted for each geometrically‐defined subvolume with each
available T50 image set. Tests for the differences in feature values extracted from paired regions (e.g.
anterior vs posterior) and from a regional subvolume versus the total lung volume were calculated
using the Wilcoxon signed‐rank test.

CT Image Feature Extraction: Voxel‐wise Feature Calculation
In addition to geometrically‐defined regions, image features were calculated in 31 x 31 pixel ROIs within
the segmented lung volume on each slice of the CT image set similar to Uppaluri et al. [73]. Within the
lung boundaries, the pixel block was translated across the each axial image with a 15 x 15 pixel overlap.
The entire ROI was not required to be fully contained within the lung volume ‐‐‐ it was only necessary
that the center of each ROI was within the delineated volume.
In each ROI, a subset of CT image features was calculated. Unlike in the geometrically‐defined
subvolumes, features were not extracted using all available parameters due to computational
limitations resulting from the increased number of ROIs considered. The feature classes considered are
detailed below with a brief description of the parameters utilized for feature calculation in each ROI:
•

First Order Histogram Features (23 HIST.MAP features): First order histogram features were
extracted using the original, unfiltered CT image set.

•

Gray Level Co‐occurrence Features (23 GLCM.MAP features): The original CT scan was linearly
downsampled to 256 gray levels (bit depth = 8). A GLCM in each of four unique directions (0o, 45o,
90o, and 135o) in the axial plane was calculated and averaged to determine a 2D GLCM with a
displacement distance of 1 pixel. The 2D GLCM was subsequently used to determine the set of
GLCM features.
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•

Gray Level Run Length Features (11 GLRLM.MAP features): As with the GLCM, the original CT scan
was linearly downsampled to 256 gray levels. Four directions in the axial plane were considered
and used to calculate a 2D GLRLM from which the GLRLM features were determined.

•

Laws' Filtered Features (119 LAWS2D.MAP features): Fifteen pairs of Laws' 1x5 filters were
applied to each axial slice of the original image and 8 histogram metrics were subsequently
extracted from each filtered image.

•

Lung‐Specific CT Features (18 LUNG.MAP features): In total, 18 unique features representing the
volume and cluster density of low attenuation areas in the lung were calculated.

On each available CT image set, this resulted in a total of 194 features extracted in each 31 x 31 ROI
spaced on 15 pixel intervals. We then used this information to create a voxel‐wise map for a given
image feature by linearly interpolating to the remaining voxels throughout the lung volume (e.g. Figure
25).
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Figure 25. An example of a voxel‐wise image feature map for a single patient. Axial, coronal, and sagittal
views of the original CT scan and the overlaid feature map (GLCM.MAP.Entropy).

Test‐Retest Repeatability and Redundancy in Geometrically‐Defined Subvolumes
Test‐retest repeatability was assessed using the concordance correlation coefficient (CCC). CCC serves
as a metric of agreement to describe the correlation between two measurements that fall on a 45o line
passing through the origin [114]. The CCC is an index scaled to the range [‐1, 1] where a value of one
indicates perfect agreement between the two measures. CCC was calculated for each feature extracted
in geometrically‐defined ROIs to determine the relative level of agreement that can be achieved in each
subvolume.
Using a method based on Kuhn et al. [115], feature set redundancy was assessed across all
geometrically‐defined ROIs. The pairwise Pearson correlation coefficients were calculated for each
feature using the values extracted from all ROIs in the test‐retest image sets. Initially, the feature set
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was limited to highly repeatable features (CCC

0.95) and then used to generate a non‐redundant

feature set with a maximum pairwise correlation of 0.85. All statistical analyses were performed using
R version 3.2.3 [116].

Test‐Retest Repeatability in Voxel‐wise Feature Maps
Repeatability for each voxel‐wise feature map was also determined via the CCC. On each image set, the
boundaries of the total lung volume similarly define the boundaries of each feature map. To facilitate
voxel‐by‐voxel comparison, a given retest feature map was resized to match the dimensions of the
feature map determined from the test image set obtained for each patient. The CCC was then
calculated with every voxel‐based feature value in the two image sets. For each patient, CCC was
determined for each feature map using the pair of test‐retest image sets. The mean and standard
deviation of CCC across all patients was then calculated for each voxel‐wise feature map to provide a
relative measure of repeatability.

RESULTS
Characterization of Features Extracted from Geometrically‐Defined Subvolumes
Figure 26 demonstrates the differences in multiple features between subvolumes. For example, lung
density tends to be higher in the central as opposed to distal region of the lung. This is similarly the
case in the inferior versus superior and posterior versus anterior subvolumes. There is a statistically
significant difference in 89.6% (6103/6528) features extracted from the central and distal subvolumes.
93.5% and 95.5% of features are significantly different when extracted from the anterior versus
posterior regions or the superior versus inferior regions, respectively. Comparison of the regionally
extracted features to those extracted from the total lung were significantly different in 91.4%, 92.6%,
96%, 93.5%, 86.6%, and 95.2%, of the total available features for the distal, central, superior, inferior,
posterior, and anterior regions, respectively.
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Figure 26. Regional variation in selected image features (Lung Density, LUNG.Reserve, and
GLCM.InDiffMomNorm).

Figure 27 shows the cumulative distribution of CCC values across all features in each of the regional
subvolumes. Using CCC

0.95 as a threshold for repeatability, 97.8%, 97.5%, 98.1%, 97.6%, 98.2%,

and 97.7% of the feature set is repeatable in the distal, central, superior, inferior, posterior, and
anterior regions, respectively. Using the total lung volume for feature extraction, 98.7% of the features
are repeatable. CCC is

0.95 across all subvolumes in 95.6% of the feature set.
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Figure 27. Cumulative distribution of CCC on test‐retest image sets in geometrically‐defined regional
subvolumes of the normal lung.

The pairwise correlation filter approach utilized to limit the redundancy was subsequently applied to
the subset of highly repeatable features. This resulted in a selection of 42 features with a maximum
pairwise correlation of 0.85. A table of these features with the parameters used for calculation are
provided in Table 7.
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Table 7. Full description of non‐redundant and highly repeatable features across all geometrically‐
defined lung subvolumes. Necessary parameters utilized for image feature extraction are provided:
Preproc = Image preprocessing method, BD = Bit depth, Dir = Offset direction, Dist = Offset distance,
Dim = Neighborhood dimension.
Feature
Class
Feature Name
Image Feature Parameters
HIST

Skewness
th

Preproc = 3D Sobel Gradient Filter

HIST

25 Percentile

Preproc = Laplacian of Gaussian Filter
(Size=12; Sigma=2.5)

HIST

99th Percentile

Preproc = Laplacian of Gaussian Filter
(Size=12; Sigma=2.5)

HIST

Entropy

Preproc = Laplacian of Gaussian Filter
(Size=12; Sigma=2.5)

HIST

Minimum

Preproc = Laplacian of Gaussian Filter (Size=6;
Sigma=1.5)

HIST

Kurtosis

Preproc = Local Entropy Filter (NHood=3)

HIST

1st Percentile

Preproc = Threshold ‐750 HU

HIST

Variance

Preproc = Threshold ‐500 HU

GLCM

Contrast

Preproc = None; BD = 4; Dist = 3; Dir = [1 0 0]

GLCM

Sum Variance

Preproc = None; BD = 4; Dist = 5; Dir = [‐1 1 1]

GLCM

Inverse Variance

Preproc = None; BD = 5; Dist = 5; Dir = [1 1 1]

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1; Dir = [0 1 0]

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1; Dir = [1 0 0]

GLCM

Information Measures of Correlation 1

Preproc = None; BD = 7; Dist = 5; Dir = [‐1 1 ‐1]

GLCM

Information Measures of Correlation 1

Preproc = None; BD = 8; Dist = 1; Dir = [1 0 0]

GLCM

Max Probability

Preproc = None; BD = 8; Dist = 3; Dir = [‐1 1 0]

GLCM

Cluster Prominence

Preproc = None; BD = 8; Dist = 3; Dir = [1 1 ‐1]

GLRLM

Long Run High Gray Level Emphasis

Preproc = None; BD = 4; Dir = [‐1 1 ‐1]

GLRLM

Short Run Low Gray Level Emphasis

Preproc = None; BD = 4; Dir = [0 1 0]

GLRLM

Short Run Emphasis

Preproc = None; BD = 4; Dir = [1 0 0]

GLRLM

Gray Level Nonuniformity

Preproc = None; BD = 4; Dir = [1 0 0]

GLRLM

Long Run High Gray Level Emphasis

Preproc = None; BD = 5; Dir = [‐1 1 ‐1]

GLRLM

Short Run Low Gray Level Emphasis

Preproc = None; BD = 5; Dir = [1 0 0]

GLRLM

Long Run High Gray Level Emphasis

Preproc = None; BD = 6; Dir = [1 0 0]

LAWS2D

L5E5_Mean

Preproc = None

LAWS2D

L5E5_Skewness

Preproc = None

LAWS2D

L5E5_Uniformity

Preproc = None

LAWS2D

L5S5_Skewness

Preproc = None

LAWS2D

L5S5_Uniformity

Preproc = None

LAWS2D

L5W5_Mean

Preproc = None

LAWS2D

E5S5_Skewness

Preproc = None
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LAWS2D

E5S5_Uniformity

Preproc = None

LAWS2D

E5W5_Mean

Preproc = None

LAWS2D

S5R5_Skewness

Preproc = None

LAWS2D

W5R5_Mean

Preproc = None

LAWS2D

R5R5_Mean

Preproc = None

LAWS2D

R5R5_Variance

Preproc = None

LUNG

Preproc = None

LUNG

%Reserve

Preproc = None

LUNG

Cluster Count

Preproc = None

LUNG

Mean Cluster Volume

Preproc = None

LUNG

Cluster Count

Preproc = None

Characterization of Voxel‐wise Feature Maps
An example of the gray level co‐occurrence matrix calculated entropy feature map
(GLCM.MAP.Entropy) is presented in Figure 25. After downsampling the image bit depth to 256 gray
levels (bit depth = 8), a 31 x 31 pixel ROI is translated across each axial slice of the image, spaced every
15 pixels. In each ROI, co‐occurrence matrices are calculated in 4 different directions (0o, 45o, 90o, and
135o) with a single voxel displacement and subsequently averaged to give a 2D, non‐directional GLCM.
From this 2D GLCM, the resulting co‐occurrence features, including entropy, are determined at each
ROI location. This value is assigned to the center pixel and then interpolation throughout the remaining
lung volume completes voxel‐wise feature map calculation. GLCM entropy, which can be considered a
measure of image randomness, is lower in more homogeneous areas of the lung volume and higher in
areas with a considerable amount of inhomogeneity. Two areas are highlighted in Figure 25 to
demonstrate such differences. This same process was applied to generate 194 different voxel‐wise
feature maps for each patient.
For most feature maps, there is good visually observed agreement in the distribution of feature values
between the pair of test‐retest images. Figure 28 demonstrates GLCM entropy for three different
patients with varying degrees of repeatability determined by calculating the CCC. The patient presented
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in the right‐most panel has a substantially reduced CCC and an area of notable difference is marked.
On review of this patient's images and contours, we believe the difference is likely a function of
inaccuracy in structure delineation due to large, branching pulmonary vessels. This is a primary
contributor to the reduced repeatability in this patient. With each feature map, CCC was determined
using each pair of test‐retest images and subsequently averaged across all patients to facilitate
reporting of a single metric. While the repeatability was not as high for most feature maps as was
observed using the regionally‐defined subvolumes, averaged voxel‐wise CCC

0.8 was noted in 24 of

194 maps considered. The mean and standard deviation of the averaged voxel‐wise CCC for this subset
of feature maps is given in Table 8.

Figure 28. Test and retest GLCM.MAP.Entropy feature maps for three different patients. Top row is the
test map, middle row is the retest map, and the bottom row is a scatter plot of all voxel values in the
test versus retest scan to illustrate relative agreement.
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Table 8. Voxel‐wise feature map repeatability assessed via the concordance correlation coefficient.
Features maps with average CCC (across all patient test‐retest image sets) 0.8
Feature Class Feature Name Mean CCC SD CCC Mean Spearman Rank SD Spearman Rank
HIST.MAP

Sum

0.828

0.071

0.831

0.077

HIST.MAP

Mean

0.823

0.069

0.851

0.060

HIST.MAP

Per10

0.812

0.087

0.839

0.071

HIST.MAP

Per25

0.812

0.091

0.855

0.065

HIST.MAP

Per90

0.803

0.070

0.812

0.067

HIST.MAP

Per95

0.800

0.074

0.790

0.073

HIST.MAP

Entropy

0.807

0.074

0.808

0.070

HIST.MAP

Energy

0.817

0.074

0.832

0.067

HIST.MAP

RMS

0.821

0.067

0.835

0.063

GLCM.MAP

Entropy

0.812

0.077

0.814

0.073

GLCM.MAP

Homogeneity1

0.800

0.093

0.814

0.083

GLCM.MAP

SumAverage

0.823

0.070

0.852

0.061

GLCM.MAP

SumEntropy

0.806

0.073

0.806

0.069

GLRLM.MAP

GLNU

0.801

0.079

0.800

0.074

GLRLM.MAP

HGRE

0.800

0.073

0.829

0.064

GLRLM.MAP

SRHGE

0.803

0.072

0.828

0.064

LAWS2D.MAP

L5L5_Mean

0.828

0.070

0.856

0.064

LAWS2D.MAP

L5L5_Energy

0.818

0.076

0.843

0.069

LAWS2D.MAP

L5L5_RMS

0.828

0.065

0.850

0.065

LAWS2D.MAP

L5E5_Energy

0.817

0.078

0.821

0.068

LAWS2D.MAP

L5E5_RMS

0.809

0.074

0.812

0.067

LAWS2D.MAP

L5S5_Energy

0.809

0.085

0.805

0.073

LUNG.MAP

LAA856

0.802

0.120

0.810

0.100

LUNG.MAP

Reserve

0.807

0.090

0.809

0.090

DISCUSSION
In the current study, we have considered the variation and repeatability of regional CT‐based image
features extracted from the normal lung subvolumes. For a majority of the considered features, simple
statistical analysis demonstrated a significant difference between opposing (e.g. anterior versus
posterior 50%) regions as well as difference between regional and global (i.e. total lung) extracted
features. Additionally, test‐retest repeatability was high (95.6% of features CCC

0.95) across all
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subvolumes and comparable to that achieved with the total lung volume (98.7% features CCC

0.95).

Due to the application of multiple methods for image preprocessing/filtering, bit depth downsampling,
and/or voxel displacements, there was substantial redundancy in the extracted features across all
regions. A simple correlation‐based filter was applied to reduce the feature set to a total of 42 non‐
redundant (Pearson

0.85) and highly repeatable features to consider in future applications. We

have also detailed our method for voxel‐wise calculation of CT‐based image feature maps. Qualitatively,
these feature maps are consistent with straightforward examination of the underlying image
characteristics (e.g. GLCM entropy, Figure 25). Furthermore, most feature maps are visually similar
when extracted from test and retest images. Voxel‐wise test‐retest analysis identified a subset of 24
maps that are considered moderately repeatable (CCC

0.8) across the investigated patient

population. Principally, whether defined by regional subvolumes or voxel‐based calculation, we have
demonstrated that CT‐based features vary across the lung volume due to the underlying
heterogeneous composition of the organ.
Previously we broadly characterized 4D‐CT based image feature reproducibility and repeatability in the
total lung volume (Chapter 3). Anatomical variation in lung volume is the primary obstacle to achieving
reproducible measures of lung density [117] and texture in the total lung volume (Chapter 3). To
minimize this effect, we have limited our analysis here to that of near end‐exhale (i.e. T50) images
acquired under quiet respiration via 4D‐CT. T50 images provided the highest overall repeatability using
the same set of extracted image features with the total lung volume (Chapter 3), but extension of these
results to geometrically‐defined regions of normal lung and voxel‐wise feature map calculation was not
previously considered.
Based on the heterogeneous nature of the lung, differences in geometrically‐defined regional lung
structure and function have been considered in different contexts. Animal models have demonstrated
a difference in radiosensitivity between the apex and base of the lung [147–149]. This led to the
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consideration of regional lung sensitivity (e.g. superior versus inferior subvolumes) as a potential means
to differentiate patients at risk of developing symptomatic RILD following RT [146]. Additional
examination was given to the regional differences in SPECT perfusion as means for quantifying
radiosensitivity [55]. Outside of an RT setting, Uppaluri et al. [72] demonstrated differences in lung
density and texture measures between anterior and posterior subvolumes of the lung. This work forms
the basis for characterizing regional differences in CT‐based image features in the current study.
Our methodology for calculation of voxel‐wise feature maps was largely based on the work of Uppaluri
et al. [73]. The choice of a 31 x 31 pixel ROI and 15 pixel overlap is consistent with other
implementations, but may vary depending on the application [150]. As an example, Cunliffe et al. [79]
have utilized non‐overlapping 32 x 32 pixel ROIs fully contained within the lung volume on CT. With
each ROI, severity of radiation damage was scored by a radiologist and image feature extraction was
performed to objectively quantify lung tissue damage after RT [79]. While we did not require that an
ROI be fully contained within the lung volume, pixels outside the contoured lung volume were excluded
from feature calculation. Other methods exist to extrapolate tissue in these "deficient" ROIs to permit
calculation of other texture feature classes (e.g. Fourier transform descriptors) [151], but this was not
a limitation with the current feature classes we considered. Extension of this voxel‐wise feature map
methodology to three dimensions as opposed to a two‐dimensional, slice‐by‐slice technique may also
be warranted [76–78]. A voxel‐by‐voxel calculation may also be preferred over a 15 pixel overlap with
linear interpolation as we have performed. Our goal, however, was not to provide a comprehensive
analysis of the various parameters or features that could be employed for feature map generation.
Optimization of such parameters could be considered for specific clinical applications.
Our preferred method to assess test‐retest repeatability is the concordance correlation coefficient.
Though not without its limitations, CCC provides a relative measure of agreement that facilitates
comparison of features with different scale. Four‐dimensional CT‐based lung ventilation has been
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investigated with voxel‐based Spearman rank correlation as means to quantitatively assess
reproducibility [152]. Accordingly, we have also provided the Spearman rank correlation for each of our
feature maps in Table 8. While CCC is a measure of agreement and Spearman rank is a nonparametric
measure of correlation, both measures return similar values in the current analysis (Table 8). As
reported by Yamamoto et al. [152], voxel‐based correlation between pairs of ventilation images is 0.50
0.15, less than observed with test‐retest image feature maps. Unlike 4D‐CT based ventilation,
however, we are not creating a feature map that relies on voxel‐wise correspondence ‐‐‐ we are using
relatively large ROIs (31 x 31 pixels) spaced on equal intervals and interpolating throughout the lung
volume. Creation of feature maps with smaller ROIs and/or with a smaller calculation grid (e.g. at each
voxel in the lung volume) would likely introduce more variation in the resulting map due to image noise
and physiologic change in the lung. The result of this would likely be an undesired decrease in the
repeatability of a feature map. The method we have implemented, however, is robust to quantify local
changes in lung structure while still providing a sufficient level of repeatability. Additionally, depending
on the application, acceptable levels in regional or voxel‐wise repeatability may differ and necessitate
a change in the suggested CCC thresholds. It may also be of interest to consider adapting a gamma
index metric [153] to consider both the absolute difference in voxel‐based features and the distance
to agreement [154,155] to better quantify repeatability.
CT‐based image features are inherently limited to poor generalizability across image acquisition
parameters and scanner designs [122–125]. In the current study, acquisition parameters were
consistent and patients were scanned on one of two different GE model CT scanners. This contributed
to high repeatability in the regional and feature map analyses presented, but performance will likely
diminish if the same methodology and features are applied to different datasets. Due to the high
repeatability measured, the approach for lung volume delineation appears satisfactory for regional
subvolume analysis; however, relatively minor discrepancies in lung contouring can negatively impact
feature map calculation, as highlighted by Figure 28. Lung segmentation via automated multi‐step
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thresholding [127] or application of model‐based methods [156] may improve repeatability and overall
accuracy of voxel‐wise feature maps. Furthermore, the registration of retest to test feature maps based
on the identification of the lung boundaries is simplistic. The anatomical variation is minimal between
test and retest acquisition, which is sufficient to allow use of this naive registration method in the
present study. There may, however, be improvement in repeatability if retest image derived feature
maps were deformably registered to the corresponding test image. More sophisticated methods of
registration should be used if feature maps are to be compared when calculated from images obtained
under different respiratory conditions (e.g. end‐exhale versus end‐inhale) or from images acquired as
part of a longitudinal study.

CONCLUSIONS
Regional and voxel‐based methods of calculating CT‐based radiomics features in the normal lung have
been explored. Before the spatial differences in the lung and the potential relationship to RT‐induced
damage can be considered, we have characterized a set of features by considering test‐retest
reproducibility and feature set collinearity. Accordingly, we have identified a non‐redundant set of
highly repeatable features. Additionally, we have proposed a method to calculate image features on a
voxel‐wise basis and have revealed a subset with sufficient repeatability to be analyzed in future work.
The heterogeneous composition of the lung can be quantified with the methods considered.
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CHAPTER 6: INVESTIGATION OF THE RELATIONSHIP BETWEEN
RADIATION PNEUMONITIS AND THE SPATIAL DIFFERENCES IN CT‐BASED
LUNG RADIOMICS FEATURES
INTRODUCTION
Radiation‐induced lung damage (RILD) is a major issue for non‐small‐cell lung cancer (NSCLC) patients
treated with radiation therapy (RT). Its symptomatic manifestation, radiation pneumonitis (RP), is the
chief dose‐limiting toxicity and presents a challenge to realizing optimal curative potential. Numerous
studies have been published on the radiation dose‐volume effect in the lung as it relates to the
incidence of RP [16,157–163]. This has resulted in the implementation of dose‐volume parameter
guidelines to minimize the risk of RP development [2]; however, approximately 15‐20% of NSCLC
patients treated with standard of care, conventionally fractionated RT for thoracic tumors go on to
develop RP. Additionally, the risk of RP can limit treatment in patients that might benefit from escalated
dose to the tumor volume [5–10].
While many dose‐volume histogram (DVH) parameters have been correlated with the rate of RP, the
influence of characteristics unique to the lung anatomy have also been considered. Specifically, several
groups have investigated how the spatial location of deposited dose may alter RILD incidence. In animal
models it has been shown that the radiation‐induced response of the lung depends on the location of
the irradiated volume [147–149,164] with the base of the lung being more radiosensitive. This may
reflect differences in the anatomy of the tracheobronchial tree [147], the distribution of target cells in
the lung [164], and/or regional differences in DNA damage repair mechanisms [148,149]. In the NSCLC
patient population, superior‐inferior spatial sensitivity been reported in multiple studies [26,27,55,146]
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and in pooled analysis [19], but similar studies on large cohorts have not reproduced these findings
[101,165,166].
Advanced quantitative image methods (e.g. texture analysis) with lung CT have been shown to
successfully localize and distinguish between normal, smoking and diseased lung [72–78]. This suggests
that quantifiable measures of lung structure may be surrogates of lung functional status. Furthermore,
though dose is the primary driver of toxicity, previous results have indicated that smoking status
[23,167,168], pre‐existing interstitial lung disease [65,66,169–171], and COPD [67,68,172] are
correlated with and improve prediction of RP. We believe that quantifying the local differences in
underlying lung pathologies (e.g. normal versus smoking/COPD lung parenchyma) using quantitative
image (i.e. radiomics [83–85,89]) features extracted from CT image sets may ultimately be correlated
to the development of symptomatic RILD.
Our goal here was to explore the relationship between RP and the spatial variation in CT‐based image
features in a cohort of NSCLC patients treated with RT. We have considered differences in CT image
features extracted from regional subvolumes of the lung as they relate to the observed incidence of
RP. Additionally, using a methodology to calculate image feature maps on a voxel‐by‐voxel basis in the
normal lung volume, we have investigated the difference between the spatial distribution of CT image
features and RP.

METHODS
Patient Database and Endpoint Definition
Between 08/2004 and 02/2009, 192 NSCLC patients treated with definitive RT at The University of
Texas MD Anderson Cancer Center were considered in this retrospective study. All patients were
treated with standard fractionation (180 ‐ 225 cGy) once daily. Total delivered dose was between 5940
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and 7425 cGy. Treatment was delivered with intensity modulated (159/192, 80%) or 3D conformal
(33/192, 20%) RT, with or without chemotherapy.
RP events were scored by the treating physician according to the Common Terminology Criteria for
Adverse Events v3.0. Two separate endpoints were considered in the presented analysis: 1) severe RP,
grade

3, where grade 3 RP is defined as symptomatic, interfering with activities of daily living or

oxygen indicated and 2) moderate RP, grade

2, where grade 2 RP is defined as symptomatic, but not

interfering with activities of daily living. To be considered in this retrospective analysis, patients were
required to have a minimum of 6 months follow up unless severe toxicity was observed earlier.

CT Image Acquisition and Segmentation
One of two available commercial CT scanners models was used for 4D‐CT treatment planning
simulation: GE Discovery ST or GE LightSpeed RT 16 (General Electric Healthcare, Milwaukee, WI). With
the assistance of the Real‐Time Position Management (RPM) Gating System (Varian Medical Systems,
Palo Alto, CA), 4D‐CT phase reconstruction was performed by sorting the images into 10 different
phases with 0% (T0) indicating end‐inhalation and 50% (T50) being near end‐exhalation. All scans were
acquired under free breathing with a cine 4D scan mode using 120 kVp, slice thickness of 2.5 mm, axial
pixel dimensions of 0.977 x 0.977 mm with the body filter and reconstructed with the standard
convolution kernel.
The total lung was delineated using a semi‐automatic region growing algorithm on the T50 image set.
The total lung region of interest (ROI) was subsequently defined as the T50 total lung volume minus
the clinically delineated GTV. All dose calculations and structure contouring were performed using the
Pinnacle3 treatment planning system (Philips HealthCare, Fitchburg, WI). Reported dosimetric data was
obtained by recalculating the original treatment plan on the T50 CT image set.
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CT Image Feature in Geometrically‐Defined Regional Subvolumes
As in Chapter 5, a manner similar to Seppenwoolde et al. [55] was applied to create geometrically‐
defined subvolumes of the total lung for subsequent image feature extraction (Figure 24). In the
superior‐inferior and anterior‐posterior orientation, the midway plane of the box encompassing the
total lung volume was used to define the superior, inferior, anterior, and posterior regional subvolumes
of the total lung. Planes at 25% and 75% of the total lung bounding box along the coronal axis were
used to create central and distal subvolumes. Additionally, the ipsilateral lung volume for each patient
was defined by identifying the lung (right or left) that contained the GTV centroid. This facilitated
determination of the contralateral lung volume as well.
The previously detailed MATLAB‐based system was used to image extract features from each
geometrically‐defined region of interest using six different radiomics feature classes: 1) first‐order
histogram (HIST), gray level co‐occurrence (GLCM), gray level run length (GLRLM), neighborhood gray
tone difference (NGTDM), Laws' filtered (LAWS2D), and lung specific (LUNG) features. A subset of non‐
redundant (Pearson

0.85) image features with high test‐retest reproducibility (CCC

0.95) was

previously identified in Chapter 5 on a separate patient cohort. This feature subset was determined
with regional lung subvolumes extracted from images acquired and reconstructed under similar
respiratory conditions. Consequently, a total of 42 features extracted from each region were
considered in this study (Table 9). Additionally, the planned dose distribution was used to calculate the
mean regional dose (MRD) in each subvolume considered.
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Table 9. Full description of non‐redundant features across all geometrically‐defined lung subvolumes.
Necessary parameters utilized for image feature extraction are provided: Preproc = Image preprocessing
method, BD = Bit depth, Dir = Offset direction, Dist = Offset distance, Dim = Neighborhood dimension.
Feature
Printed Feature Name
Class
Feature Name
Image Feature Parameters
HIST.Skewness

HIST

Skewness

Preproc = 3D Sobel Gradient Filter

HIST.Per25

HIST

25th Percentile

Preproc = Laplacian of Gaussian
Filter (Size=12; Sigma=2.5)

HIST.Per99

HIST

99th Percentile

Preproc = Laplacian of Gaussian
Filter (Size=12; Sigma=2.5)

HIST.Entropy

HIST

Entropy

Preproc = Laplacian of Gaussian
Filter (Size=12; Sigma=2.5)

HIST.Min

HIST

Minimum

Preproc = Laplacian of Gaussian
Filter (Size=6; Sigma=1.5)

HIST.Kurtosis

HIST

Kurtosis

Preproc = Local Entropy Filter
(NHood=3)

HIST.Per01

HIST

1st Percentile

Preproc = Threshold ‐750 HU

HIST.Variance

HIST

Variance

Preproc = Threshold ‐500 HU

GLCM.Contrast

GLCM

Contrast

Preproc = None; BD = 4; Dist = 3;
Dir = [1 0 0]

GLCM.SumVariance

GLCM

Sum Variance

Preproc = None; BD = 4; Dist = 5;
Dir = [‐1 1 1]

GLCM.InVariance.1

GLCM

Inverse Variance

Preproc = None; BD = 5; Dist = 5;
Dir = [1 1 1]

GLCM.InVariance.2

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1;
Dir = [0 1 0]

GLCM.InVariance.3

GLCM

Inverse Variance

Preproc = None; BD = 7; Dist = 1;
Dir = [1 0 0]

GLCM.InfoMC1

GLCM

Information
Measures of
Correlation 1

Preproc = None; BD = 7; Dist = 5;
Dir = [‐1 1 ‐1]

GLCM.InfoMC2

GLCM

Information
Measures of
Correlation 1

Preproc = None; BD = 8; Dist = 1;
Dir = [1 0 0]

GLCM.MaxProb

GLCM

Max Probability

Preproc = None; BD = 8; Dist = 3;
Dir = [‐1 1 0]

GLCM.ClusterProminence

GLCM

Cluster Prominence

Preproc = None; BD = 8; Dist = 3;
Dir = [1 1 ‐1]

GLRLM.LRHGE.1

GLRLM

Long Run High Gray
Level Emphasis

Preproc = None; BD = 4; Dir = [‐1 1
‐1]

GLRLM.SRLGE.1

GLRLM

Short Run Low Gray
Level Emphasis

Preproc = None; BD = 4; Dir = [0 1
0]

GLRLM.SRE

GLRLM

Short Run Emphasis

Preproc = None; BD = 4; Dir = [1 0
0]
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GLRLM.GLNU

GLRLM

Gray Level
Nonuniformity

Preproc = None; BD = 4; Dir = [1 0
0]

GLRLM.LRHGE.2

GLRLM

Long Run High Gray
Level Emphasis

Preproc = None; BD = 5; Dir = [‐1 1
‐1]

GLRLM.SRLGE.2

GLRLM

Short Run Low Gray
Level Emphasis

Preproc = None; BD = 5; Dir = [1 0
0]

GLRLM.LRHGE.3

GLRLM

Long Run High Gray
Level Emphasis

Preproc = None; BD = 6; Dir = [1 0
0]

LAWS2D.Mean.1

LAWS2D

L5E5_Mean

Preproc = None

LAWS2D.Skewness.1

LAWS2D

L5E5_Skewness

Preproc = None

LAWS2D.Uniformity.1

LAWS2D

L5E5_Uniformity

Preproc = None

LAWS2D.Skewness.2

LAWS2D

L5S5_Skewness

Preproc = None

LAWS2D.Uniformity.2

LAWS2D

L5S5_Uniformity

Preproc = None

LAWS2D.Mean.2

LAWS2D

L5W5_Mean

Preproc = None

LAWS2D.Skewness.3

LAWS2D

E5S5_Skewness

Preproc = None

LAWS2D.Uniformity.3

LAWS2D

E5S5_Uniformity

Preproc = None

LAWS2D.Mean.3

LAWS2D

E5W5_Mean

Preproc = None

LAWS2D.Skewness.4

LAWS2D

S5R5_Skewness

Preproc = None

LAWS2D.Mean.4

LAWS2D

W5R5_Mean

Preproc = None

LAWS2D.Mean.5

LAWS2D

R5R5_Mean

Preproc = None

LAWS2D.Variance

LAWS2D

R5R5_Variance

Preproc = None

LUNG.LAA960

LUNG

LUNG.ReservePer

LUNG

%Reserve

Preproc = None

LUNG.Number910

LUNG

Cluster Count

Preproc = None

LUNG.MeanVol910

LUNG

Mean Cluster Volume

Preproc = None

LUNG.Number960

LUNG

Cluster Count

Preproc = None

Preproc = None

Comparison of features extracted from a regional subvolume versus the total lung was determined by
calculating the Pearson correlation coefficient. Univariable logistic regression was utilized to determine
whether MRD was significantly associated with RP. This was similarly applied to each regionally‐
extracted image feature with p‐values being adjusted using the Benjamini & Hochberg false discovery
rate method [132] to account for multiple comparisons. All statistical analyses were performed using
R version 3.2.3 [116].
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Voxel‐based CT Image Feature Maps
Within the total lung volume, voxel‐based feature maps were calculated using the same methodology
detailed in Chapter 5. We translated a 31 x 31 pixel ROI across each slice of the CT image set similar to
Uppaluri et al. [73]. Within each ROI, image features were calculated using our MATLAB software. Each
31 x 31 ROI was spaced on 15 pixel intervals, but linear interpolation throughout the remaining lung
volume was used to create each feature map (e.g. Figure 25).
Previous analysis in Chapter 5 of test‐retest feature map calculation on a similar cohort identified a
subset of highly repeatable feature maps (average voxel‐wise CCC

0.80). We limit our current analysis

to this subset of 24 feature maps (Table 10). Furthermore, to facilitate voxel‐wise comparison of
feature maps between patients, the total lung bounding box was used to crop each map and resize the
result to a 3 dimensional array with common dimensions of 60 x 90 x 30.
Table 10. Full description of feature maps considered with necessary parameters utilized for image
feature extraction: Preproc = Image preprocessing method, BD = Bit depth, Dir = Offset direction, Dist =
Offset distance, Dim = Neighborhood dimension.
Image Feature
Printed Feature Name
Feature Class Feature Name
Parameters
HIST.MAP.Sum

HIST.MAP

Sum

Preproc = None

HIST.MAP.Mean

HIST.MAP

Mean

Preproc = None

HIST.MAP.Per10

HIST.MAP

th

10 Percentile

Preproc = None

HIST.MAP.Per25

HIST.MAP

25th Percentile

Preproc = None

HIST.MAP.Per90

HIST.MAP

th

Preproc = None

th

90 Percentile

HIST.MAP.Per95

HIST.MAP

95 Percentile

Preproc = None

HIST.MAP.Entropy

HIST.MAP

Entropy

Preproc = None

HIST.MAP.Energy

HIST.MAP

Energy

Preproc = None

HIST.MAP.RMS

HIST.MAP

Root Mean Square

Preproc = None

GLCM.MAP.Entropy

GLCM.MAP

Entropy

Preproc = None; BD = 8;
Dist = 1; Dim = 2D

GLCM.MAP.Homogeneity1

GLCM.MAP

Homogeneity 1

Preproc = None; BD = 8;
Dist = 1; Dim = 2D

GLCM.MAP.SumAverage

GLCM.MAP

Sum Average

Preproc = None; BD = 8;
Dist = 1; Dim = 2D
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GLCM.MAP.SumEntropy

GLCM.MAP

Sum Entropy

Preproc = None; BD = 8;
Dist = 1; Dim = 2D

GLRLM.MAP.GLNU

GLRLM.MAP

Gray Level
Nonuniformity

Preproc = None; BD = 8;
Dim = 2D

GLRLM.MAP.HGRE

GLRLM.MAP

High Gray Level Run
Emphasis

Preproc = None; BD = 8;
Dim = 2D

GLRLM.MAP.SRHGE

GLRLM.MAP

Short Run High Gray
Level Emphasis

Preproc = None; BD = 8;
Dim = 2D

LAWS2D.MAP.L5L5_Mean

LAWS2D.MAP L5L5_Mean

Preproc = None

LAWS2D.MAP.L5L5_Energy

LAWS2D.MAP L5L5_Energy

Preproc = None

LAWS2D.MAP.L5L5_RMS

LAWS2D.MAP L5L5_RMS

Preproc = None

LAWS2D.MAP.L5E5_Energy LAWS2D.MAP L5E5_Energy

Preproc = None

LAWS2D.MAP.L5E5_RMS

LAWS2D.MAP L5E5_RMS

Preproc = None

LAWS2D.MAP.L5S5_Energy

LAWS2D.MAP L5S5_Energy

Preproc = None

LUNG.MAP.LAA856

LUNG.MAP

Preproc = None

LUNG.MAP.Reserve

LUNG.MAP

Reserve

Preproc = None

To illustrate potential differences in a voxel‐based feature map, two maps were formed by taking the
median voxel value among the patients with and patients without RP. The resulting median maps were
compared on a voxel‐by‐voxel basis with the concordance correlation coefficient (CCC) [114].

RESULTS
Thirty of 192 (15.6%) patients presented with severe RP (grade
(grade

3) after RT. Moderate to severe RP

2) was observed in 42.7% of the population studied. The distribution of CTCAE v3.0 RP scores

is presented in Figure 29. No statistically significant association between mean dose to any subvolume
and RP was observed for either of the endpoints considered (Table 11).
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Figure 29. Distribution of RP scores. Of 192 patients, 45 patients were grade 0, 65 were grade 1, 52 were
grade 2, 28 were grade 3, 0 were grade 4, and 2 were scored as grade 5.

Table 11. Association between mean regional doses and RP. P values were determined from univariable
logistic regression analysis.
Region
Mean Regional Dose (Gy) p value, Severe RP p value, Moderate RP
Anterior

19.0

0.793

0.985

Posterior

18.5

0.523

0.384

Inferior

12.6

0.245

0.384

Superior

25.2

0.383

0.384

Central

23.0

0.766

0.820

Distal

14.9

0.450

0.384

Ipsilateral Lung

31.5

0.245

0.395

Contralateral Lung

7.8

0.245

0.783

Total Lung

18.7

0.531

0.447

Generally, features extracted from regional subvolumes were correlated with features calculated using
the total lung volume. Of the investigated features, 39, 38, 37, 36, 36 and 37 had pairwise Pearson
correlation with the total lung features

0.7 in the distal, central, posterior, anterior, ipsilateral, and
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contralateral subvolumes, respectively. In the superior and inferior volumes, all features were highly
correlated (

0.7) to the total lung extracted values.

Univariable logistic regression analysis of the regionally‐extracted image features returned a small
subset significantly associated (FDR‐adjusted p value

0.05) with RP (Table 12). In total, there were 12

different features that met these criteria in at least one regional subvolume or the total lung. Nine of
12 features were significant when extracted from the total lung region. One feature, HIST.Variance,
was significant in all of the regions considered. Figure 30 shows HIST.Variance was greater among the
patients who did develop RP across all regions. Since the superior‐inferior differences were of particular
interest, two different features that were significant in only the superior or inferior volumes were
investigated further in Figure 31. Values for these two features extracted in the superior subvolume
were plotted against the inferior subvolume. Feature values between the two regions appear
correlated and fail to reveal a regional relationship in the distribution of RP events. Similar regional
analysis of the image features with moderate RP did not return a single significant result.
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Table 12. Regional features with significant association to severe RP as determined via univariable logistic regression.
Anterior

Posterior

Inferior

Superior

Central

Distal

Ipsilateral Lung

Contralateral
Lung

Total Lung

HIST Kurtosis

HIST Per01

HIST Kurtosis

HIST Per01

HIST Kurtosis

HIST
Variance

HIST Per01

HIST Kurtosis

HIST Kurtosis

HIST Variance

HIST
Variance

HIST Variance

HIST Variance

HIST Per01

GLCM
ClustProm

HIST Variance

HIST Variance

HIST Per01

GLCM
InfoMC2

GLCM
InVariance 2

GLRLM GLNU

GLCM
InfoMC2

HIST Variance

LUNG
ReservePer

GLCM
ClustProm

GLCM
InfoMC2

HIST Variance

GLRLM GLNU

GLCM
InfoMC2

LAWS2D
Mean 5

GLCM
ClustProm

GLCM
InVariance 2

LUNG LAA960

GLRLM GLNU

GLCM
InfoMC2

LUNG LAA960

GLCM
ClustProm

LUNG LAA960

GLRLM LRHGE
2

GLCM InfoMC2

LUNG
MeanVol910

LUNG LAA960

GLCM
ClustProm

LUNG
MeanVol910

LUNG
LAA960

LUNG
ReservePer

LUNG LAA960

GLCM
ClustProm

LUNG
ReservePer

GLRLM GLNU

LUNG
ReservePer

LUNG
MeanVol910

LUNG
ReservePer

GLRLM GLNU

LUNG
MeanVol910

LUNG LAA960

LUNG
MeanVol910

LUNG LAA960

LUNG
ReservePer

LUNG
ReservePer

LUNG
MeanVol910

LUNG
MeanVol910
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Figure 30. Distribution of HIST.Variance calculated in each of the subvolumes considered and grouped
by endpoint (severe RP).

Figure 31. GLRLM.LRHGE.2 and LAWS2D.Mean.5 extracted from the superior subvolume versus the
inferior subvolume. Both features were significantly associated with RP in univariable analysis in either
the superior (GLRLM.LRGHE) or inferior (LAWs2D.Mean) regions.
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Agreement determined by CCC between the median maps generated for patients with and without
severe RP is given in Table 13. Nineteen of 24 maps had a CCC

0.8, indicating a relatively high degree

of similarity between the two groups of patients and the absence of an image feature defined spatial
effect. Voxel‐by‐voxel comparison of three distinct feature maps with varying levels of relative
agreement is presented in Figure 32. Across the population, LUNG.MAP.Reserve is the least similar in
patients with and without severe RP as indicated by a CCC of 0.392. This is evident in Figure 32, as the
voxel‐wise difference in this feature is generally higher in the subset of patients that did not develop
severe RP. It is noted that this difference is roughly uniform across the entire lung volume suggesting
there is no clear spatial variation. Only 2 features had a CCC

0.8 when the population was divided

based on moderate RP, indicating reduced ability to differentiate the feature maps relative to those
generated with severe RP as the endpoint.
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Figure 32. Midplane coronal views of median feature maps for LUNG.MAP.Reserve, GLCM.MAP.Entropy,
and LAWS2D.MAP.L5S5_Energy. Top row is the median map for patients with severe RP, middle row is
median map for patients without severe RP, and the bottom row is the resulting difference.
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Table 13. Agreement between median feature maps for patient with and without RP as determined by
CCC.
Printed Feature Name
CCC, Severe RP CCC, Moderate RP
HIST.MAP.Sum

0.854

0.939

HIST.MAP.Mean

0.799

0.918

HIST.MAP.Per10

0.598

0.830

HIST.MAP.Per25

0.675

0.866

HIST.MAP.Per90

0.867

0.937

HIST.MAP.Per95

0.903

0.949

HIST.MAP.Entropy

0.802

0.910

HIST.MAP.Energy

0.877

0.942

HIST.MAP.RMS

0.848

0.933

GLCM.MAP.Entropy

0.808

0.912

GLCM.MAP.Homogeneity1

0.806

0.894

GLCM.MAP.SumAverage

0.802

0.920

GLCM.MAP.SumEntropy

0.802

0.914

GLRLM.MAP.GLNU

0.829

0.918

GLRLM.MAP.HGRE

0.854

0.936

GLRLM.MAP.SRHGE

0.856

0.937

LAWS2D.MAP.L5L5_Mean

0.812

0.926

LAWS2D.MAP.L5L5_Energy

0.904

0.950

LAWS2D.MAP.L5L5_RMS

0.851

0.940

LAWS2D.MAP.L5E5_Energy

0.944

0.967

LAWS2D.MAP.L5E5_RMS

0.919

0.962

LAWS2D.MAP.L5S5_Energy

0.945

0.966

LUNG.MAP.LAA856

0.428

0.759

LUNG.MAP.Reserve

0.392

0.779

DISCUSSION
The presented work explores the spatial relationship between RP incidence and CT‐based radiomics
features extracted in the normal lung. Generally, there is high correlation between features extracted
from regional subvolumes to those extracted from the total volume. This suggests there is insufficient
regionally‐defined spatial variation in such measures. However, a limited subset of features was found
to be significantly associated with severe RP (Table 12). Voxel‐wise analysis of image feature maps
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similarly failed to identify a clear spatially related difference among the patients who develop severe
RP, but uniform differences across the lung volume were observed with some feature maps (e.g.
LUNG.MAP.Reserve, Figure 32). When this analysis was repeated with moderate RP (grade

2), no

significant regional feature was isolated and the relative similarity of feature maps between patients
with and without moderate RP was high. With the moderate RP endpoint, we fail to identify a spatial
effect and also fail to demonstrate that normal lung characterized by such image features is associated
with RP incidence.
In contrast to previous work [55,146,165], we did not identify mean dose to any region of the lung
volume or the total lung to be related with RP incidence. Both Yorke et al. [146] and Seppenwoolde et
al. [55] identified dose to the inferior subvolume to be significantly correlated with RP grade

3.

Vinogradskiy et al. [165] were unable to identify a spatial difference between dose to the superior and
inferior subvolumes as dose to both regions was significantly associated with RP. This discrepancy is
likely a function of the population studied, the majority of which were treated with IMRT (159/192
patients) in the current study. The ability to set and meet constraints on dosimetric parameters with
IMRT [173] has not only reduced the overall incidence of RP [174], but also resulted in relative similarity
in DVH metrics across the patient population. We illustrate this in Figure 33, as the average DVH curve
in the total lung is nearly identical among patients who do or do not develop toxicity. Dose is still the
primary driver of radiation‐induced lung toxicity, but conventional dosimetric parameters, including
mean lung dose and the considered mean regional doses, are not sufficient to discriminate between
patients at risk of developing toxicity. Efforts to stratify patients based on other factors are needed.
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Figure 33. Mean total lung cumulative DVH for patients with and without severe RP. Shaded regions
indicate 95% CI.

As we did not observe a relationship between regional dose and RP, we sought alternative means to
describe a potential spatial effect by considering CT‐based image features. The spatial variation of such
features, however, is limited, as evidenced by the high correlation to total lung features. In particular,
features that demonstrated a significant relationship to severe RP were highly correlated with features
extracted from the total lung. This explains why the majority (9/12) of extracted features associated
with severe RP were identified with not only regional subvolumes, but with the total lung features as
well (Table 12). Of the remaining features, two were significant in only the superior or inferior volumes,
but these features fail to illustrate a clear difference between values in the two regions that would
possibly explain a spatial sensitivity (Figure 31). This does not imply the absence of a spatial effect, but
does illustrate that a single image feature is not sufficient to describe the regional variation in the lung
volume as it relates to potential radiosensitivity. The residual variation between regionally‐extracted
features does not eliminate their utility for describing a spatially‐related structural difference in the
lung parenchyma; however, the high correlation to total lung feature values indicates that subsequent
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analysis should focus on characterization of the total lung volume, consideration of the spatial
differences using an alternative methodology (e.g. lung volume receiving

20 Gy), or multivariable

methods.
Creation of voxel‐wise feature maps provides an alternative method to look at spatially related
differences in the lung structure. Resizing each feature map to a common array allows for probing of
spatially corresponding voxels across the population, but the results of this approach largely agree with
the regionally‐defined features. Median feature maps created with the patients who did and did not
develop RP are generally similar as evidenced by high CCC (Table 13). It is possible that more subtle
differences are missed by calculating CCC with feature values determined in the entire lung volume,
but qualitative comparison failed to identify any clear patterns. Recently, Palma et al. [175] proposed
a voxel‐based approach for comparison of local lung dose and RILD in a set of Hodgkin lymphoma
patients. This involved registration of dose distributions to an anatomical reference and multiple
permutation inference for statistical comparison. Employing such methods to analyze image feature
maps may help to identify a spatial signature. However, among maps that have less relative agreement
(e.g. LUNG.MAP.Reserve), the difference appears to be approximately uniform throughout the volume.
The calculation of median feature maps is intended to identify a population‐wide effect as it does not
adequately describe the substantial variability between patients. It is important to consider how
patient‐specific variation in voxel‐wise feature maps might contribute to RP risk in a more
comprehensive manner by considering the interplay with the spatial location of the dose. This can be
considered analogous to the concept of a dose‐function histogram [54] with a voxel‐wise image feature
map serving as a surrogate of function.
The absence of any significant regional feature when the considered endpoint is moderate RP is
consistent with our previous work which failed to identify RP

2 as a significant fixed effect during

modeling of time and dose‐related feature changes (Chapter 4). Castillo et al. also demonstrated that
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a limited subset of first‐order histogram metrics extracted from the total lung volume on CT were not
significant predictors of symptomatic RP in a cohort of NSCLC [59] and esophageal cancer [176]
patients. Accordingly, we believe that severe RP provides a more stable and clinically‐relevant endpoint
that may be suitable for investigation of CT‐based radiomics features. However, lower grade RP may
still be accurately predicted with CT image features if more complex, multivariable modeling schemes
and/or alternative image feature methods are considered. Furthermore, accurate quantification of
radiation‐induced lung disease may provide a more useful endpoint for such investigations.
Consideration of an expanded set of regional features and/or feature maps may be worthy of
investigating in the context of spatially‐related differences. In future work, it is also of interest to
consider whether image features relate to measures of global lung status (e.g. pulmonary function test
metrics) or whether there is a relationship to COPD and/or smoking status in this population.
Comparison of CT image features to other imaging modalities (e.g. SPECT, PET, 4D‐CT ventilation)
considered for RP prediction, quantification, or RT functional avoidance is also of interest.
This study is not without its limitations. We limited our analysis here to a subset of features with
demonstrated repeatability and non‐redundancy on an independent dataset from our institution;
however, both datasets were acquired with identical imaging protocols on one of two different GE
scanner models. Applicability of these results across institutions with different scanners or image
acquisition parameters may be problematic. Similarly, though volume contouring was consistently
applied across the dataset, we used a semi‐automatic approach that may be difficult to replicate.
Inaccuracies in volume delineation may be particularly problematic with feature map calculation
(Chapter 5); there may be benefit to applying fully automated approaches.
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CONCLUSIONS
The application of CT‐based image features calculated in regional subvolumes and on a voxel‐wise basis
in the normal lung were explored in the context of RP incidence among a cohort of NSCLC patients
receiving definitive RT. While the concept of regional lung radiosensitivity has been reported, there
was no clear spatial variation in the considered regionally extracted features or voxel‐based feature
maps. However, a limited subset of features were significantly associated with RP which may be a useful
finding to consider in development of predictive models to assess RP risk.
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CHAPTER 7: INCORPORATION OF CT LUNG RADIOMICS FEATURE
DISTRIBUTIONS

INTO

PREDICTIVE

MODELS

FOR

RADIATION

PNEUMONITIS
INTRODUCTION
Improved treatment personalization for non‐small‐cell lung cancer patients treated with radiation
therapy (RT) requires a balance between achieving local tumor control and limiting the risk of radiation‐
induced lung damage (RILD). In approximately 20% of patients, severe acute symptomatic RILD, termed
radiation pneumonitis (RP), still occurs. Identifying the individuals at risk of RP prior to treatment
provides tremendous potential to improve RT by providing the physician with information to assist in
making clinical decisions that optimize the therapeutic ratio.
While numerous clinical and patient‐specific factors have been considered in the context of RP
prediction, the most robust parameters used to assess RP risk are based on simple dose‐volume metrics
[2]. Widely used dosimetric parameters including mean lung dose (MLD) and the volume of the lung
receiving greater than a threshold dose (e.g. volume

20Gy,

) are derived from a two‐dimensional

representation of the 3D dose distribution, the dose‐volume histogram (DVH). Such parameters are
easy to use in clinical practice, but fail to take into account the spatial distribution of dose resulting
from the use of different treatment modalities [177]. Similarly, DVH metrics do not consider the
patient‐specific biological, genetic, and functional mechanisms that may contribute to radiation‐
induced toxicities.
Beyond treatment specific parameters, RP risk is modulated by the underlying function of the lung.
Physiologic characteristics are not only patient‐specific, but heterogeneous throughout the organ as a
result of disease (e.g. COPD) or underlying genetic factors. This has resulted in several groups
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investigating imaging methods as means to localize or quantify lung radiosensitivity on a personalized
basis. SPECT perfusion studies have been used to identify functional areas of the lung which may be
more vulnerable to damage for NSCLC patients treated with RT [54–57]. Pre‐RT FDG‐PET studies have
also been used to localize areas of lung more susceptible to injury [58,59]. 4D‐CT ventilation has been
considered for post‐treatment assessment in NSCLC patients [178] and for correlation with RILD [62].
Additionally, while only potential surrogate measures of lung function, CT‐based image (i.e. radiomics
[83–85,89]) features have been utilized for quantification of post‐RT RILD by Cunliffe et al. [80].
The use of functional lung measures in RP prediction is well‐established, if still limited in clinical viability.
DVH measures have been extended to consider the functioning volume of the lung resulting in the
concept of a dose‐function histogram (DFH) [54]. Originally applied to include SPECT‐determined lung
function, there is renewed interest in the concept using 4D‐CT ventilation [179,180] for the purposes
of functional avoidance in RT treatment planning [178,181] and correlation to RP [62,182]. Our goal
was to assess whether CT‐based radiomics features, which have demonstrated application for
classifying a variety of interstitial and diffuse lung diseases [72–78], can be similarly considered. We
extend the concept of the dose‐function histogram to use for analysis with CT radiomics features

METHODS
Patient Specific Clinical and Treatment Data
The population analyzed in the current study has been described elsewhere (Chapter 6). To briefly
summarize, 192 patients treated for NSCLC between 08/2004 and 02/2009 with definitive RT at The
University of Texas MD Anderson Cancer Center were considered. Treatment was delivered with
intensity modulated (159/192, 80%) or 3D conformal (33/192, 20%) RT, with or without chemotherapy.
Severe RP (scored as grade

3), where grade 3 defined as symptomatic, interfering with activities of

daily living or oxygen indicated, was the endpoint of interest. All RP events were scored by the treating
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physician according to the Common Terminology Criteria for Adverse Events v3.0. Unless toxicity was
observed earlier, patients without at least 6 months of follow up were excluded.

CT Image Acquisition and Dosimetric Analysis
All patients underwent 4D‐CT treatment planning simulation on one of two available commercial CT
scanner models: GE Discovery ST or GE LightSpeed RT 16 (General Electric Healthcare, Milwaukee, WI).
4D‐CT phase reconstruction was performed using the respiratory signal acquired from the Real‐Time
Position Management (RPM) Gating System (Varian Medical Systems, Palo Alto, CA) to bin images into
10 equally spaced phases. End‐inhalation was labeled as the 0% (T0) phase while near end‐exhalation
was labeled as the 50% (T50) phase. In the current cohort, scans were acquired using the 4D cine mode
under free breathing conditions. The slice thickness (2.5 mm), axial pixel dimensions (0.977 x 0.977
mm), peak kilovoltage (120 kVp), and standard convolution kernel were consistent across all patient
scans.
Prior to 2006 at our institution, treatment plans were generated using free breathing datasets, though
many of these patients were also simulated with 4‐dimensional CT. 4D‐CT subsequently became our
standard for treatment planning with total lung volumes contoured on the 50% phase image set, GTV
contoured using the maximum intensity projection image set and all other normal structures contoured
on the average intensity projection (AVE‐IP) image set. Dose is calculated on the AVE‐IP image set. For
consistency in this analysis, however, all reported dosimetric variables were obtained by recalculating
the original treatment plan on the 50% phase CT image set. The total lung was delineated using a semi‐
automatic region growing algorithm on the T50 image set. The total lung region of interest is defined
as the 50% phase total lung volume minus the clinically delineated GTV. Dose calculation and structure
contouring were performed using the Pinnacle3 treatment planning system (Philips HealthCare,
Fitchburg, WI).
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Voxel‐based CT Image Feature Maps
The method for image feature map calculation has been detailed previously (Chapter 5). This procedure
involved translating a 31 x 31 pixel ROI across each slice of the CT image set spaced at 15 pixel intervals
(similar to [73]). A limited subset of image features was calculated within each ROI and assigned to the
center pixel. Each feature map was subsequently defined at every voxel within the total lung ROI by
using linear interpolation (e.g. Figure 25).
Integration of each feature map with the dosimetric data requires a normalization method be applied.
We did so by converting each map to a percentile image [178,183]. This required defining the
cumulative distribution function (CDF) such that:
∈

where

,

is the number of voxels with a feature value that falls in the range

number of voxels in the lung volume.

,

and

is the total

is the minimum feature value in the given map. The CDF is

scaled to the range [0, 100]:
100 ∗
This normalization method was applied obtain the percentile feature map value,
location

in the original feature map,

, at each

.

In Chapter 5, test‐retest analysis was utilized to identify a subset of repeatable feature maps to be
considered in subsequent analyses. Accordingly, we limit the analysis here to this subset of 24 feature
maps. Specifics of the considered feature maps, including the parameters used for calculation are
provided in Table 10.
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NTCP Model Building
Normal tissue complication probability models for RP were constructed using the Lyman‐Kutcher‐
Burman (LKB) model [12,14,15], which is described using a probit (or cumulative normal distribution)
function:

NTCP

1

/

√2

d

where
TD
TD
TD

is the dose resulting in 50% complication probability,

to the slope of the curve, and

is a model parameter inversely related

is the effective dose to the total lung.

is defined as:

/

The index loops over all dose bins,
interest,

, in a differential dose‐volume histogram (DVH) for the organ of

is the volume receiving dose

,

is the total volume of the lung, and

is the volume

parameter [184]. The effective dose is that which, if applied homogeneously to the entire organ, would
produce the same probability of complication. As the volume parameter
that maximum dose to the organ correlates with NTCP while the case of

approaches 0, this implies
1 reduces

to the

mean dose to the organ. The LKB model is fit via maximum likelihood analysis to determine the
parameters, TD ,

, and .

In addition using dose‐volume histogram data, methods have been proposed to incorporate lung
function information with dose resulting in the concept of a dose‐function histogram [54]. In effect,
lung volume is replaced by a measure of function resulting in a differential dose‐function histogram
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(DFH). The DFH can then be readily extended to calculate a functional effective dose (fD ) or, by fixing
the volume parameter to 1, a functional mean lung dose (fMLD):

fD

Here,

/

is a given measure of lung function receiving dose

total lung function,

which is normalized to the sum of the

[56].

In most other applications of the DFH concept, function has been defined by SPECT perfusion [56,57]
or 4D‐CT ventilation [62,182]. In the current study, strictly speaking, we are not using a measure of
function. Instead, our CT‐based image feature maps are being considered surrogates of function for
the calculation of dose‐radiomic histograms (DRH) and the corresponding radiomic effective dose,
rD , and radiomic mean lung dose, rMLD.
For each image feature map, the LKB model is fit twice using the formalism described. First, the volume
parameter, , is fixed at 1, such that the LKB model is fit using the rMLD. Subsequently, the LKB model
is fit with rD , which introduces an additional fit parameter for . In addition to fitting all of the DRH
resulting from application of the considered feature maps, the original DVH data was similarly fit to
provide a baseline "best" model for comparison of predictive performance. In all cases, confidence
intervals were obtained using the profile likelihood method. Comparison of each rD

model to its

reduced, nested model (rMLD) was done via the likelihood ratio test.
Comparison of model performance was done via ROC analysis and calculation of the area under the
curve (AUC). The 95% confidence interval for AUC is determined from 2000 stratified bootstrap
replicates. Improvement in model AUC relative to our baseline (DVH) relied on the method of Delong
et al. [135] to test for a statistically significant difference.

111
All models were built in R version 3.2.3 [116]. ROC analysis was performed with the pROC version 1.8
package [137].

RESULTS
The distribution of RP scores was previously provided in Chapter 6. In total, RP grade

3 was observed

in 30 of 192 patients (15.6%).
Figure 34 demonstrates the cumulative DVH and DRHs for two representative patients. As with
implementation of the DFH concept, each DRH was normalized to the sum of the calculated image
feature in the entire lung volume. This is in contrast to normalization based on the total volume of the
lung, as is the case with the displayed DVH curves. Though the dose distribution is weighted by the
percentile image feature map, which is scaled from [0, 1], this normalization causes some of the DRH
curves to appear as though larger volumes are irradiated as compared to the DVH curve.

Figure 34. Cumulative DVH and DRH curves for two representative patients. The red line represents
the DVH curve. Each blue line represents a DRH curve calculated with one of the considered feature
maps.
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Comparison of the mean lung dose and radiomics‐weighted mean lung dose calculated across all
patients is presented in Table 14. Averaged over the population, the difference between MLD and
rMLD is on the order of 1 Gy, but there is a notable increase in the variation of the rMLD relative to
MLD. This is illustrated in Figure 35, which plots rMLD (calculated from GLCM.MAP.Entropy) against
MLD for all patients. While there is a correlation between the two measures, the spread in the data
illustrate an ability to differentiate patients by introducing an image measure into the MLD calculation.
Table 14.

and

Feature Map

for the considered feature maps.
(r)MLD
Difference, rMLD‐
(Gy)
MLD

Min
Difference

Max
Difference

Dose

18.7

GLCM.MAP.Entropy

19.4

0.7

‐6.3

6.7

GLCM.MAP.Homogeneity1

17.9

‐0.8

‐6.8

6.8

GLCM.MAP.SumAverage

19.0

0.3

‐8.5

7.5

GLCM.MAP.SumEntropy

19.4

0.7

‐6.1

6.5

GLRLM.MAP.GLNU

17.9

‐0.8

‐6.5

7.3

GLRLM.MAP.HGRE

19.1

0.4

‐8.2

7.4

GLRLM.MAP.SRHGE

19.1

0.4

‐8.1

7.3

HIST.MAP.Energy

18.9

0.2

‐7.6

6.9

HIST.MAP.Entropy

19.4

0.7

‐6.4

6.6

HIST.MAP.Mean

19.0

0.3

‐8.5

7.5

HIST.MAP.Per10

18.5

‐0.2

‐9.0

6.4

HIST.MAP.Per25

18.6

‐0.1

‐8.9

7.1

HIST.MAP.Per90

19.3

0.6

‐7.4

7.1

HIST.MAP.Per95

19.3

0.6

‐7.2

6.4

HIST.MAP.RMS

19.1

0.4

‐8.2

7.4

HIST.MAP.Sum

18.6

‐0.1

‐6.4

6.0

LAWS2D.MAP.L5E5_Energy

19.0

0.3

‐4.0

4.2

LAWS2D.MAP.L5E5_RMS

19.3

0.6

‐4.7

6.1

LAWS2D.MAP.L5L5_Energy

18.8

0.1

‐5.5

5.8

LAWS2D.MAP.L5L5_Mean

19.1

0.4

‐8.3

7.4

LAWS2D.MAP.L5L5_RMS

19.2

0.5

‐8.0

7.3

LAWS2D.MAP.L5S5_Energy

19.1

0.4

‐3.7

3.9

LUNG.MAP.LAA856

18.8

0.1

‐7.1

28.6

LUNG.MAP.Reserve

18.3

‐0.4

‐6.6

8.6
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Figure 35. Mean lung dose versus radiomic mean lung dose determined with GLCM.MAP.Entropy.

The LKB fit parameters for MLD/rMLD are provided in Table 15. Figure 36 illustrates the incidence of
RP and the corresponding LKB fit generated with MLD. Fit values for
and values for

range from 62.7 to 146.9 Gy

range from 0.682 to 0.862 across the different rMLD investigated. AUC values for

each model are also provided in Table 15 with the LKB MLD fit producing an AUC of 0.53. Compared to
the LKB model generated with MLD, there is no statistically significant improvement in discriminatory
performance as measured by AUC for any of the rMLD models generated.
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Table 15. LKB fit parameters for the
and
Delong test for comparison of
AUC to
Feature Map

(95% CI)

models. Presented p value is determined from the
AUC.
p value
m (95% CI)
AUC (95% CI)
(Delong)

Dose

63 (39‐∞)

0.69 (0.40‐1.22)

0.53 (0.43‐0.63)

GLCM.MAP.Entropy

72 (46‐∞)

0.72 (0.42‐1.22)

0.47 (0.36‐0.58)

0.96

GLCM.MAP.Homogeneity1

95 (78‐∞)

0.80 (0.48‐1.24)

0.54 (0.44‐0.63)

0.84

GLCM.MAP.SumAverage

73 (48‐∞)

0.73 (0.43‐1.22)

0.47 (0.36‐0.57)

1.00

GLCM.MAP.SumEntropy

71 (44‐∞)

0.72 (0.42‐1.22)

0.47 (0.35‐0.58)

0.92

GLRLM.MAP.GLNU

83 (68‐∞)

0.77 (0.46‐1.23)

0.54 (0.43‐0.64)

0.83

GLRLM.MAP.HGRE

68 (39‐∞)

0.71 (0.42‐1.22)

0.54 (0.43‐0.64)

0.90

GLRLM.MAP.SRHGE

68 (39‐∞)

0.71 (0.42‐1.22)

0.53 (0.42‐0.64)

0.91

HIST.MAP.Energy

69 (42‐∞)

0.71 (0.42‐1.22)

0.53 (0.43‐0.64)

1.00

HIST.MAP.Entropy

71 (43‐∞)

0.72 (0.42‐1.22)

0.46 (0.36‐0.58)

0.90

HIST.MAP.Mean

73 (46‐∞)

0.73 (0.43‐1.22)

0.47 (0.37‐0.58)

0.97

HIST.MAP.Per10

75 (52‐∞)

0.74 (0.44‐1.23)

0.54 (0.43‐0.64)

0.91

HIST.MAP.Per25

79 (61‐∞)

0.75 (0.44‐1.23)

0.47 (0.36‐0.57)

0.98

HIST.MAP.Per90

64 (34‐∞)

0.69 (0.41‐1.21)

0.54 (0.43‐0.64)

0.84

HIST.MAP.Per95

63 (34‐∞)

0.68 (0.41‐1.21)

0.54 (0.43‐0.65)

0.79

HIST.MAP.RMS

68 (39‐∞)

0.71 (0.42‐1.22)

0.53 (0.43‐0.64)

0.91

HIST.MAP.Sum

65 (38‐∞)

0.70 (0.41‐1.22)

0.53 (0.43‐0.63)

0.96

LAWS2D.MAP.L5E5_Energy

66 (41‐∞)

0.70 (0.41‐1.22)

0.47 (0.37‐0.57)

0.95

LAWS2D.MAP.L5E5_RMS

65 (37‐∞)

0.69 (0.41‐1.22)

0.47 (0.36‐0.57)

0.89

LAWS2D.MAP.L5L5_Energy

65 (38‐∞)

0.70 (0.41‐1.22)

0.53 (0.42‐0.63)

0.99

LAWS2D.MAP.L5L5_Mean

75 (53‐∞)

0.74 (0.43‐1.23)

0.53 (0.43‐0.64)

0.99

LAWS2D.MAP.L5L5_RMS

73 (48‐∞)

0.73 (0.42‐1.22)

0.53 (0.42‐0.63)

0.97

LAWS2D.MAP.L5S5_Energy

66 (41‐∞)

0.70 (0.40‐1.22)

0.47 (0.36‐0.58)

0.89

LUNG.MAP.LAA856

147 (55‐∞)

0.86 (0.53‐1.24)

0.53 (0.41‐0.63)

0.89

LUNG.MAP.Reserve

94 (77‐∞)

0.79 (0.46‐1.24)

0.54 (0.43‐0.64)

0.89
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Figure 36. Incidence of RP grade
fit to all patient data.

LKB fits using D /rD
values for

3 with respect to mean lung dose. Solid line represents the LKB model

are provided in Table 16. Fit values for

range from 63.5 to 96.9 Gy with

ranging between 0.417 and 0.563. The volume parameter, , was between 0.231 and

0.361. AUC values are provided in Table 15 with none of the rD
than the LKB D

models being significantly different

in terms of performance. Furthermore, likelihood ratio test p values are provided in

Table 15 and indicate no effective dose model was able to produce a significantly better fit than its
corresponding reduced mean lung dose model.
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and
models. Presented p value is determined from the
Table 16. LKB fit parameters for the
model to the reduced
model.
likelihood ration test by comparing each
m
n
AUC (95% CI)
p value (LRT)
Feature Map
Dose

65

0.44 0.35

0.56 (0.46‐0.67)

0.34

GLCM.MAP.Entropy

70

0.46 0.34

0.46 (0.35‐0.56)

0.39

GLCM.MAP.Homogeneity1

79

0.49 0.25

0.55 (0.44‐0.65)

0.34

GLCM.MAP.SumAverage

72

0.48 0.35

0.46 (0.36‐0.57)

0.43

GLCM.MAP.SumEntropy

70

0.45 0.33

0.46 (0.35‐0.57)

0.38

GLRLM.MAP.GLNU

77

0.51 0.29

0.55 (0.45‐0.66)

0.36

GLRLM.MAP.HGRE

69

0.47 0.35

0.46 (0.35‐0.57)

0.41

GLRLM.MAP.SRHGE

70

0.47 0.35

0.46 (0.36‐0.57)

0.41

HIST.MAP.Energy

67

0.45 0.35

0.54 (0.44‐0.65)

0.35

HIST.MAP.Entropy

70

0.45 0.33

0.46 (0.35‐0.57)

0.39

HIST.MAP.Mean

72

0.48 0.35

0.46 (0.35‐0.57)

0.43

HIST.MAP.Per10

73

0.51 0.35

0.54 (0.44‐0.65)

0.43

HIST.MAP.Per25

76

0.52 0.36

0.53 (0.43‐0.64)

0.46

HIST.MAP.Per90

67

0.44 0.34

0.45 (0.34‐0.56)

0.38

HIST.MAP.Per95

67

0.44 0.34

0.55 (0.44‐0.66)

0.38

HIST.MAP.RMS

70

0.47 0.35

0.46 (0.35‐0.56)

0.42

HIST.MAP.Sum

64

0.43 0.35

0.56 (0.45‐0.66)

0.31

LAWS2D.MAP.L5E5_Energy

64

0.42 0.35

0.55 (0.44‐0.65)

0.28

LAWS2D.MAP.L5E5_RMS

65

0.43 0.35

0.45 (0.34‐0.56)

0.32

LAWS2D.MAP.L5L5_Energy

63

0.42 0.35

0.56 (0.45‐0.66)

0.29

LAWS2D.MAP.L5L5_Mean

71

0.48 0.35

0.54 (0.43‐0.64)

0.40

LAWS2D.MAP.L5L5_RMS

69

0.46 0.35

0.54 (0.43‐0.65)

0.37

LAWS2D.MAP.L5S5_Energy

64

0.42 0.35

0.56 (0.45‐0.66)

0.30

LUNG.MAP.LAA856

97

0.56 0.23

0.54 (0.43‐0.65)

0.44

LUNG.MAP.Reserve

78

0.47 0.24

0.55 (0.43‐0.66)

0.36

DISCUSSION
As methods to advance personalized RT for NSCLC patients are influenced by assessment of patient‐
specific RP risk, there is a significant need to improve the accuracy of normal tissue complication
probability (NTCP) models. We have adapted the concept of a dose‐function histogram to explicitly
consider quantitative measures of lung parenchyma by incorporating image feature maps. We have
coined the term dose‐radiomics histogram (DRH) to describe this methodology and have successfully
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integrated DRH measured into phenomenological models for assessing NTCP in the lung. Application
of DRH determined mean lung dose and effective dose, however, do not produce sufficient
improvement in model accuracy than can be achieved using corresponding measures determined from
the dose‐volume histogram.
We believe the incorporation of radiomics feature maps with the dose‐volume histogram is novel, but
not without precedent. Multiple groups have utilized SPECT images in this manner [54–57] and recently
4D‐CT ventilation has been considered for functional assessment in the context of RP prediction
[62,182]. While radiomics features do not directly measure function, the creation of several proposed
feature maps is loosely related to at least one 4D‐CT based ventilation implementation. Sophisticated
deformable image registration methods are often used for 4D‐CT ventilation assessment [179,180], but
a more direct approach was proposed by Kimura et al. [182,185] that involves identifying the low
attenuation areas (LAA) on near end‐exhale (40‐60%) 4D phase image sets. While this method only
provides a binary measure of local function, we have also explicitly used the concept of LAA for image
feature map creation with two different features, LUNG.MAP.LAA856 and LUNG.MAP.Reserve. Kimura
et al. [182,185] identify LAA on temporally adjacent phase image sets while our method averages LAA
in spatially adjacent regions. We do not propose that our methods can be considered functional
measures, but several of the numerous radiomics maps considered may provide information that
complements proven measures of lung function.
Fitting our data to the LKB model using MLD and D

produce results in conflict with several previous

analyses conducted using an overlapping and expanded cohort of patients from our own institution
[165,173]. Vinogradskiy et al. [165], used the LKB approach to fit data from 547 patients and report a
of 33.8 Gy. More recently, Briere et al. [173] analyzed 579 patients and reported a
Gy for a MLD fit and 43.3 Gy for a D
current study produces a

fit with

of 63.3 Gy with

of 32.2

= 0.45. The same modeling technique applied in the
= 1 (i.e. MLD model) and 65.0 Gy when using D .
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Nearly all of the presented models generated using the DRH‐derived metrics result in a

on the

order of 70 Gy. There are some differences between the current study due to structure definition and
dose calculation. Specifically, we are using the 4D‐CT end‐exhale image set to define the total lung and
calculate dose, while free‐breathing data sets were used by Briere et al. [173]. While this may account
for some differences in our dosimetric measures [186] and subsequent LKB fits [187], the greatest
contrasting element between our results and both Briere et al. and Vinogradskiy et al. is in the
treatment modality. The current study investigates a population in which the majority of patients
(82.8%) were treated with IMRT, whereas Briere et al. report 41.3% received IMRT and Vinogradskiy et
al. report only 16% were treated with IMRT. The use of IMRT allows constraints on dose to the total
lung volume to be more easily set and met during treatment planning resulting in a relative similarity
in the DVH parameters for the total lung across the population when treated with IMRT. This can be
exacerbated further within a single institution that has consistent treatment planning standards. Figure
36 illustrates this as there is clustering of the MLD values across the population. The consequence of
this is difficulty in model parameter estimation, as evidenced by the confidence intervals for
presented in Table 15 and discrepancy in the fit parameters presented in the literature. The values for
we have reported are still reasonable and valid, but are a reflection of the cohort analyzed. The
use of phenomenological models such as LKB, which have theoretical basis in observed dose‐volume
responses, is limited when applied to data with reduced variation in dose‐volume metrics. Modification
must be made to alter the framework to include other parameters which may better differentiate the
population [23] or alternative and more flexible modeling strategies should be employed.
Although numerous image feature maps were considered in the present study, none were able to
produce a significant increase in AUC relative to the MLD model. Furthermore, the MLD model is not
statistically different than a purely random guess (AUC = 0.5). However, our reported AUC values are
not entirely divergent from others reported in the literature. For prediction of low grade RP, Lind et al.
[188] calculated AUC values in the range of 0.5 to 0.68 when analyzing several metrics that combined
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SPECT‐based perfusion and dose. Kocak et al. [189] utilized two sets of data, one from Duke and
another from NKI to report AUC using both dose‐volume and dose‐function metrics. Use of MLD as a
single parameter predictor of RP grade

2 resulted in an AUC of 0.62 and 0.61 in the Duke and NKI

datasets, respectively. SPECT perfusion‐weighted mean lung dose as a single parameter predictor
resulted in a worse AUC (0.59) in the Duke cohort while an increase in the NKI data (0.72). In a different
study that includes an intersection of the patients currently analyzed, Vinogradskiy et al. [62] showed
that the addition of 4D‐CT based ventilation function into dose‐function histogram concept resulted in
an increase in AUC over the baseline MLD model (0.569 versus 0.500) when using univariable logistic
regression; however, that result did not represent a significant improvement in performance. While
the dose‐function concept has been used previously and now extended to incorporate radiomics
feature maps, its clinical applicability for improving RP prediction is in doubt if reduced to univariable
(i.e. fMLD or fD ) metrics.
We believe a substantial improvement in model accuracy can be achieved in the future by considering
multiple metrics to describe dose‐radiomic histograms with other demographic, clinical, functional
and/or genetic information. Metrics such as rV

(percentage of the total lung radiomics "function"

receiving at least 20 Gy) may be useful for improving the description of the DRH curve. Similarly,
combining rMLD calculated from multiple image feature maps is also a viable option as each DRH
contains potentially complementary information. This will require new modeling strategies and
application of robust methods for statistical validation [190]. Improvement in model accuracy by
considering clinical, total lung DVH, heart DVH, and total lung extracted image features is considered
in the following chapter.
The recognized limitations of radiomics feature calculation can negatively impact the generalizability
of any results. Acquisition protocols and scanner design may have an influence on the reproducibility
of such image features [125]. The maps used have demonstrated repeatability (Chapter 5) but
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alternative parameters and/or features could be selected that might provide more encouraging results.
Methods for lung segmentation, while consistent in the analysis presented, could be automated to
minimize user‐specific dependency and improve the consistency of feature map calculation.

CONCLUSIONS
The dose‐function histogram concept has been successfully extended to consider quantitative
measures of the lung as determined via CT. We refer to this as the dose‐radiomic histogram (DRH).
Subsequently, multiple image features were used to calculate DRH and assess prediction accuracy of
the Lyman‐Kutcher‐Burman model to predict RP grade

3. No significant improvement in model

performance was noted; however, we believe this is an important step towards identifying CT‐based
radiomics features that will improve RP prediction.
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CHAPTER 8: THE UTILITY OF QUANTITATIVE CT RADIOMICS FEATURES
FOR IMPROVED PREDICTION OF RADIATION PNEUMONITIS
INTRODUCTION
Radiation‐induced lung damage can result in reduced quality of life and diminished treatment efficacy
for non‐small cell lung cancer (NSCLC) patients treated with radiation therapy (RT). Its symptomatic
manifestation, radiation pneumonitis (RP), is reported to occur in as much as 50% of patients [2] and
presents a challenge to realizing maximum curative potential for patients treated with RT.
Various patient‐specific factors have been associated with the development of RP in the literature.
Tumor location, pulmonary comorbidity, gender, smoking status, and age have been identified as
potential risk factors, but findings are often inconsistent [19,20]. Numerous treatment and dosimetric
parameters have also been related to lung toxicity with the volume of lung receiving

20 Gy (

) and

mean lung dose the two most widely reported metrics for which consensus limiting guidelines exist [2].
Despite the wealth of data that has been considered for RP prediction, findings are often imprecise and
inconsistent due to small sample size [19], inappropriate statistical evaluation [21], and/or difficulty
with endpoint definition [22].
In addition to these challenges, current RP models lack the ability to adequately consider the baseline
differences in patient lung function and radiosensitivity. Genetic and/or environmental diversity
between patients can influence lung function and often result in parenchymal changes throughout the
volume. Using pre‐treatment CT studies, few groups have associated RP to radiologist‐examined visual
scoring of interstitial lung disease [65,66] and pulmonary emphysema [67,68] in patients treated with
conventionally fractionated RT. While this work suggests baseline lung status influences injury
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susceptibility, they rely on semi‐quantitative scoring which does not capture the heterogeneity in lung
function across the patient population.
We hypothesize that quantitative image (i.e. radiomics) features [83,84] may capture additional data
useful for describing different lung phenotypes that impact underlying RP risk. While radiomics analyses
have tended to focus on quantification of tumor phenotypes, the extraction of image data to
characterize normal tissue structures, including normal lung, may produce clinically relevant
improvement in prediction of treatment‐related toxicities. Quantitative CT‐derived measurements,
including texture features, have demonstrated utility for differentiating among lung phenotypes
resulting from underlying lung diseases [74,75,77,98,99], but consideration of these quantitative
features for RP prediction is sparse. With pre‐treatment PET/CT imaging, Castillo et al. [176] considered
a subset of first order CT measures, but achieved better prediction of RP with FDG‐PET SUV metrics.
Here we consider an expanded set of radiomics features for prediction of RP using pre‐treatment CT
data with multivariable modeling techniques.
Improved outcomes for NSCLC patients via individualized RT requires integration of various data
sources to develop highly accurate models of tumor response and toxicity risk [82]. Our goal was to
demonstrate the potential gain in predictive accuracy of normal tissue complication probability (NTCP)
models for RP by considering multiple data categories which included pre‐treatment total lung CT
image features in addition to clinical and dosimetric parameters. To select a small subset of variables
for predictive modeling and to prevent overfitting, least absolute shrinkage and selection operator
(LASSO) logistic regression was utilized [191]. LASSO is a method with demonstrated success for analysis
of high‐dimensional data including genome wide association studies [192] and recently for NTCP
modeling [190,193] thereby providing a framework suitable for predictive modeling using numerous
features that may be associated with increased risk of RP.
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METHODS
Patient Specific Clinical and Treatment Data
With an expanded set of clinical and treatment data, the same patient cohort originally introduced in
Chapter 6 is used in the current analysis. A total of 192 patients treated for NSCLC between 08/2004
and 02/2009 with definitive RT at The University of Texas MD Anderson Cancer Center were considered
in this retrospective study. Patients without an available pre‐treatment 4D‐CT scan were excluded.
Additionally, patients were required to have a minimum of 6 months follow up unless toxicity was
observed earlier. Treatment was delivered with intensity modulated (159/192, 80%) or 3D conformal
(33/192, 20%) RT, with or without chemotherapy. All patients were treated with standard fractionation
once daily. The total number of fractions, delivered dose, age, gender, chemotherapy, COPD status,
smoking status, treatment modality and GTV location [26] were considered as candidate predictors of
RP. Table 17 provides a description of the available clinical and treatment parameters in patients who
did or did not experience RP. P values are computed from the chi‐square test (categorical variables) or
Mann‐Whitney U test (continuous variables).
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Table 17. Patient Specific Clinical and Treatment Characteristics
Clinical Variable
Median (Range) / N (%)

RP Incidence p

Total Number of Fractions

35 (30 ‐ 40)

0.83

Delivered Dose (cGy)

6600 (5940 ‐ 7425)

0.89

Age

67 (34 ‐ 88)

0.28

Gender

M: 106 (55.2%)

15.1%

F: 86 (44.8%)

16.3%

NONE: 20 (10.4%)

10.0%

NEOADJ: 9 (4.7%)

11.1%

CONCUR: 160 (83.3%)

16.2%

POSTADJ: 3 (1.6%)

33.3%

FALSE: 153 (79.7%)

14.4%

TRUE: 39 (20.3%)

20.5%

NON SMOKER: 14 (7.3%)

0.0%

Chemotherapy

COPD

Smoking Status

0.85

0.71

0.45

0.18

FORMER SMOKER: 137 (71.4%) 18.2%

Treatment Modality

GTV Location, Superior‐Inferior

CURRENT SMOKER: 41 (21.4%)

12.2%

3D: 33 (17.2%)

18.2%

IMRT: 159 (82.8%)

15.1%

0.79

0.59 (0.20 ‐ 0.91)

0.05

GTV Location, Anterior‐Posterior 0.42 (0.13 ‐ 0.78)

0.54

GTV Location, Right‐Left

‐0.01 (‐0.79 ‐ 0.81)

0.61

GTV Location, Medial‐Lateral

0.59 (0.01 ‐ 0.99)

0.15

RP events were scored by the treating physician according to the Common Terminology Criteria for
Adverse Events v3.0. For this analysis, the outcome of interest was clinically significant RP (scored as
grade

3), where grade 3 is defined as symptomatic, interfering with activities of daily living or oxygen

indicated.
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Dosimetric Analysis
All reported dosimetric variables were obtained by recalculating the original treatment plan on the 50%
phase CT image set. The total lung region of interest (ROI) is defined as the 50% phase total lung volume
minus the clinically delineated GTV. The heart was also considered and taken as the volume contoured
from the AVE‐IP image set. Dose calculation and structure contouring were performed using the
Pinnacle3 treatment planning system (Philips HealthCare, Fitchburg, WI).
To facilitate dosimetric and image analysis, we utilized the MATLAB‐based (Mathworks, Natick, MA)
software originally discussed in Chapter 2. For both the total lung and heart regions of interest, the
dose distribution was generated and used to calculate 149 dosimetric features in each ROI. This
included first order statistics, absolute and relative volume receiving at least X Gy (
dose to the hottest X% volume (

,

), minimum

), and mean dose to the hottest and coldest X% volume (

,

).

CT Image Feature Extraction
Each 50% phase CT image set used in this analysis was reconstructed as part of a 4D‐CT protocol for
treatment simulation at our institution. All scans were acquired on either a GE Discovery ST or GE
LightSpeed RT16 scanner under free breathing with a cine 4D scan mode using 120 kVp, slice thickness
of 2.5 mm, axial pixel dimensions of 0.977 x 0.977 mm with the body filter and reconstructed with the
standard convolution kernel.
The same in‐house system used for dosimetric feature calculation was extended to extract image
features from the total lung ROI. Six different radiomics feature classes were utilized including first‐
order histogram (345 features), gray level co‐occurrence (5175), gray level run length (825),
neighborhood gray tone difference (50), Laws' filtered (120), and lung specific (23) features resulting
in a total of 6538 features considered in this study.
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Univariable logistic regression was applied to every extracted dosimetric and image feature to
determine if there was a significant association with RP. Reported p values are adjusted using the
Benjamini & Hochberg false discovery rate method [132].

LASSO Logistic Regression
Predictive models for RP were built with the least absolute shrinkage and selection operator (LASSO)
logistic regression [191]. The LASSO performs feature selection during model construction by penalizing
the magnitude of the regression coefficients (

norm). Large regression coefficients are restricted by

the imposed penalty, , to reduce overfitting. As this penalty is increased, more regression coefficients
shrink to zero resulting in a more regularized (i.e. sparser) model. The LASSO logistic regression
objective function is:

,

min
∈

1

⋅

where s are the set of model coefficients,
and

log 1

|| ||

is a vector of the input variable values for the ith patient,

is a tuning parameter that controls the strength of the penalty. All variables were initially

standardized (mean = 0, standard deviation = 1) to account for differences in scale.
Fifty iterations of a 10‐fold nested cross‐validation were utilized similar to Xu et al. [190]. For each
iteration, the dataset was divided into 10 parts with one part being retained as a test set. Model
building and optimization was achieved via a nested 9‐fold cross validation performed with the
remaining 9 parts used as training and validation sets. A model was fit using each training partition and
then used to determine prediction performance in each held‐out validation set. Figure 37 provides a
schematic representation of this nested cross validation scheme.
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Figure 37. Fifty iterations of a 10‐fold nested cross‐validation were utilized similar to Xu et al. [190]. For
each iteration, the dataset was divided into 10 parts with one part being retained as a test set. Model
building and optimization was achieved via a nested 9‐fold cross validation performed with the
remaining 9 parts used as training and validation sets. A model was fit using each training partition and
then used to determine prediction performance in each held‐out validation set. In this study, model
performance was assessed by computing the area under the receiver operator characteristic curve
(AUC). The average AUC across the validation sets were used to determine the optimal value for the
model tuning parameter, , by determining the value that produced the most regularized model such
that the AUC was within one standard error of the maximum,
[115,194]. After determining , the
model was used to generate predictions on the test set and assess prediction performance. The use of
50 repeats with resampling of the test, training, and validation sets reduces the observed bias and
variance of the performance estimates [195]. This approach constructs 500 models used to generate a
distribution of AUC values to estimate how well the LASSO applied to a given set of candidate predictors
may generalize to other datasets.

The outer cross‐validation loop provides a profile of model performance and serves to estimate how
well the LASSO applied to a given set of candidate predictors may generalize to other datasets. Model
performance was assessed by computing the area under the receiver operator characteristic curve
(AUC) for each constructed model on a held‐out test partition. The inner (i.e. nested) cross‐validation
loop was applied to determine the optimal value for the model tuning parameter, , such that the
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resulting model was guarded against overfitting. The value of

for each cross‐validation partition was

selected by determining the value that produced the most regularized model such that the AUC was
within one standard error of the maximum [194]. The use of 50 repeats with resampling of the test,
training, and validation sets reduces the observed bias and variance of the performance estimates
[195]. 50 resampled iterations with 10‐fold nested cross‐validation constructs 500 models used to
generate a distribution of AUC values to estimate how well model construction with LASSO generalizes
to other datasets.
Four sets of candidate features were used to demonstrate the potential for improved prediction of RP
when additional categories of data are considered:
1.

Clinical variables (dummy coded): 15 total features

2.

Add 149 total lung dosimetric variables: 164 total features

3.

Add 149 heart dosimetric variables: 313 total features

4.

Add 6538 total lung image features: 6851 total features

A paired t‐test was used for comparison of the prediction performance (AUC) determined using each
feature set [196] with significance assessed at the p < 0.05 level. All statistical analyses were performed
using R version 3.2.3 [116] with the glmnet version 2.0.5 [194] and caret version 6.0.64 [197] packages.

RESULTS
In total, RP grade

3 was observed in 30 of 192 patients (15.6%). Zero patients had grade 4 RP; two

had grade 5 RP. None of the available clinical features were significantly associated with RP incidence
(Table 17).
Figure 38 provides the average DVH curves for the total lung and heart volumes separated by RP
endpoint. No dosimetric parameters in the heart or total lung were significant on univariable logistic
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regression analysis at a p = 0.05 level after multiplicity correction with false discovery rate. A total of
449 (6.9%) radiomics features were significant on univariable logistic regression analysis after
multiplicity correction.

Figure 38. Mean heart and total lung cumulative DVH for patients with and without RP. Shaded regions
indicate 95% CI.

Using only clinical features, the average cross‐validated AUC (CV‐AUC) is 0.47. Addition of the total lung
and subsequently the heart dosimetric features results in a CV‐AUC of 0.44 and 0.53, respectively. The
final feature set including the extracted CT image features results in a CV‐AUC of 0.67. Using LASSO
logistic regression, the distribution of CV‐AUC values resulting from the different cross‐validation
partitions for the 4 different feature sets is shown in Figure 39. There is a significant difference (p < 10‐
6

) between CV‐AUC values calculated from the final feature set relative to CV‐AUC calculated in each

of the other feature sets investigated.
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Figure 39. Test AUC for each investigated feature set constructed from 50 repeats of nested 10‐fold
cross‐validation. The average cross‐validated AUC (CV‐AUC) is 0.47 (sd = 0.17), 0.44 (sd = 0.16), 0.53
(sd = 0.16), and 0.67 (sd = 0.16) for the clinical, +Total Lung dosimetric, +Heart dosimetric, and +Image
feature sets, respectively. Similarly, the average number of selected features is 6.1 (sd = 4.3), 11.6 (sd =
11.6), 13.0 (sd = 15.6), and 15.7 (sd = 13.0) for the respective feature sets.

Using all available features, the repeated cross‐validation scheme also demonstrates the most
frequently selected parameters. 236 of 6851 candidate predictors are selected in at least one model.
Figure 40 shows the features selected by LASSO in at least 40% of the 500 models generated along with
the distribution of standardized coefficient values obtained for each variable during model building.
This subset of features includes at least one from 5 of the 6 radiomics classes investigated. Additionally,
three heart related variables (volume,

,

) and one total lung dosimetric variable (variance)

are selected in at least 200 models. Table 18 provides further description with the parameters utilized
for feature extraction.
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Figure 40. Most frequently selected features and standardized coefficient stability from cross‐validated
model building. Displayed are only features included in 40% of the 500 models generated.

Table 18. Full description of most frequently selected features occurring in 40% of the 500 models
generated. Necessary parameters utilized for image feature extraction are provided: Preproc = Image
preprocessing method, BD = Bit depth, Dir = Offset direction, Dist = Offset distance, Dim = Neighborhood
dimension.
Printed Feature
Feature
Name
Class
Feature Name
Image Feature Parameters
HIST.Variance

HIST

Variance

Preproc = Threshold ‐250 HU

LUNG.StdVol910

LUNG

Standard Deviation
Cluster Volume

Preproc = None

HEART.Volume

HEART DVH

Volume

GLRLM.SRE

GLRLM

Short Run Emphasis
th

Preproc = None; BD = 4; Dir = [1 0 ‐1]

HIST.Per75

HIST

75 Percentile

Preproc = Local Entropy Filter
(NHood=3)

LAWS2D.Mean

LAWS2D

R5R5_Mean

Preproc = None

NGTDM.Complexity

NGTDM

Complexity

Preproc = None; BD = 7; Dist = 1; Dim =
3D

HEART.moc5

HEART DVH

HEART.rD100

HEART DVH

TLUNG.Variance

TLUNG DVH

Variance
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DISCUSSION
We have successfully revealed the limitation of clinical and dosimetric parameters to produce highly
discriminative models for RP in our patient cohort (CV‐AUC ∼ 0.5, Figure 39). Subsequently, we have
demonstrated that the addition of CT radiomics features extracted from the total lung significantly
improves RP model performance. Using LASSO logistic regression, the nested cross‐validation method
used provides appropriate internal validation of these findings and suggest CT radiomics features
should be considered to improve predictive model accuracy for RT‐induced normal lung toxicity.
Average discriminative ability of models generated with clinical, total lung dosimetric and heart
dosimetric parameters is poor. We believe this is a result of the relative similarity in DVH metrics across
the patient cohort. Figure 38 highlights this, as the average DVH curve in the total lung is nearly identical
in patients who did and did not develop toxicity. This is, in part, a function of our ability to set and meet
constraints on dosimetric variables during treatment planning. While dose distributions are
qualitatively different, conventional dosimetric parameters are similar and may no longer be useful as
independent predictors for discriminating toxicity response.
This, however, does not suggest that dose plays an inconsequential role in RP risk. Both heart and lung
dose metrics are frequently selected during model building. The apparent role of heart metrics, as
evidenced by Figure 40 is of note. Previous studies have indicated that heart dose may impact RP risk
[28,198], but a study from our institution did not observe this effect [199]. Similarly, when heart
variables are considered in the absence of normal lung radiomics features, the predictive performance
is poor, suggesting that the heart does not play a role in RP response. Analysis of the full cohort of
predictors, however, selects two dosimetric heart parameters and volume in a large number of the
cross‐validation models. Though the association and interaction between the heart and pulmonary
comorbidities is not well understood, this suggests that dose should be considered in addition to direct
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or indirect (e.g. radiomics) measures of lung function and/or radiosensitivity to achieve better
estimates of RP risk.
Multiple groups have investigated the impact of pre‐existing lung disease, including interstitial lung
disease (ILD) [65,66] and chronic obstructive pulmonary disease (COPD) [67,68], on the risk of RP.
Makimoto et al. [65] suggested that pre‐existing lung changes assessed on CT or plain chest films may
predict for symptomatic RP in patients treated with thoracic RT. Sanuki et al. [66] similarly
demonstrated that pre‐existing pulmonary changes on CT judged by a panel of radiologists was
significantly associated with RP grade

3 in patients treated with conventionally fractionated thoracic

RT. The literature is more inconsistent on whether chronic obstructive pulmonary disease (COPD),
which includes pulmonary emphysema, is associated with RP [20]. Visual classification of severe
pulmonary emphysema by radiologists using low attenuation areas (LAAs) on CT was significantly
associated with higher incidence of RP by Kimura et al. [67]. However, an ordinal or binary score
measuring ILD or COPD severity does not quantify the full range of variation within the lung volume
and heterogeneity between patients.
As the rationale for considering CT radiomics features in RP prediction stems from the idea that
baseline lung status impacts RP risk, it is similarly of interest to know if image features are associated
with available measures of COPD and smoking status. Among the most frequently selected model
features, two are significantly associated with a binary measure of COPD on univariable analysis (Table
19). Two other image features are trending toward significant association with smoking status. This
indicates that these metrics are reasonable quantitative measures of clinical lung status and their
selection during model building suggests quantification of pulmonary status using CT radiomics
features may improve our ability to discriminate between patients at high risk or low risk of RP.
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Table 19. Association between most frequently selected image features and COPD and Smoking Status.
P values determined by Kruskal‐Wallis test.
Printed Feature
COPD,
Smoking
Name
Feature Name
P Value Status, P Value
LUNG.StdVol910

Standard Deviation Cluster Volume

0.001

0.147

LAWS2D.Mean

R5R5_Mean

0.031

0.350

NGTDM.Complexity

Complexity

0.056

0.202

GLRLM.SRE

Short Run Emphasis

0.325

0.056

HIST.Variance

Variance

0.177

0.714

0.132

0.056

HIST.Per75

th

75 Percentile

While dose‐dependent changes in the lung post‐RT have been demonstrated using both density [49]
and texture features [80] extracted from CT datasets, similar quantitative analyses of CT images for
prediction of RP using pre‐RT data is limited. Castillo et al. [176] examined a small number of CT derived
first order parameters but found no significant association to symptomatic RP. We also found no
univariable significance in any CT derived image feature (including those investigated in [176]) after
multiplicity correction. However, in our multivariable analysis using LASSO, the mean CV‐AUC
determined with the full feature set achieved similar discriminative performance (AUC = 0.67) to that
of FDG‐PET

suggested in [176] (AUC = 0.68). Though there is advantage in using a single

predictor, the quantitative nature and increased availability of pre‐treatment CT relative to PET makes
our approach viable for RP prediction. Furthermore, the improvement in RP prediction by combining
features from multiple imaging modalities, including PET, should be considered.
Use of LASSO regression for analysis of high‐dimensional datasets is not without limitations.
Specifically, the problem of multicollinearity in any dataset may influence the frequency of selected
parameters. When pairwise correlations exist between predictors, the LASSO picks one correlated
predictor and ignores the rest [200]. Correlations between many of the dosimetric and radiomics
features are high, but our intent is not to identify optimal individual predictors ‐ that is, we have not
utilized the LASSO as purely a variable selection method. It is also important to understand the inherent
uncertainty in the predictor values makes successful construction and generalization of predictive
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dosimetric and radiomics models challenging. While some test‐retest analyses have been performed
with CT radiomics features in lung tumors [201], there is still a need to quantify feature reproducibility
in the normal lung volume and to understand the impact of CT scanner and protocol on extracted
features [125]. In this single institution study, variation in scanner and acquisition parameters was well
controlled by requiring the same kVp, voxel dimensions, and reconstruction kernel. Investigation of the
same CT features under different acquisition conditions may influence feature values and make
generalization of these findings to other datasets difficult.
We do not attempt to identify optimal individual predictors or to present a highly generalizable "best"
model as this is the first work to demonstrate the gain in model performance by considering pre‐
treatment CT radiomics data in RP prediction. The best fit models from many cross‐validated partitions
were still poor discriminators (AUC

0.5) despite the specific focus on discriminative ability above

model calibration. Apparent in model instability is high as demonstrated by large variance in AUC values
(Figure 39). The reasons for this are likely due to the limitations of the LASSO, uncertainty in the
predictor values, and the inherent challenges in RP endpoint definition [22]. Consideration of non‐
linear modeling methods using larger datasets (both patients and predictors) will likely improve RP
models in the future. Additionally, there may be benefit in considering regional changes in the total
lung (e.g. lung volume receiving

20 Gy) as opposed to characterizing the entire volume. Incorporation

of additional radiomics features from CT or additional imaging modalities could likewise benefit
performance. Relating radiomics features to available genomics/proteomics data (i.e. radiogenomics)
may help our understanding of the mechanisms for lung response and could guide selection of robust
imaging predictors. Most importantly, future work must use appropriate methods for radiomics feature
extraction and model validation applied to independent datasets, but this study suggests CT radiomics
features is one category of data that should be considered in development of clinically useful models
for RP prediction.
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CONCLUSIONS
To achieve clinically useful gains in predictive modeling of RP, novel types of data must be explored in
addition to clinical and dosimetric features. This is necessary to describe the range of inter‐ and intra‐
patient variation the subsequent impact this has on toxicity risk. We have considered the utility of pre‐
treatment total normal lung CT radiomics features in this context and have successfully demonstrated
that such features are capable of improving prediction of a clinically relevant normal lung toxicity
endpoint. Using a repeated, nested cross‐validation approach, the distribution of cross‐validated AUC
values demonstrates improved overall model discrimination using LASSO logistic regression for NTCP
model building relative to feature sets with clinical and dosimetric variables only.
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CHAPTER 9: DISCUSSION
To accomplish the project goals, the first step was to build a framework for image feature calculation
and dosimetric data extraction from RT treatment plan data (Chapter 2). Accordingly, we developed a
MATLAB‐based system named TREX, which has implemented multiple CT image analysis methods and
provides comprehensive analysis of RT dosimetric data. This was fundamental to subsequent analysis
of the temporal response of the normal lung during RT (Specific Aim 1), investigation of the spatial
variation in lung volume (Specific Aim 2), and, ultimately, prediction of radiation pneumonitis (Specific
Aim 3).
The goal of Specific Aim 1 was to determine if we could utilize image features to identify early predictors
of RP during treatment. This first required consideration of the uncertainties in radiomics feature
calculation methods that might be useful for monitoring progression of disease or assessing
therapeutic response. In Chapter 3 we demonstrated the respiratory‐related variation in image
features using 4D‐CT image sets. Despite this, there is high test‐retest repeatability of features in 4D‐
CT image sets with near end‐exhale (T50) providing the best repeatability among the 4D‐CT phase
images and breath‐hold studies investigated. There is demonstrated redundancy within the set of
considered image features that can be reduced on the basis of a simple correlation filter to identify a
subset of repeatable and non‐redundant lung CT image features extracted from 4D‐CT image sets.
In Chapter 4 we analyzed a small cohort of patients who received weekly CT scans during RT. The goal
was to identify a time and/or dose response of the normal lung using CT features that might be useful
for treatment adaptation prior to the end of RT. However, using a series of linear mixed models, we
failed to identify a significant image feature with demonstrated temporal response. Multiple features
exhibited significant association to the dose‐defined region of the lung from which they were extracted,
but the modeled patient‐specific time and dose effects were not able to produce a more discriminative
model for classifying RP than a limited subset of treatment‐related metrics.
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The goal of Specific Aim 2 was to potentially understand and localize regions of the lung that are more
susceptible to injury using CT image features. Regional and voxel‐based methods of calculating CT‐
based radiomics features in the normal lung were explored in Chapter 5. Before the spatial differences
in the lung and the potential relationship to RT‐induced damage can be considered, it was necessary
to characterize a set of features by considering test‐retest repeatability and feature set collinearity. We
were able to identify a non‐redundant set of highly repeatable features for use in regional lung analysis.
Additionally, we developed a method to calculate image features on a voxel‐wise basis and revealed a
subset of feature maps with sufficient repeatability to be analyzed in future work.
The application of CT‐based image features calculated in regional subvolumes and on a voxel‐wise basis
in the normal lung were explored in the context of RP incidence among a cohort of NSCLC patients
receiving definitive RT in Chapter 6. While the concept of regional lung radiosensitivity has been
reported, there was no clear spatial variation in the considered regionally extracted features or voxel‐
based feature maps. However, a limited subset of features were significantly associated with RP which
may be a useful finding to consider in development of predictive models to assess RP risk.
Specific Aim 3 focused on integration of CT image features into predictive models for RP. Specifically,
Chapter 7 extended the concept of the dose‐function histogram to consider quantitative measures of
the lung. We refer to this as the dose‐radiomic histogram (DRH). Subsequently, multiple image features
were used to calculate DRH and assess prediction accuracy of the Lyman‐Kutcher‐Burman model to
predict RP grade

3; however, no significant improvement in model performance was noted.

Chapter 8 considered the utility of pre‐treatment total normal lung CT radiomics features for RP
prediction. We were able to demonstrate that such features are capable of improving prediction of a
clinically relevant normal lung toxicity endpoint. Using a repeated, nested cross‐validation approach,
the distribution of cross‐validated AUC values demonstrated improved overall model discrimination
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using LASSO logistic regression for NTCP model building relative to feature sets with clinical and
dosimetric variables only.

Future Directions
Application of the techniques presented in Chapter 4 should be considered in the future. Inclusion of
more patients may enable detection of smaller effects. Additionally, if possible, a different endpoint
(i.e. severe RP) should be considered. Some effort has also been directed at using the methodology
presented to analyze post‐treatment CT datasets with the goal of being able to identify a true objective
endpoint. Additionally, understanding the influence of scan acquisition parameters and scanner design
on calculation of CT image features is vital work that should be conducted.
Further refinement of the voxel‐wise map analysis should be considered. Due to computational
limitations, fully optimizing the parameters that can be used is currently not tenable, but limited
consideration of different image feature parameters can be considered. Development and
implementation of an automatic method for lung segmentation would likely benefit all aspects of this
project, but will have the greatest impact on the voxel‐wise technique.
Probing the relationship between CT image features and other imaging modalities is of interest,
particularly 4D‐CT ventilation. Combining CT features with additional imaging data has the potential to
further improve RP model accuracy. Correlating CT based changes with genetic information (also
known as radiogenomics) can help our understanding of the mechanisms for lung response and could
guide selection of robust imaging predictors.
We have demonstrated the limited utility of the LKB model to consider CT image features. In the future,
numerous other machine learning techniques can be considered that may better account for the
dimensionality of the feature space and the complex interactions between predictor variables. As with
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any model, correct internal statistical validation is necessary, but future work should seek to validate
models on external datasets.
Finally, the majority of patient data utilized for analysis throughout this project were from individuals
with locally advanced NSCLC treated with conventionally‐fractionated RT. In the future, it will be of
interest to develop robust models that predict toxicity in patients treated with stereotactic body
radiation therapy (SBRT) for stage I or II disease.
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APPENDIX 1: CT IMAGE FEATURE EXTRACTION
First Order Histogram Features
Image of size

with a total number of voxels, .

is the ordered image histogram, where

is the number of voxels of the

HIST Feature List:
•

Sum:

Sum

•

Mean:

1

Mean

•

Median:
Median

•

˜

Minimum:
Minimum

•

Maximum:
Maximum

•

Variance:

gray level.
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1

Variance

•

1

Skewness:
1
Skewness

•

1

∑

Kurtosis:
1
Kurtosis

•

∑

1

∑
∑

Range:
Range

•

Mean absolute deviation:
MeanAbsDeviation

•

Median absolute deviation:
˜

MedianAbsDeviation
•

•

•

1st Percentile:
Per01

%

Per10

%

10th Percentile:

25th Percentile:
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•

•

•

•

•

Per25

%

Per75

%

Per90

%

Per95

%

Per99

%

75th Percentile:

90th Percentile:

95th Percentile:

99th Percentile:

Interquartile range:
IQR

•

%

%

Energy:

Energy

•

Root mean square:

RMS

∑

Entropy and Uniformity are both calculated after linearly downsampling the image bit depth to 8 (i.e.
256 gray levels).
•

Entropy:
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log

Entropy

•

Uniformity:

Uniformity

Preprocessing and Filter List:
•

None: Features extracted from the original, unfiltered image.

•

2D Gradient Sobel Filter: 2D correlation 3‐by‐3 sobel (gradient) filter applied slice by slice (z
direction) to the 3D CT image set.

•

3D Gradient Sobel Filter: 3D correlation 3‐by‐3‐by‐3 sobel (gradient) filter applied to the 3D CT
image set.

•

Local Entropy Filter (NHood=3): Resulting filtered image contains the entropy of the 3‐by‐3
neighborhood around each pixel. 2D filter applied slice by slice (z direction) to the 3D CT image
set.

•

Local Range Filter (NHood=3): Resulting filtered image contains the range (max ‐ min) of the 3‐by‐
3 neighborhood around each pixel. 2D filter applied slice by slice (z direction) to the 3D CT image
set.

•

Local Standard Deviation Filter (NHood=3): Resulting filtered image contains the standard
deviation of the 3‐by‐3 neighborhood around each pixel. 2D filter applied slice by slice (z direction)
to the 3D CT image set.

•

Laplacian of Gaussian Filter (Size

4,

1.0): 2D correlation LoG filter of size

created using:

,

4 and

1.0
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,

2

2
∑ ∑

,

Applied slice by slice (z direction) to the 3D CT image set.
•

Laplacian of Gaussian Filter (Size

6,

1.5): 2D correlation LoG filter of size

6 and

1.5

8 and

1.8

applied slice by slice (z direction) to the 3D CT image set.
•

Laplacian of Gaussian Filter (Size

8,

1.8): 2D correlation LoG filter of size

applied slice by slice (z direction) to the 3D CT image set.
•

Laplacian of Gaussian Filter (Size

10,

2.0): 2D correlation LoG filter of size

10 and

2.0 applied slice by slice (z direction) to the 3D CT image set.
•

Laplacian of Gaussian Filter (Size

12,

2.5): 2D correlation LoG filter of size

12 and

2.5 applied slice by slice (z direction) to the 3D CT image set.
•

Threshold at 0 HU: All voxels greater than 0 HU are removed from the image.

•

Threshold at ‐250 HU: All voxels greater than ‐250 HU are removed from the image.

•

Threshold at ‐500 HU: All voxels greater than ‐500 HU are removed from the image.

•

Threshold at ‐750 HU: All voxels greater than ‐750 HU are removed from the image.

Gray Level Co‐occurrence Features
The gray level co‐occurrence matrix (GLCM) is used to define texture in an image by determining the
distribution of co‐occurring voxel values that occur along a given displacement [86]. The displacement
vector is defined by both the direction and distance for comparison of voxel pairs. Thirteen unique
directions in 3‐dimensional space were considered. Two additional GLCMs were calculated by summing
the GLCM from all axial (i.e. 2D) directions and from summing all 13 3D directions.
is the maximum number of gray levels in the image.
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gray level co‐occurrence matrix for an image I of size

is a

,

displacement

,

,

.

1, if

,

,

, ,

entry in the marginal row matrix is

The

entry in the marginal column matrix is
is the mean of

is the standard deviation of
∑

∑

, ,

∑

∑

, ,|

,

and
,
0, otherwise

∑

The

is the mean of ,

|

2,3,4, . . . ,2

,

0,1,2, . . . ,

∑

log

.

The entropy of

is

∑

log

.

∑

, log

1

∑

∑

2

∑

∑

GLCM Feature List:
•

Autocorrelation [89]:

,

.

is

is

, .

is the mean of

,

∑

, log

.

log

.

,

, .

∑

The entropy of

The entropy of

along a given

.

1.

,

.

is the standard deviation of

, and
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,

Autocorrelation

•

Cluster prominence [89]:

ClusterProminence

•

,

Cluster shade [89]:

,

ClusterShade

•

Cluster tendency [89]:

,

ClusterTendency

•

Contrast [89]:

|

Contrast

•

∑

∑

,

Difference entropy [86]:

DiffEntropy

•

,

Correlation [86]:

Correlation

•

|

Dissimilarity [89]:

log
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|

Dissimilarity

•

|

Energy [86]:

Energy

•

,

Entropy [86]:

, log

Entropy

•

,
1

Homogeneity 2 [89]:

,

Homogeneity2

•

1

Information measures of correlation 1 [86]:
1

InfoMC1

•

,

Information measures of correlation 2 [86]:

InfoMC2
•

,

Homogeneity 1 [89]:

Homogeneity1

•

,

1

Inverse difference moment normalized [89]:
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,

InDiffMomNorm

|

1

•

Inverse difference moment [86]:

InDiffMom

•

1

,

1

Inverse difference normalized [89]:

,

InDiffNorm

|

1
•

,
|

|

Max probability [89]:
MaxProb

•

,

Sum average [86]:

SumAverage

•

Sum entropy [86]:

SumEntropy

•

|

Inverse variance [89]:

InVariance

•

|

Sum variance [89]:

log

,
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Sum entropy

SumVariance

•

Variance [89]:

,

Variance

Gray Level Run Length Features
The gray level run length matrix (GLRLM), similar to the GLCM, is used to define texture in an image by
considering strings of consecutive voxels that have similar gray values along a given direction [90]. As
with the GLCM, 13 individual 3D directions as well as the 2D and 3D summed GLRLMs were calculated.
is the maximum number of gray levels in the image and

is the number of different run lengths

in the image.
gray level run length matrix for an image I of size

is a

,

displacement

,

along a given

.

is the total numer of voxels in the image which can be extracted from
∑

∑

The sum of

,

.

serves as a normalizing factor and is defined as

GLRLM Feature List:
•

Short Run Emphasis [90]:

SRE

1

,

∑

∑

,

using
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•

Long Run Emphasis [90]:

1

LRE

•

Gray Level Nonuniformity [90]:

1

GLNU

•

,

Run Length Nonuniformity [90]:

1

RLNU

•

,

,

Run Percentage/Fraction [90]:

Fraction

•

Low gray‐level run emphasis [91,93]:

•

High gray‐level run emphasis [91,93]:

HGRE

•

,

1

LGRE

1

Short run low gray‐level emphasis [92,93]:

,
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•

,

1

SRLGE

Short run high gray‐level emphasis [92,93]:

SRHGE

•

1

,

1

,

Long run low gray‐level emphasis [92,93]:

LRLGE

•

Long run high gray‐level emphasis [92,93]:

LRHGE

1

,

Neighborhood Gray‐Tone Difference Features
The neighborhood gray‐tone difference matrix (NGTDM) defines texture in an image by calculating the
average gray level difference between each voxel and its neighboring voxels [94]. Each neighborhood
was defined by considering only immediately adjacent voxels (i.e. distance = 1) in both two and three
dimensions.
is the maximum number of gray levels in the image.

,

is the actual number of gray levels in the image (i.e. counting only the different gray levels

that occur in the image).
Generalized to 3 dimensions, the average gray level (or gray‐tone) of a voxel contained within the
region of interest over a neighborhood centered at but excluding

, ,

is:
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1

, ,

Where

2

,

1
,

1

,

,

,

∉

, ,

,

0

accounts for any voxels that are

not included in the possibly irregularly shaped ROI.
1 neighborhood gray tone difference

is the set of all voxels with a gray level , such that the
matrix is:

, for ∈

if

0

0, otherwise

NGTDM Feature List:
•

Coarseness [94]:

Coarseness

•

Contrast [94]:

Contrast

•

1
,

1

,

Busyness [94]:

Busyness

•

1

∑
∑

,

∑

0,

0

Complexity [94]:

Complexity

|

|

,

0,

0
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•

Strength [94]:

Strength

∑

∑

,

∑

0,

0

Laws' Filtered Features
Laws' filters are a series of 5 one dimensional spatial filters that are convolved with the image to
emphasize textural structure [95]. Fifteen pairs of the Laws' 1x5 filters were applied to each axial slice
of the image.
The Laws filters utilized are:
Level 5: L5

1

Energy 5: E5

1

Spot 5: S5

1 0

Wave 5: W5
Ripple 5: R5
Image of size

4

2 0
0

1
1

0

2

1

4

6

4

1

1

is the number of voxels of the

Mean:

Mean

Variance:

2

1 2

LAWS2D Feature List:

•

2

1

with a total number of voxels, .

is the ordered image histogram, where

•

6 4

1

gray level.
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1

Variance

•

1

Skewness:
1
Skewness

•

1

∑

Kurtosis:
1
Kurtosis

•

∑

1

∑
∑

Energy:

Energy

•

Root mean square:

Root mean square

∑

Entropy and Uniformity are both calculated after linearly downsampling the image bit depth to 8 (i.e.
256 gray levels).
•

Entropy:

Entropy

•

Uniformity:

log
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Uniformity

Lung‐Specific CT Features
Multiple methods have been proposed to quantify COPD in patients using CT by representing the
volume and cluster density of low attenuation areas in the lung.
Image of size

with a total number of voxels, , with voxel volume .

is the ordered image histogram, where

is the number of voxels of the

LUNG Feature List:
•

Mode [76]:
Mode

•

gray level with the highest frequency

Volume of low attenuation area voxels below ‐856 HU [100]:

⋅

•

Percent volume of low attenuation area voxels below ‐856 HU [100]:

%

•

1

⋅

Volume of low attenuation area voxels below ‐864 HU [76]:

⋅

•

Percent volume of low attenuation area voxels below ‐864 HU [76]:

gray level.
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%

•

1

⋅

Volume of low attenuation area voxels below ‐900 HU [98]:

⋅

•

Percent volume of low attenuation area voxels below ‐900 HU [98]:

%

•

1

⋅

Volume of low attenuation area voxels below ‐910 HU [70,76,96]:

⋅

•

Percent volume of low attenuation area voxels below ‐910 HU [70,76,96]:

%

•

1

⋅

Volume of low attenuation area voxels below ‐960 HU [97,98]:

⋅

•

Percent volume of low attenuation area voxels below ‐960 HU [97,98]:

%

•

Volume of non‐emphysematous lung [98]:

1

⋅
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Reserve

•

⋅

Percent volume of non‐emphysematous lung [98]:

%Reserve

1

⋅

Using thresholds of ‐910 HU and ‐960 HU, emphysematous lesion clusters were defined using 26‐
neighbor connectivity. We let

denote the volume of the

cluster where

of clusters at a given HU threshold.
•

Number of clusters below ‐910 HU [99]:
Cluster Count

•

Mean volume of clusters below ‐910 HU [99]:

1

Mean Cluster Volume

•

Standard deviation of volume of clusters below ‐910 HU [99]:

Std Cluster Volume

•

1
1

Number of clusters below ‐960 HU [97]:
Cluster Count

•

Mean volume of clusters below ‐960 HU [97]:

Mean Cluster Volume

1

is the total number
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•

Standard deviation of volume of clusters below ‐960 HU [97]:

1

Std Cluster Volume

1

A power law relationship was used to describe the relationship between the cumulative number of
cluster lesions

and the lesion volume

such that:
⋅

Least squares regression of log

versus log

gives estimates of the fit parameters

•

Power law slope for emphysematous lesion clusters below ‐910 HU [99]:

•

Power law intercept for emphysematous lesion clusters below ‐910 HU [99]:

•

Power law slope for emphysematous lesion clusters below ‐960 HU [97]:

•

Power law intercept for emphysematous lesion clusters below ‐960 HU [97]:

and .
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APPENDIX 2: DOSIMETRIC FEATURE EXTRACTION
Dose array
•

of size

with a total number of voxels, , and voxel volume, .

Sum:

Sum

•

Mean:

1

Mean

•

Minimum:
Minimum

•

Maximum:
Maximum

•

Variance:

Variance

•

1
1

Skewness:
1
Skewness

•

Kurtosis:

1

∑
∑
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1
Kurtosis

•

1

∑
∑

Range:
Range

•

Mean absolute deviation:
MeanAbsDeviation

•

Median absolute deviation:
˜

MedianAbsDeviation
•

Interquartile range:
IQR

•

%

%

Energy:

Energy

•

Root mean square:

RMS

For x = 5‐100 Gy or 5‐100% volume:
•

Absolute volume receiving at least x Gy:

∑
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•

Percent volume receiving at least x Gy:

•

Minimum Dose to the hottest x% volume:

•

Mean Dose to the Coldest x% volume:

•

Mean Dose to the Hottest x% volume:

For multiple values of

on the range

0.15 to 1/0.15 :

*Generalized Equivalent Uniform Dose [184,202]:
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